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Livestock animals are an ancient, vital renewable natural resource. Many livestock 
species have the ability to convert inedible crops and waste food into food fit for human 
consumption, in the form of meat, eggs and dairy products. As the global demand for 
high value animal protein is ever increasing, the livestock market continues to play a 
major role in worldwide economics.   
Animal disease has the potential to be a huge burden on the livestock industry, 
impacting both welfare and production. Major outbreaks of transboundary diseases, 
such as foot and mouth disease, rinderpest and classical swine disease, have resulted 
in devastating global economic losses. As a result, scientific research is engaged in 
lowering this impact by generating effective preventative measures and treatments. 
One way to reduce livestock disease is to select animals that are genetically resistant, 
traditionally carried out through selective animal breeding programs; however, this is 
a time-consuming process and requires that appropriate genetic variation exists within 
the population. Advances in genome engineering technologies offer us an alternative 
approach, with the capability to make genetic improvements in livestock within a 
single generation. It is hypothesised that resilience to a disease, known as African 
swine fever (ASF), could be genetically engineered into the domestic pig. 
ASF is a highly contagious disease of domestic pigs and is a re-emerging global threat 
to the swine industry. It is a lethal haemorrhagic disease caused by a virus, known as 
the African swine fever virus (ASFV). At present, there is no vaccine or treatment for 
ASF, and disease control relies on rapid diagnosis, quarantine and the mass slaughter 
of animals. Unlike the domestic pig, swine indigenous to Sub-Saharan Africa, such as 
the warthog, show no clinical signs of disease following infection with ASFV. A 
comparative study was carried out to identify host genetic variation that could underlie 
the difference in response to ASFV, with candidate genes selected based on their 
potential involvement with the viral protein A238L, involved in immune evasion. 
Functional polymorphisms where identified in the porcine RELA gene, encoding 
RelA, a subunit of the NF-κB transcription factor family. This evolutionary conserved 
protein family plays a vital role in mediating inflammatory and immune responses. 




within the C-terminal transactivation domain of RelA which have been found to 
modulate NF-κB transcriptional activity in vitro. We set out to investigate whether 
genome editing tools could be employed to engineer the RELA sequence of domestic 
pigs. Initial attempts targeted the final exon of RELA, producing animals with a 
truncated RelA protein; modified animals lack the final 60 amino acids of the C-
terminal transactivation domain. The aim of this thesis was to genotype and 
characterise the effects of this RELA modification at a molecular, cellular, 
morphological and whole organism level. The ultimate goal of this project was to 
investigate whether this RELA modification altered the domestic pig’s response to 
ASFV in vitro and in vivo. 
Unlike rela-/- mice which have an embryonic lethal phenotype, these RELA-edited 
pigs were born healthy and were fully viable when housed in a typical farm 
environment. Phenotypic analysis of lymphoid tissues from the RELA-edited pigs 
demonstrated no significant anatomical or histological changes compared to 
unmodified counterparts. Pigs homozygous for the RELA mutation had a significantly 
lower body weight compared to wild-type pigs. Molecular studies of samples from 
these pigs have shown that the modified RelA has an altered activity; however, the 
RELA modified pigs do develop the characteristic disease phenotype when challenged 
with ASFV. Finally, genome editors have been developed to introduce a specific 
warthog allele into the domestic pig RELA locus, these editors are currently being 
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Chapter 1  General Introduction 
1.1 Global importance of livestock 
Farm animals are an important global provider of human livelihoods and source of 
high quality dietary protein. Many livestock species, such as pig, goat, cattle and 
chickens, have the ability to convert inedible crops and waste food into food fit for 
human consumption. Moreover, ruminants often graze on land that is unsuited to 
arable crops, accounting for ~75% of total agricultural land (Oltjen et al., 1996). Of 
course, some land utilised currently for livestock could be used for biomass production 
for energy or to grow crops for human consumption. A major disadvantage of livestock 
production is the impact it has on climate change, currently representing 14.5% of all 
human induced CO2 emissions (Gerber et al., 2013). Despite this, there is an ever-
increasing global demand for high value animal protein, driven by a combination of 
factors, including population growth, rising affluence and increasing levels of 
urbanisation. Livestock also provides an estimated one billion poor people in 
developing countries with food security and income (Herrero et al., 2013). 
The global population is projected to reach up to 9.2 billion people by 2050. If the 
current trend for livestock products remains, this is estimated to lead to an increase in 
demand for livestock products by 70% by 2050 (Robinson, 2014). There is an ever-
increasing pressure on the livestock sector to meet these demands, therefore there is 
particular focus on increasing the sustainability by increasing production efficiencies 
at animal and herd level to reduce impact on climate change, biodiversity and use of 
land and water resources. 
1.2 Traditional breeding and selection 
For centuries humans have bred livestock with the intention of improving desirable 
qualities in the next generation. Even before a knowledge of genetics, a selective 
breeding approach was used to improve livestock by selecting parents with a particular 
desired characteristic. This led to the generation of a wide variety of livestock breeds 
and animal pedigrees being recorded for individuals. As our awareness of genetics 




quantitative statistics and genetic information derived from pedigrees. Another 
development in animal breeding was the use of artificial insemination, allowing a 
single father to parent more offspring. These methods accelerated livestock 
productivity however led to an increase in inbreeding over time (Daetwyler et al., 
2007, Clark et al., 2013). Increased inbreeding rate led to a reduction of genetic 
variation within a population, often resulting in an increased risk of disease and lower 
productivity (Croquet et al., 2006, Norberg & Sørensen et al., 2006, Yavarifard et al., 
2014, Eteqadi et al., 2015). Currently, many breeding companies use DNA markers to 
estimate breeding values and selectively breed to maintain genetic diversity alongside 
genetically improving breeds (Garrick., 2011, Bouquet & Juga., 2013). 
1.3 Animal transgenesis 
Our ability to manipulate the genomes of cells and organisms has become fundamental 
to scientific research, aiding our understanding of biology processes and offering 
potential solutions to problems in human health, biosecurity and climate change. 
Genetically modified organisms (GMOs) are organisms that have had either a segment 
of foreign DNA inserted into, or a modification made to, their genomic sequence. 
Escherichia coli transformed with exogenous DNA were the first reported GMOs 
(Cohen et al, 1972; Jackson et al, 1972). Subsequently, the transfer of genetic material 
has been carried out in multicellular eukaryotes, including nematodes (Stinchcomb et 
al., 1985), plants (Bevan et al., 1983), insects (Rubin et al., 1982), fish (Maclean et al., 
1987), birds (Bosselman et al., 1989) and mammals, including mice (Jaenisch & 
Mintz., 1974), sheep (Hammer et al., 1985) pigs (Hammer et al., 1985) and primates 
(Chan et al., 2001). 
In 1981, a technique known as pronuclear injection (PNI) was used to inject DNA into 
the pronuclei of mouse zygotes to produce transgenic mice with foreign DNA stably 
incorporated into the genome, which was passed down to progeny through the 
germline (Gordon & Ruddle., 1981; Brinster et al., 1981). This technique was 
subsequently used to produce transgenic livestock (Hammer et al., 1985). Initial efforts 
in transgenic livestock research focussed on producing animal bio-reactors for 
pharmaceuticals, by transferring genes encoding a significant human bio-medical 




the transgenic animal (Simons et al., 1987, Clark et al., 1998). PNI requires a high 
level of technical expertise for success and its inefficiency of producing founder 
animals proved very expensive, especially for large mono-zygotic animals. Despite 
this, the production of many transgenic livestock species has been accomplished 
through random integration of naked DNA introduced using PNI into single-cell 
embryos (Lo et al., 1991., Golovan et al., 2001, van Berkel et al., 2002). However, 
techniques utilising viral vectors and transposons soon came to be the preferred 
method to generate transgenic animals as this significantly increased gene transfer 
efficiencies (Chan et al., 2001). These techniques rely on random integration of the 
transgene into the genome, which can be error-prone and unpredictable. A significant 
breakthrough was made with the development of gene targeting through homologous 
recombination (HR), which made precise manipulation of the genome possible. 
HR-mediated targeting involves the exchange of nucleotide sequences between two 
similar or identical DNA molecules. In this way, precise changes can be introduced at 
a specific site in the genome, permitting the production of gene knock-in and gene 
knock-out animal models. However, the frequency of HR-mediated targeting in 
mammalian cells is extremely low. The inefficiency of this method makes it 
impractical for use in zygotes for the production of transgenic animals. However, by 
incorporating a selectable marker in the HR construct, and performing HR-mediated 
targeting and artificial selection in vitro, transgenic cells can be selected for embryo 
production. Furthermore, strategies involving a site-specific recombinase system, 
known as Cre-Lox recombination, can be utilised to remove undesired marker genes 
following targeting (Hamilton & Abremski, 1984). This has been demonstrated for the 
production of transgenic animals using embryonic stem (ES) cells and induced 
pluripotent stem (iPS) cells (Thomas and Capecchi, 1987, Doetschman et al., 1987, 
Tong et al., 2010, Okita et al., 2007). Stem cell lines retain the capacity to differentiate 
into a range of embryonic tissue types in culture. Hence, they can be modified and 
screened in vitro before transferring to an early stage host embryo to contribute to 
further development. This method generates chimeric founder animals where tissues 
derived from the in vitro modified stem cells will contain the desired modification, 
which is often present in the germ cells. However, at present this resource only exists 




To date, the robust culture of livestock stem cells is yet to be established, however 
somatic cell nuclear transfer (SCNT), more commonly referred to as cloning, gives an 
alternative route to produce transgenic livestock (Wilmut et al, 1997). Utilising the 
SCNT technique the nucleus of a transgenic cell can be used to reconstitute an 
enucleated oocyte for embryo production. Gene targeting and screening can be 
achieved in primary somatic cells in culture, following similar methodologies used in 
stem cell lines. SCNT has permitted the generation of livestock with HR-targeted 
genetic modifications (Denning et al., 2001, Yu et al., 2006, Richt et al., 2007). 
However, the efficiency of producing live animals by SCNT is low and it is technically 
challenging, few laboratories have acquired the technical expertise required for 
successful livestock cloning.  
The development of a group of tools collectively known as genome editors has been 
transforming the field of animal genetic modification (for a detailed discussion on 
Genome editing see Section 1.4). In brief, genome editors are programmable nucleases 
which can be utilised to induce a double strand break (DSB) at a specific DNA target 
site. DSBs are known to induce endogenous repair mechanisms which in turn can 
increase the efficiency of site specific genome modification through two broad 
mechanisms; non-homologous end joining (NHEJ) or homology dependent repair 
(HDR). Most often DSBs are repaired by NHEJ, an error-prone process frequently 
leading to small insertions or deletions, however if a repair template is available the 
DSB can be repaired by HDR; this mechanism is sought to achieve precise changes at 
a target site. This technology can be used to introduce site-specific mutations without 
leaving any other genetic marks on the genome, with the potential to induce 
modifications that are indistinguishable from naturally occurring mutations. These 
programmable nucleases have boosted the activity of research in the field of large 
animal transgenics in part due to the high efficiencies of targeted mutagenesis 
achieved. The efficiencies are high enough that it is no longer necessary to perform 
targeting and selection in vitro before embryo production. Furthermore, genome 
editors can even be injected directly into zygotes for efficient production of transgenic 




With advances in genotyping and sequencing technologies, livestock companies are 
successively collecting more and more genomic data. In turn, analysis of allelic 
sequence variation is leading to an increased understanding of the genetics underlying 
desirable traits. With current genome editor techniques, it is possible to introduce 
genetic changes to remove alleles associated with deleterious traits and increase 
desirable alleles associated with favourable traits. Genetic improvement of livestock 
via transgenesis has many benefits over traditional selective breeding methods as it 
permits; 1) the fixation of alleles without any deleterious inbreeding effects 2) the 
introduction of alleles that are not present in the population 3) the desired genetic 
change within one generation.  
Thus far, genetic engineering in livestock species has been used for the following 
applications; as bio-reactors for human pharmaceuticals (Liu et al., 2013), for human 
disease models (Tan et al., 2013), for xenotransplantation (Hauschild et al., 2011; Li 
et al., 2015) and to improve livestock for agricultural proposes, for example enhanced 
productivity (Luo et al., 2014, Proudfoot et al., 2015), disease resistance (Liu et al., 
2014, Wu et al., 2015, Whitworth et al., 2016, Burkard et al., 2017) or animal welfare 
(Tan et al., 2013, Carlson et al., 2016). 
1.4 Genome engineering  
Genome engineering tools, such as the zinc finger nucleases (ZFNs), transcription 
activator-like effector nucleases (TALENs) and the Clustered regularly interspaced 
short palindromic repeats (CRISPR)/Cas 9 system, allow us to modify the genomes of 
living cells and organisms with unprecedented ease and accuracy. Applications 
utilizing these tools are bringing forward a new era of biological understanding and 
control. 
Advances in sequencing technologies has progressed faster than our understanding of 
gene functions, and with the increasing availability of whole genome sequences, many 
genetic differences underling the predisposition to various diseases and traits have 
been identified. In scientific research, genome engineering tools are often used to the 
study these differences and investigate gene functions. In addition to research, these 




crops and livestock, and in medicine, for modelling and treating human disease. To 
date most human therapeutic applications of genome engineering are pre-clinical, 
however the few that have progressed into clinical trials have thus far shown success; 
these include genome engineering of T-lymphocytes to protect against HIV and treat 
cancers (Tebas et al., 2014, Qasim et al., 2015, McGranahan et al., 2016, Cyranoski., 
2016).  
Genome editors consist of two principle components; 1) a customisable DNA-binding 
molecule, currently either a protein or RNA, and 2) an endonuclease which relies on 
the DNA-binding molecule to direct its cleavage specificity. When introduced into a 
cell, genome editors induce double-strand breaks (DSBs) at their target DNA locus. 
These breaks, in turn, stimulate the cell’s DNA damage response and eventual repair 
of the DNA. In this way, programmable nucleases rely in part on the cells innate repair 
mechanisms to generate desired genetic modifications. 
Genome engineering tools can also be used for regulating gene expression; in this case 
the nuclease component is modified or replaced with a domain which acts as a 
transcriptional activator or repressor or acts to install or remove epigenetic marks 
(Konermann et al, 2013; Mendenhall et al, 2013; Gilbert et al, 2014; Konermann et al, 
2015; Vojta et al, 2016). In this chapter, I will primary discuss the use genome 
engineering tools to edit the genome via the induction of DSBs.  
1.4.1 DNA double strand break (DSB) repair 
DSBs, although common, can inflict critical damage to the cell. DSBs as the name 
suggests, are induced when DNA breaks are generated in both complementary strands 
of the DNA double helix simultaneously, as a consequence the two broken DNA ends 
are vulnerable to dissociating from one another, posing a major threat to the genomic 
integrity of the cell. Despite their potential lethality, DSBs occur frequently in the 
genome; known causes include reactive oxygen species, endogenous nucleases, 
ionizing radiation, and programmed genomic rearrangements. The cell has many 
mechanisms in place to repair such damage. Following the formation of a DSB, there 




genome, involving either homology-directed repair (HDR) or non-homologous end 
joining (NHEJ) at the cut site. 
Genome editors are used to generate DSBs at a specific genomic site, subsequent 
exploitation of the cells innate DSB repair mechanisms allows the creation of desired 
genetic changes. In order to knock-out or disrupt a gene, the NHEJ repair pathway is 
ideal as it is error prone, typically introducing small insertions or deletions (indels) at 
the site of repair. These mutations often lead to a frameshift of an open reading frame, 
introducing premature stop codons that can result in either degradation of mRNA 
transcripts following detection by the cells nonsense-mediated decay (NMR) 
surveillance system or translation termination leading to a truncated protein with 
reduced or ablated activity. If a precise change is desired to modify a gene of interest, 
the genome editors are introduced alongside a donor DNA template, which contains 
the desired changes within a sequence that is homologous to the sequences flanking 
the DSB, which is incorporated into the genome by the HDR pathway. In addition, 
DSBs can be used to induce chromosomal rearrangements and delete specific genomic 




Figure 1.1 Potential applications of genome editors. A) Genome editor induced 
DSBs can lead to precise changes in the genome if repaired by the HDR pathway 
using a donor template containing the desired changes (red box) surrounded by 
sequence homologous to target. DSBs can also be repaired through error prone 
NHEJ, often leading to small indels. B) Two DSBs can be induced on the same 
chromosome to generate a large deletion or inversion. C. Two DSBs generated 
on two different chromosomes can induce chromosomal translocations. Figure 





Non-homologous end joining 
NHEJ is the predominant mechanism for DSB repair in multicellular eukaryotes. 
NHEJ repair is vital for the development of our immune system as the antibody 
maturation process relies on repair of programmed DSBs to make DNA 
rearrangements, known as V(D)J recombination and class switch recombination, in 
lymphocytes. In short the NHEJ repair mechanism involves modifying the broken 
DNA ends and making them compatible for re-joining, it is often imprecise and leads 
in the introduction of small deletions or insertions at the site of damage. 
The best understood mechanism of NHEJ is known as the canonical non-homologous 
end joining (C-NHEJ) pathway. This pathway relies on the Ku70-Ku80 heterodimer, 
which binds the broken DNA ends forming a ring providing protection from further 
degradation and recruiting other NHEJ factors required for repair. Early NHEJ repair 
factors often include DNA-PKcs–Artemis nuclease, DNA polymerases μ and λ, and 
DNA ligase IV-XX (Lieber et al, 2010). The DNA-PKcs–Artemis nuclease and DNA 
polymerases μ and λ process the broken DNA ends in preparation for ligation by the 
DNA ligase IV-XX to re-seal the break. C-NHEJ does have the potential to accurately 
repair DSBs if the broken ends of the DNA are fully complementary. However, most 
breaks typically do not possess such complementary ends and the process proceeds 
with the annealing of short (1-4 nucleotide) homologous sequences resulting in small 
(1-4bp) insertions or deletions in the repaired sequence (Lieber et al, 2010).  
Mechanisms of NHEJ that do not require the Ku70-Ku80 heterodimer have be termed 
alternative-non-homologous end joining (A-NHEJ) or micro-homology-mediated end 
joining (MMEJ). The distinguishing feature of MMEJ is the use of 5-25 nucleotide 
homology sequences, known as micro-homologous sequences (McVey et al, 2008). 
These sequences anneal with one another and all the additional nucleotides are 
removed and gaps are filled in, often resulting in longer deletions and insertions 
compared to the C-NHEJ pathway (McVey et al, 2008). For a detailed review on the 






Homology Directed Repair 
HDR is the cells method of repairing DSBs largely error free, for this it requires a 
homologous DNA template. In multicellular eukaryotes HDR typically occurs only in 
late S/G2 and M phases of the cell cycle, when sister chromatids are optimally 
positioned to be used as templates. NHEJ is supressed during late S/G2 stages of the 
cell cycle promoting the HDR pathway for repair of DSBs (Zhang et al., 2009, Davis 
el al., 2014). Moreover, the complexity of chromatin structure at the position of the 
DSB influences the DNA repair pathway choice (Goodarzi et al, 2010). 
There are a number of HDR repair mechanisms, however all share a set of core 
biochemical steps; the first step is termed ‘end resection’ where repair of a DSB is 
initiated by nucleolytic processing of the 5’-terminal DNA ends. The end resection 
process commits the repair of the DSB to HDR, as the long 3'-single stranded DNA 
tails it generates are poor substrates for NHEJ (Symington et al, 2016). The sequence 
of these 3’-ssDNA tails defines the homologous pairing. Once the 3’-ssDNA tails have 
been generated they act as a scaffold for the assembly of the RecA (in prokaryotes) or 
Rad51 (in eukaryotes) proteins into long helical filaments. Combined they form a 
nucleoprotein filament that promotes the search for complementary sequence, then 
catalyses the exchange of DNA strands, known as strand invasion. The invading strand 
is subsequently repaired via extension by polymerases and annealing to the end of the 
break, forming four-stranded DNA intermediate structures known as Holliday 
junctions, which are disjoined by either nucleolytic resolution or topological 
dissolution. The described mechanisms are conserved in most phage, prokaryotic and 
eukaryotic organisms (Kuzminov et al., 1999, Kreuzer et al., 2000, Seitz et al., 2001, 







1.4.2 Genome editors  
Genome editors are used to induce a DSB in the DNA at a given target locus. Each 
genome editor consists of two main components; a customisable DNA-binding 
molecule, which is usually a protein or RNA molecule, and an endonuclease which 
relies on the DNA-binding molecule for its cleavage specificity. So far such 
customisable DNA binding molecules have been derived from eukaryotic zinc finger 
proteins (ZFs), prokaryotic TALE (transcription activator-like effectors) proteins and 
the prokaryotic derived CRISPR (clustered regularly interspaced short palindromic 
repeat)/Cas9 (CRISPR-associated protein 9 nuclease) system. Each will be discussed 
here in order of discovery. 
Zinc Fingers (ZFs) 
Zinc Finger (ZF) domains were first described as the DNA-binding motif in 
transcription factor TFIIIA from the African clawed frog (Xenopus laevis) (Miller et 
al., 1985). This motif comprised of nine repeating units, of approximately 30 amino 
acids length, each unit was folded around a zinc ion forming individual protein 
structures which bound to the DNA, these structures were thought to resemble fingers, 
hence their name, Zinc Fingers (Klug et al., 1987). ZF domains have since been 
identified as a common DNA binding domain of eukaryotic transcription factors and 
the rules underlying their DNA recognition have been uncovered leading to the 
creation of ‘programmable’ synthetic DNA binding motifs. 
The Cys₂His₂ class of ZF domains is one of the largest families found in eukaryotes 
and recognise a diverse set of DNA sequences. A single Cys₂His₂ zinc finger unit is 
composed of a two-stranded antiparallel β-sheet, containing a loop made by two 
cysteine residues, and an alpha helix containing two histidine residues. The two 
distinct secondary structures are held together by a small hydrophobic core. The zinc 
ion is contained within this core, coordinated by the conserved cysteine and histidine 
residues (Neuhaus et al., 1992; Nakaseko et al., 1992; Figure 1.2.A). The crystal 
structure of a zinc finger domain bound to its DNA target, revealed that each zinc 




3 or 4 amino acids located within the alpha helix (Pavletich et al., 1991, Elrod-
Erickson., 1998). Adjacent zinc finger units are joined together by flexible linkers 
allowing the recognition of varying lengths of DNA sequences (Neuhaus et al., 1992). 
The Cys₂His₂ class of ZF motifs were identified as an attractive candidate for 
designing customisable DNA-binding proteins due to the following factors; DNA 
recognition is made principally via individual amino acids to an individual DNA base, 
each finger unit can have different triplet specificities, single fingers act as independent 
modules and can be linked together to give specific recognition of longer DNA target 
sequences. 
FokI nuclease 
FokI bacterial type II restriction endonuclease, was first discovered in Flavobacterium 
okeanokoites (Li et al, 1992). In its natural form, it comprises of an N-terminal DNA 
binding domain which recognises 5’-GGATG-3’ sequences and a C-terminal non-
specific DNA cleavage domain (Hiroyuki and Susumu, 1981; Li et al, 1992). When 
FokI dimerises, the cleavage domain becomes active and cleaves the target DNA 9 
base pairs downstream of the recognition site (Wah et al, 1998).  
It was first reported in 1994, that the FokI non-specific DNA nuclease domain could 
be fused to an alternative DNA binding domain, enabling the creation of a hybrid 
restriction enzyme (Kim and Chandrasegara, 1994). This discovery was key for the 
development of both ZFNs and TALENs. The FokI endonuclease domain has been 
modified for optimal use in these genome editor systems, a number of point mutations 
were introduced to increase the cutting efficiency and specificity of the editors. A 
commonly used modified FokI has been dubbed ‘Sharky’, it contains two point 
mutations, S418P and K441E, which confer an increase in activity when compared to 
wild-type FokI of up to 15-fold (Guoetal, 2010). 
Zinc finger nucleases (ZFNs) 
The customisable ZF domains were fused to the FokI endonuclease to create ZFNs, 
one of the first representatives of a new generation of tools termed ‘genome editors’. 
A pair of ZFNs are required for a DSB to occur as the FokI nuclease domain must 




together the two FokI nuclease domains, ZFNs are designed to bind opposite sides of 
the DNA target in an inverted position, separated by 5-7 nucleotides (Figure 1.2.B). 
Once both ZFNs have bound their DNA target, the Fok1 nuclease can dimerise and 
induce a DSB. This requirement for a pair of ZFNs increases the length of recognition 
sequence thereby increasing the accuracy and reducing the probability of cutting at 
non-target sites. In principle, a pair of ZFNs, each composed on three zinc fingers will 
recognise a sequence of 18 nucleotides which is sufficient specificity for targeting a 
single site in a genome.  
Figure 1.2 ZFNs. A) Single zinc finger structure B) Schematic diagram of ZFN 
pair bound to DNA. Each ZF domain interacts with three nucleotides. The two 
FokI endonucleases are required to dimerise before induction of a double strand 





Synthetic zinc finger domains have been produced that recognise all possible 5’-GNN-
3’, 5’-ANN-3’, 5’-CNN-3’ DNA triplets, where N represents any base (Segal et al., 
1999; Dreier et al., 2000; Dreier et al., 2001). However currently only a few ZFs have 
been developed to recognise 5’-TNN-3’ DNA triplets (Dreier et al., 2005).  
ZFN pairs have been designed and successfully used for modifying the genomes of 
various different species including drosophila (Bibikova et al., 2002), silkworm 
(Morton et al., 2006), zebrafish (Meng et al., 2008), mouse (Meyer et al., 2010), pig 
(Hauschild et al., 2011), cow (Liu et al., 2014), sheep (Zhang et al, 2014) and human 
(Porteus and Baltimore, 2003). Despite this widespread success of ZFN targeting, this 
technology has many limitations. Initially, it was thought that each zinc finger module 
could be linked together to gain the desired specificity, however production of ZFNs 
in this way lead to high failure rates likely due to context dependent behaviour i.e. the 
ZF DNA-binding efficacy fluctuated depending on the neighbouring ZF module 
(Ramirez et al., 2008). The interactions between ZF units has complicated the design 
process however a number of context-sensitive selection approaches exist to 
efficiently generate active ZFNs (Maeder et al. 2008). These strategies involve the 
construction of large randomised zinc finger libraries followed by selection to identify 
ZF combinations that work well together. Constructing ZFNs requires specialised 
expertise and is often labour intensive. Researchers that choose to use ZFNs, often 
purchase them from commercial biotechnology companies which can be expensive 
(Scott, 2005). 
Transcription Activator-Like Effectors (TALEs) 
Transcription activator-like effectors (TALEs) are proteins which originate from 
bacteria belonging to the Xanthomonas family, which infect plants (Bonas et al, 1989). 
Naturally occurring TALE proteins are virulence factors secreted by the 
proteobacteria, they are injected into plant cells where they enter the nucleus and bind 
specific DNA promoter sequences to activate transcription of host genes. In 
susceptible plants, TALEs manipulate host gene expression to benefit bacterial 
virulence. Each TALE protein consists of a DNA-binding motif flanked by an N- 




which is required for activating transcription of host genes and for nuclear localisation 
(Römer et al., 2007). 
The DNA binding motif is often referred to as the central repeat domain, it consists of 
repeating units of 33-35 amino acids. Each TALE repeating unit is identical with the 
exception of two amino acids at positions 12 and 13, known as the repeat variable di-
residues (RVDs). These RVDs define each unit’s binding specificity for a single base 
pair in the target DNA (Moscou et al., 2009). Structural studies of TALE DNA-binding 
domains bound to their DNA target sites revealed that each repeating unit is composed 
of two α-helices linked by a short loop containing the RVDs. Each unit forms a 
superhelical structure around the DNA with the RVDs positioned in the major groove, 
residue 12 is involved in stabilising this contact and residue 13 makes the base-specific 
contacts (Deng et al., 2012; Mak et al., 2012). The number of the TALE repeating units 
is typically 13-28, the RVDs they contain determines the length and nucleotide 
composition of the target sequence each TALE recognises. Common RVDs include 
amino acids NI, HD, NG and NN, which recognise A, C, T and G/A bases respectively 
(Bosh et al, 2009). This simple DNA recognition pattern and modular nature of TALEs 
makes them ideal for the generation of designer DNA binding domains for use in 
genome editors. 
Transcription Activator-Like Effector Nucleases (TALENs) 
In 2010, transcription activator-like effector nucleases (TALENs) brought about a new 
generation of ‘customable’ DNA-binding proteins (Christian et al., 2010). TALENs 
contain the FokI endonuclease domain, engineered in ZFN development, fused to the 
DNA binding motif of the TALEs adapted to recognise a specific DNA target. 
TALENs, like ZFNs, are employed in pairs to allow dimerization of the FokI 
endonuclease domains (Figure 1.3).  
TALENs have been successfully used in a wide-range different species, including rice 
(Li et al, 2012), drosophila (Liu et al., 2012), zebrafish (Huang et al, 2011), frog (Lei 
et al., 2012), mouse (Wefers et al., 2013), rat (Tesson et al., 2011), pig and cattle 
(Carlson et al., 2012), to induce targeted DNA modification. Comparative in vitro 
studies between TALENs and ZFNs targeting the same locus have revealed that both 




lower cytotoxicity effects (Mussolino et al., 2014; Dreyer et al., 2015). TALENs have 
grown in popularity due to their relative ease in design and assembly compared with 
ZFNs. TALEs have a simple 1:1 interaction between a RVD code and a single 
nucleotide, compared to ZFs where multiple ZFs can bind a given nucleotide triplet. 
Furthermore, unlike ZFs, individual TALE repeats are largely independent of their 
neighbouring units, giving TALENs greater flexibility in their DNA recognition 
sequence (Cermak et al., 2011). However, TALENs aren’t without their limitations; 
genes encoding for TALENs are typically three times the size of those which encode 
corresponding ZFNs, often reducing the efficiency of vector delivery into cells in vitro 
(Holkers et al., 2013). Moreover, the generation of TALENs that contain a large 
number of repeating units can be challenging due to recombination stimulated by the 
high sequence homologies of each TALE unit (Briggs et al., 2012). 
Figure 1.3 TALENs bound to target DNA site. Each TALEN consists of the TALE 
DNA binding domain and a FokI nuclease domain. The TALE DNA binding domain is 
composed of TALE repeat units, shown as coloured ovals, each specifies for the binding 
of a single nucleotide, which is defined by two residues known as its hypervariable RVD 
motif. The amino acid sequence of a single TALE repeat is expanded with the two 
hypervariable residues highlighted in red. The TALE code is displayed in the table 
showing which RVD motifs target which base. Once the two TALENs bind the Fok1 





CRISPRs and CRISPR associated (Cas) proteins 
Clustered regularly interspaced palindromic repeats, more often referred to as 
CRISPRs, are part of an adaptive defence mechanism that protects bacteria against 
invading DNA viruses and plasmids. CRISPRs first described in the genome of E.coli 
as a repetitive series of palindromic sequences interspersed by short ‘spacer’ sequences 
(Ishino et al., 1987, Nakata et al., 1989). CRISPRs have since been discovered in a 
range of bacteria and archaea species (Mojica et al., 2000). It was observed that the 
‘spacer’ sequences in the array were of pathogenic bacteriophage or plasmid origins, 
which lead to the identification of CRISPRs as part of a prokaryotic immune response 
(Bolotin et al., 2005, Mojica et al., 2005, Pourcel et al., 2005). This heritable adaptive 
immunity is achieved in three following steps; 1) short sequences of invading nucleic 
acid are inserted into the CRISPR locus in the form of a ‘spacer’, 2) the CRISPR locus 
is transcribed and processed into small CRISPR RNAs (crRNAs), 3) mature crRNAs 
associate with the CRISPR associated (Cas) proteins and direct them their 
complementary sequences which the Cas proteins cleave (Barrangou & Marraffini., 
2014). 
Three broad CRISPR-Cas system types have been described, each utilising a distinct 
molecular mechanism to achieve DNA recognition and cleavage (Makarova et al., 
2011). The type I and III systems use a complex consisting of multiple Cas proteins to 
process crRNAs and cleave target DNA. By contrast, the type II system only requires 
a single large Cas protein, for RNA-guided recognition and cleavage of foreign DNA. 
This feature of the type II systems has proved extremely useful for the development of 
the CRISPR-Cas9 system as a tool for genome engineering (Gasiunas et al., 2012).  
CRISPR-Cas system 
The CRISPR-Cas9 editor system is the latest of the customisable genome editor 
approaches, and is currently the most widely used system for genome editing due to 
its efficiency and ease of use. The CRISPR-Cas9 editors consist of two molecules; a 
‘programmable’ guide RNA molecule that recognises the target site via Watson-Crick 





There are many different CRISPR-Cas systems described from varies prokaryotic 
species, however, currently the most widely used genome editor is the CRISPR-Cas9 
system adapted from Streptococcus pyogenes (Jinek et al., 2012). In the S. pyogenes 
system, an active CRISPR-Cas9 complex consists of three molecules; the S. pyogenes 
Cas9 (SpCas9) endonuclease, for DNA cleavage, the crRNA, for recognition of target 
DNA, and a trans-activating-crRNA (tracrRNA) that hybridises with the crRNA and 
facilitates in Cas9 binding. For genome engineering purposes, a chimeric RNA 
molecule is often used, known as single guide RNA (sgRNA), where the 3’ end of the 
crRNA is fused to the 5’ end of the tracrRNA, retaining critical features for Cas9 
binding and target recognition (Jinek et al., 2012). The target DNA sequence is 
specified by a 20nt sequence located in the crRNA portion of the sgRNA (Figure 1.4).  
A requirement for Cas9 cleavage is that the target DNA must have a protospacer 
adjacent motif (PAM) sequence adjacent to the crRNA-target. The PAM sequence is 
important in its natural system as it prevents autoimmunity as ‘spacer’ sequences 
within the CRISPR locus lack the adjacent PAM sequence required for Cas9 cleavage. 
Cas9 proteins isolated for various prokaryotic species contain differing PAM site 
requirements, however in the case of SpCas9 this is a 5’-NGG-3’, where N is any 
nucleotide (Sander & Joung., 2014). 
Figure 1.4 S. pyogenes Cas9-CRISPR complexes bound to target DNA. A) 
structure of Cas9 complexed in native form with dual-RNAs (tracrRNA & 
crRNA) bound to target DNA B) structure of Cas9 complexed with synthetic 
sgRNA and target DNA. The black triangles indicate the site of Cas9-induced 





The CRISPR-Cas9 system has proven to be simple and efficient, relying only on the 
design of a 20 nucleotide section of the synthetic sgRNA to direct the DSB induced 
by Cas9. Unlike the ZFN and TALEN systems, the protein component of the CRISPR-
Cas9 system, the Cas9, is constant, eliminating the need for protein design and 
construction. One constrain in designing CRISPRs is the requirement of the PAM site, 
however a different species of Cas9 can be utilised if there are no SpCas9 PAM sites 
in the desired sequence. Furthermore, SpCas9 has recently been adapted to have novel 
PAM specificities, allowing more choice of targetable sequences (Kleinstiver et al., 
2015, Anders et al., 2016). The SpCas9 protein has also been modified to increase its 
DNA specificity and therefore reduce off-target effects by altering the amino acids 
involved in non-specific contact with the DNA (Kleinstiver et al., 2016).  
 
1.5 Global importance of domestic swine 
The species Sus scrofa encompasses all domestic pigs, including wild boar, and forms 
part of the Suidae family of the Cetartiodactyla order, which originate around 20 
million years ago (Frantz et al., 2015). Phylogeny analysis of S.scrofa revealed that 
different populations diverged over a million years ago (Figure 1.5). The 
domestication of S.scrofa began approximately 9-10 thousand years ago in two 
independent locations, in Europe and in China, which has resulted in the many modern 
European and Chinese varieties we have today (Groenen., 2016). 
Domestic pigs are an important source of human dietary protein in many countries, 
particularly where the production of beef cattle is difficult. Pigs efficiently convert 
human food waste and by-products into high quality protein. The demand for pork has 
been rising as a result in differing consumption patterns of nations where incomes are 
increasing in developing countries with fast growing economies. Together with 
poultry, the pig sector is the fastest growing livestock sub-sector, supplying the world 
with over a 100 million tonnes of animal protein annually (FAOstats, 2016). Pig 
production is a global industry, with exception of regions where there are religious and 
cultural reservations on the consumption of pork. Small scale pig production is also an 




(http://pigtrop.cirad.fr/). To keep up with the rising global demand, pig breeding 
companies are investing in novel technologies alongside animal husbandry techniques 
to increase production efficiencies. 
The domestic pig is also a valuable model for biomedical research, due to its 
biological, physiological and anatomical similarities to humans (Vodicka et al., 2005, 
Aigner et al., 2010, Schomberg et al., 2016). 
 
Figure 1.5 Schematic diagram of phylogeny of Suidae family. Reproduced from 
Groenen, 2016. The phylogenetic tree is based on studies carried on whole-genome 





1.6 Diseases of domestic swine 
Animal disease is a huge burden on the livestock industry, impacting on both welfare 
and production. Disease arises due to a variety of pathogenic agents, including 
bacteria, viruses, fungi, worms, nematodes and prions. Diseases of swine that are 
classified as ‘List A’ by the World Organisation for Animal Health include foot and 
mouth disease, swine vesicular disease, vesicular stomatitis, rinderpest, classical swine 
fever and African swine fever (Table 1.1). These diseases are on the highest risk 
category as they have the potential to spread across the world, i.e. they are 
transboundary diseases. Moreover, all are viral diseases. The majority of high threat 
transboundary diseases are often viral, unlikely coincidental, as viruses have extremely 
high mutation rates leading to rapid adaption to various environments.  
Diseases of swine often have a significant socio-economic impact in affected 
countries. Scientific research in effective preventative measures and treatments is 
fundamental to lowering this impact. Diseases of swine are often controlled by the 
following; biosecurity methods, improved husbandry, vaccination, the use of drugs 
and mass culls. A combination of these approaches is often required for the successful 
management of a disease. An alternative approach to tackle pig diseases is through 
their genetics. This can be carried out through selective breeding programs however, 
this is a time-consuming process and requires that appropriate genetic variation both 
exists and can be located within the population. Advances in genome engineering 
technologies offer us an alternative approach, with the capability to make genetic 
modifications in pigs within a single generation. Recently, a genome editing approach 
has been used to generate pigs that are resistant to viral infection with porcine 
reproductive and respiratory syndrome virus by disrupting a gene involved in viral 




Table 1.1 Diseases of swine listed by the World Organisation for Animal 





1.7 African swine ever 
African swine fever (ASF) is a highly contagious disease of domestic and feral pigs. 
African swine fever virus (ASFV), a DNA arbovirus, is the causative agent of ASF. 
Upon infection with highly virulent isolates of ASFV, domestic pigs develop an acute 
haemorrhagic fever and die within 10-14 days of infection. ASF has a huge socio-
economic impact in affected countries and its current spread is increasing its risk to 
global pig production. 
1.7.1 Distribution and epidemiology 
ASF was first reported in Kenya in 1909 and close proximity with warthogs was 
implicated as a likely source of infection (Montgomery., 1921). It has since been 
reported all over the African continent and is considered endemic to Sub-Saharan 
Africa. The disease was confined to Africa until 1957 when an outbreak was reported 
in Portugal, thought to have been introduced by the importation of contaminated pork 
products in airline waste (Manso Ribeiro et al., 1961). This outbreak was effectively 
eradicated through the slaughter of herds, however new outbreaks were reported again 
in Portugal in 1960. From these initial outbreaks the disease spread throughout the 
Iberian Peninsula (Spain and Portugal), where it remained endemic until eradication 
in the mid-1990s. During this time ASF outbreaks were also reported in Holland, 
France, Belgium, Madeira, Sardinia, Malta, Italy, Cuba, Dominican Republic, Haiti 
and Brazil. In most jurisdictions it has been eradicated by the mass slaughter of 
animals, with the exception of Sardinia (Costard et al., 2009). Eradication programs in 
Sardinia are unsuccessful likely due to infected wild boar populations which contribute 
to the spread to free ranging domestic pigs (Mur et al., 2016). In a Spanish outbreak, a 
species of soft tick, Ornithodoros erraticus, was discovered to be a reservoir and 
vector of ASFV (Diaz Montilla et al., 1966). Subsequently, other tick vectors of the 
Ornithodoros genus where identified as reservoirs and vectors of ASFV in Africa 
(Plowright et al., 1969). However, the spread of disease to unaffected areas is most 
often due to the feeding of contaminated pork products to domestic pigs, brought in 
from aeroplanes and boats. Once infection is established in herds, the disease is 
disseminated through infected pigs and contaminated pork products. Within the last 




countries not previously affected such as Côte d′Ivoire (1996), Nigeria (1997), Togo 
(1997), Ghana (1999), Burkina Faso (2003), Chad (2010) and to islands on the coast 
of the continent, Madagascar (1998) and Mauritius (2007). In 2007, ASFV was re-
introduced into the European continent, first reported in Georgia following rapid 
spread into surrounding countries, including Armenia (2007), the Russian Federation 
(2007), and Azerbaijan (2008). The disease has since spread to Armenia (2010) 
Ukraine (2012), Belarus (2013), Estonia (2014), Latvia (2014), Lithuania (2014), 
Poland (2014), Moldova (2016). This European spread in still not under control with 
new outbreaks occurring regularly in affected countries (OIE, November 2016). 
This recent spread and increasing incidence of ASF means that it now affects more 
countries than ever before in the history of the disease. A contributing factor to this 
may be globalization; as the movement of people, animals and products increases so 
does the potential for introducing pathogens to new territories. Despite intensive 
research towards development of ASFV vaccines, to date no effective vaccine or 
antiviral drugs exists (Zakaryan & Revilla, 2016). Current management of ASF 
consists of strict biosecurity methods, rapid diagnostics and the mass slaughter of 
animals. Culling as a method for eradication of disease was successful in the 
previously ASF affected European countries. However, the more recent European 
spread of ASF is further complicated by the prevalence of ASFV in the wild boar 
population, contributing to the spread of the disease.  
1.7.2 Sylvatic cycle 
In Africa, ASFV is maintained in a sylvatic cycle between natural hosts, wild swine 
including the common warthog (Phacochoerus africanus), bushpigs species 
(Potomochorus larvatus and Potomochorus porus), and soft ticks of the Ornithodoros 
genus (Heuschele & Coggins., 1969, Plowright et al., 1969, Plowright et al., 1981, 
Thomson et al., 1980, Thomson et al., 1985, De Tray et al., 1957, Anderson et al., 
1998). There has also been one report of ASFV isolation in a giant forest hog, although 
their role in the maintenance of ASF is considered insignificant (Hylochoerus 
meinertzhageni; Heuschele & Coggins., 1965, Penrith et al., 2007). In natural hosts, 
the virus causes a persistent but clinically inapparent infection, thus they act as 




African wild suid, the role in the maintenance of ASF is best described in the warthogs 
of the genus Phacochoerus. Moreover, the warthogs are more widespread and 
numerous compared to both the bushpigs and giant forest hog, ranging across most of 
sub-Saharan Africa (Jori & Bastos., 2009). Evidence for the bushpigs and giant forest 
hog role in the maintenance of ASF in Africa is generally lacking (Jori et al., 2007). 
The role of warthogs in maintaining ASFV in sub-Saharan Africa is thought to be 
essential to the disease persistence, making eradication of the disease extremely 
difficult in this continent. 
Direct viral transmission between warthogs or from infected adult warthogs to 
domestic pigs is not thought to occur (Plowright et al., 1981). Maintenance of ASFV 
is dependent on the sylvatic cycle involving warthogs and soft bodied ticks of the 
Ornithodoros genus (Figure 1.6). The Ornithodoros porcinus species is the most 
abundantly studied for its involvement in this sylvatic cycle (Jori et al., 2013). This 
species often lives in warthog burrows and feeds on the suid inhabitants. Once 
infected, juvenile warthogs transiently develop a sufficient viremia to infect 
subsequent feeding ticks, with infectious period typically lasting 2-3 weeks (Thomson 
et al., 1985). The virus circulating in the sylvatic cycle can be transmitted to domestic 
pigs through infected ticks (Plowright et al., 1981). The levels of virus in adult 
warthogs is insufficient for viral transmission to feeding ticks or other warthogs (Jori 
& Bastos., 2009). The O. porcinus soft tick species can transmit ASFV through 
transstadial (from one life stage to the next; Hess et al., 1989), transovarial (from 
parent to offspring; Plowright et al., 1970) and sexual transmission (from male to 
female; Plowright et al., 1974). The O. porcinus ticks are long-lived, and viral infection 
has been demonstrated to persist for several years (Hess et al., 1989). A study of ASFV 
infection rates on warthogs living in eastern and southern Africa found that over 80% 
of the population are infected in areas where these Ornithodoros spp. of tick are 




Figure 1.6 Warthog-Tick Sylvatic cycle. ASFV transmission pathways 
between the soft bodied tick, Ornithodoros porcinus, and the common warthog, 





1.7.3 African swine fever virus  
African swine fever virus is a large, enveloped, icosahedral, double stranded DNA 
(dsDNA) virus. ASFV is morphologically similar to some Iridoviruses, those which 
are enveloped and have an icosahedral nucleocapsid, but has a genome organisation 
and replication mechanism more similar to the Poxviruses. ASFV was deemed 
significantly different to both of these viral families to warrant classification as a novel 
virus family, the Asfarviridae family of the genus Asfivirus of which it is the sole 
member. All of these viral families belong to a superfamily known as 
nucleocytoplasmic large DNA viruses (NCLDV) which also includes the 
Phycodnaviries and Mimivirus, all of which are proposed to share a common ancestor 
(Iyer et al., 2001; Raoult et al., 2004; Iver et al., 2006). Members of the NCLDV 
predominantly replicate in the cytoplasm and their viral replication cycle is typically 
independent of host replication or transcriptional factors (Dixon., 2005). ASFV is the 
only known DNA arbovirus (virus transmitted by arthropods). 
Each ASFV virion contains a nucleoprotein core structure containing the DNA, 
surrounded by an internal layer of core protein (inner core shell; Figure 1.7) This core 
structure is enclosed in an internal lipid bilayer (inner membrane) derived from the 
endoplasmic reticulum (Cobbold et al., 2001) and an outer icosahedral capsid (Andrés 
et al., 1998; Carrascosa et al., 1984). An external lipid envelope (outer envelope) is 
added to the virion on exiting the cell via budding through the plasma membrane 




Figure 1.7 African swine fever virus morphology. A) Schematic diagram of 
ASFV virion section indicating the inner membranes, outer envelope, capsid and 
nucleoid core. B) Thin section, C) cyrosection and D) negative contrast electron 
micrograph of ASFV particles. Figure reproduced from Dixon et al., (2003).  
 
The genome of ASFV is 170-190 kbp in length and contains between 151 and 167 
open reading frames (ORFs) depending on the virus isolate (Yáñez et al., 1995 
Chapman et al., 2008, de Villiers et al., 2010). The genome is a single molecule of 
linear dsDNA containing inverted and complementary end sequences that form 
covalently closed hairpin loops at either end (Gonzalez et al., 1986). To date, the 
complete genome sequences of 14 ASFV isolates have been determined (de Villiers et 
al., 2010, Dixon et al., 2013, Bishop et al., 2015). Most of the variation between 
isolates is present with the terminal end regions of the genome which contain five 
multigene families (MGFs), these are sets of paralogous genes which present in 
multiple copies per genome (Yáñez et al., 1995). The copy number of these genes 
varies considerably between isolates, which largely accounts for differences in genome 
length and gene number between isolates (Dixon et al., 2013). The function of these 
genes is currently not fully understood; however, some are known to play a role in 




et al., 2004, Golding et al., 2016). A total of 22 ASFV genotypes have been defined 
based on comparison of a part of the B646L gene sequence, which encodes the main 
capsid protein vp72 (Dixon et al., 2013). Complete sequencing of ASFV genomes has 
only been completed for 8 of these 22 genotypes. 
ASFV replicates mainly in cells derived from the monocyte/macrophage lineage and 
exhibits a predominantly cytoplasmic replication cycle. ASFV has been identified to 
enter a range of species and cells in vitro, but then does not lead to effective viral 
production in most circumstances (Alcamí et al., 1989, Alcamí et al., 1990, Carrascosa 
et al., 1999). The virus enters swine macrophages by either receptor-mediated 
endocytosis, although the receptor(s) are currently unknown, or through 
macropinocytosis (a non-selective uptake mechanism; Alcami et al., 1990, Hernáez et 
al., 2016). Once inside the cell, the virions are recruited to the host endosomal 
compartment by various proteins and lipids before the virion inner membrane is 
exposed and fuses to host endosomal membrane in a pH-dependent process, releasing 
the nucleoprotein core into the cytosol (Hernáez et al., 2016). Early viral gene 
expression occurs in the cytosol, using several viral enzymes carried in the viral core 
(Carrascosa et al., 1986). ASFV assembly and replication takes place within 
perinuclear viral factories (VFs), which share similarities with aggresomes, which are 
formed in a cell as a result of misfolded proteins (Heath et al., 2001, Muñoz-Moreno 
et al., 2015). Following viral assembly, mature virions are transported from VFs to the 
cellular membrane via microtubules and released through budding (Jouvenet et al., 
2004, Jouvenet et al., 2006) 
1.7.4 ASFV infection in domestic pigs 
The ability of ASFV to infect and replicate in cells of the monocyte/macrophage 
lineage is considered to play a critical role in the pathogenesis of this disease. 
Macrophages are key cells involved in activating and co-ordinating the innate and 
adaptive immune response to infection. The dysregulation of gene transcription in 
ASFV infected macrophages has been demonstrated by many studies and has been 
implicated in causation of disease pathogenesis (Powell et al., 1996, Gomez del Moral 
et al., 1999). ASFV also infects other cell types during later stages of infection, 




Gomez-Villamandos et al., 1997). However, this is not thought to play a central role 
in disease pathology as it occurs after characteristic symptoms of ASFV have been 
observed. 
The clinical symptoms of ASF vary considerably depending on the virus isolate, host 
species, dose and route of exposure. In domestic pigs the disease is characterised into 
4 forms: peracute, acute, subacute and chronic (Boinas et al., 2004, Hess., 1981; 
Wardley et al., 1983). Symptoms range from 100 % mortality within a few days of 
infection before clinical signs are detected (peracute), to chronic infections where pigs 
exhibit few signs of illness. Pigs infected with moderately virulent isolates of ASFV 
can recover from infection, but remain persistently infected, providing a potential 
reservoir of virus in domestic herds. Virus has been isolated from the lymph nodes of 
recovered animals up to 48 days post-infection (Oura et al., 1998) and viral DNA has 
been detected in peripheral blood mononuclear cells (PBMCs) at greater than 500 days 
post-infection by a PCR assay (Carrillo et al., 1994). Clinical effects of acute form 
ASF is characterised by multiple haemorrhages, lymphopenia associated with intense 
destruction of lymphoid tissue and disseminated intravascular coagulation, leading to 
death within a few days as a result of shock. 
A characteristic of the disease pathogenesis is extensive apoptosis of uninfected 
lymphocytes surrounding ASFV infected macrophages in the lymphoid tissue (Oura 
et al., 1998). The mechanisms involved in ASFV induced lymphocyte apoptosis have 
not been defined, but are thought to involve the release of proinflammatory cytokines, 
such as TNFα and IL-1β from infected monocytes/macrophages. An increase in the 
macrophages expressing proinflammatory cytokines TNFα, IL-1 and IL-6 was 
observed nearby lymphocytes undergoing apoptosis (Salguero et al., 2002; Salguero 
et al., 2005). Lymphopenia is wide-spread, observed in the peripheral blood, lymph 
nodes and spleen of pigs infected with highly virulent strains (Zakaryan et al., 2015) 
T cell apoptosis has been shown to precede that of B cells in pigs infected with the 
virulent isolate Malawi LIL 20/1 (Oura et al., 1998).  
Factors secreted from ASFV infected macrophages have also been associated with 
increased vascular permeability and the stimulation of bystander uninfected 




levels of TNFα has been shown to coincide with ASFV disease pathology (Carrasco 
et al., 2002, Gomez del Moral et al., 1999, Salguero et al., 2002), and is thought to 
make a significant contribution to some of the major clinical manifestations of acute 
ASF. In addition to providing signals involved in the induction of apoptosis, TNF-α 
induces vasodilation, an increase in vascular permeability and activation of the 
vascular endothelium (Mantovani et al., 1997). These contribute to damage to the 
vascular endothelial cells and result in haemorrhage. 
Protection against ASFV is not fully understood and no current vaccine exists. 
Although ASFV infection induces production of neutralizing antibodies against some 
virion proteins (Ruiz-Gonzalvo et al., 1986; Zsak et al., 1993; Gomez-Puertas et al., 
1996), this protection is not enough to effectively counter viral challenge (Neilan et 
al., 2004). Cellular immunity plays an important role in protection against ASFV 
infection, with CD8+ cytotoxic T lymphocytes and natural killer (NK) cells playing 
an important role in the destruction of virus infected cells (Leitão et al., 2001, Oura et 
al., 2005). Cross-protection has been also demonstrated by challenging infected 
animals with homologous isolates, (Mebus & Dardiri, 1980, Ruiz-Gonzalvo et al., 
1986, Leitão et al., 2001, Boinas et al., 2004, King et al., 2011). It is thought that these 
animals develop sufficient adaptive immunity with ASFV-specific cytotoxic T-cells, 
as experimental depletion of the CD8+ T-cells removes this immunity (Oura et al., 
2005). Most recently, attenuated viruses produced experimentally via the deletion of 
genomic region encoding MGF360 and MGF530 genes can provide approaching 
100% protection from subsequent challenge with pathogenic homologous isolates 
(O’Donnell et al., 2015, Reis et al., 2016). 
1.7.5 ASFV infection in natural swine hosts 
In persistently infected adult warthogs, no detectable viremia is displayed in peripheral 
blood and the virus is restricted to lymphoid tissues (Heuschele & Coggins 1965, 
Plowright et al., 1969, Thomson et al., 1980, Anderson et al., 1998). Neonate warthogs 
are infected by feeding ticks in burrows that they inhabit, these young warthogs 
develop a viremia which is infectious to ticks for up to 3 weeks (Thomson et al., 1985, 
Anderson et al., 1998, Kleiboeker & Scoles., 2001). Direct transmission from warthog 




virus to domestic pigs when kept in an adjacent pen (Anderson et al., 1998). In 
bushpigs, ASFV infected adult bushpigs develop high level of viremia post-infection, 
sufficient for infecting feeding ticks, however after for 8 months no virus can be 
detected even within lymph tissues (Anderson et al., 1998).  
1.7.6 Modulation of host defences by ASFV proteins 
As intracellular obligate “parasites”, viruses depend on the host cell for survival. The 
co-evolution of viruses and their hosts often leads to the development of a complex 
anti-viral host immune response in an arms race with the diverse viral mutational 
variants that circumvent and indeed exploit the hosts immune response. ASFV encodes 
between 150-167 proteins, some of which are known to modulate host immune 
responses (Table 1.2; Dixon et al., 2004, Tulman et al., 2009).  
Inhibition of host cell apoptosis by ASFV 
One host cell strategy to prevent viral replication is to trigger apoptosis of infected 
cells. ASFV induces apoptosis in both infected macrophages in vitro and in vivo and 
in non-infected lymphocytes in vivo (Oura et al., 1998, Portugal et al., 2009). 
Apoptosis is triggered in host cells after viral DNA replication, allowing sufficient 
time for completion of the replication cycle (Reis et al., 2017). Subsequent apoptosis 
of the host cell could be beneficial for the virus, as it may lead to the recruitment of 
additional macrophages to the infection site to clear apoptotic debris.  
Four ASFV proteins are known to interact with the host apoptosis pathways, namely 
A224L, A179L and EP153R, which inhibit this pathway, and E183L which can 
activate it. Each of these proteins are expressed at different times during the ASFV 
infection and target different members of the host apoptosis pathway. A224L is an 
inhibitor of apoptosis (IAP) homologue, which inhibits capase-3 and is expressed late 
in ASF infection (Nogal et al., 2001). Deletion of this gene from a virulent ASFV 
isolate does not affect its virulence in domestic pigs however it may be more important 
in natural host infections (Reis et al., 2017). A179L, is an anti-apoptotic Bcl-2 
homologue and is expressed throughout ASFV infection (Neilan et al., 1993, Brun et 
al., 1996). A179L also interacts with a component of autophagy, suggesting a broader 
role of this protein in modulating host cell responses (Banjara et al., 2017). EP153R is 




apoptosis is not yet known (Hurtado et al., 2004). E183L is a pro-apoptotic ASFV 
gene, encoding structural protein p54 which induces apoptosis by activation of 
caspase-3 through a mechanism that is dependent on interaction with dynein (a family 
of cytoskeletal motor proteins), which is also essential for viral replication (Hernaez 
et al., 2004). 
Inhibition of host immune response by ASFV 
ASFV encodes many proteins known to regulate host transcription of cytokines, 
chemokines, interferons (IFNs), adhesion proteins and other immunoregulatory 
proteins. Important viral genes for immune regulation include I329L, A238L and 
multigene families 360 (MGF360) and MGF530. 
The multigene family 360 (MGF360) and MGF530 genes are known to be involved in 
inhibiting induction of IFNs in host cell (Afonso et al., 2004, Golding et al., 2016). 
However, the mechanistic roles of the encoding proteins have yet to be discovered. It 
has recently been discovered that deletion of these multigene families can attenuate 
several highly virulent isolates in the domestic pig, demonstrating that IFNs play a 
crucial role in the severity of ASF pathogenesis (O’Donnell et al., 2015, Reis et al., 
2016). Moreover, in the soft-tick vector, deletion of these genes severely reduces viral 
replication (Burrage et al., 2004). Another viral protein known to inhibit the host 
interferon response is I329L, a viral Toll-like receptor (TLR) homologue. This viral 
protein acts as an inhibitor of toll-like receptor (TLR) 3 reducing transcription of genes 
downstream of this receptor, including NF-κB (an immunoregulatory factor) and IRF3 
(an interferon regulatory factor; de Oliveira et al., 2011).  
Many viral pathogens have evolved to manipulate the NF-κB pathway in order to 
evade host immune response, influence host cell cycle and enhance viral replication 
(Hiscott et al, 2001). The NF-κB signalling pathway (described in Section 1.8) 
regulates transcription of a diverse range of genes including cytokines, chemokines, 
IFNs, cell adhesion molecules, anti-apoptotic genes and other immunoregulatory 
proteins (Ghosh et al., 1998). Another ASFV protein known to inhibit NF-κB is A238L 
(Powell et al., 1996; Revilla et al., 1998; Tait et al., 2000). A238L has also been shown 
to regulate transcription factor Nuclear Factor of Activated T Cells (NFAT), which 




receptors (Rao et al., 1997, Miskin et al., 1998). A238L inhibits activation of these 
pathways through inhibition of PKC-theta-mediated p300 transactivation (Granja et 
al., 2006, Granja et al., 2008, Granja et al., 2009). p300 along with CREB binding 
protein (CBP) are transcriptional co-activators that play a key role in recruiting and 
assembly of transcription enhancer complexes to specific promotor regions of 
immunoregulatory genes. The deletion of A238L does not impact on viral replication 
in vitro and does not reduce viral virulence in the domestic pig in vivo (Neilan et al., 
1997). However, A238L is highly conserved between different ASFV field isolates 
indicating that it may have an important role in the replicative cycle of ASFV in one 
or more of its natural hosts (Neilan et al., 1997). 
Viral protein CD2v has a role in immunoregulation as it was found to inhibit in vitro 
lymphocyte proliferation (Borca et al., 1998). CD2v is known to be involved in 
haemaglutination and mediating the attachment of virus to the surface of erythrocytes 
via an interaction with a ligand expressed on these cells (Borca et al., 1998). CD2v is 
present on the viral particles, facilitating viral dissemination. In in vivo infections with 
CD2v deleted ASFV, domestic pigs show a delay in onset of clinical signs and viremia 
(Borca et al, 1998). Interestingly, deletion of CD2v was also shown to reduce viral 
replication in the soft-tick vector (Rowlands et al., 2009).  
Another ASFV protein known to regulate the host cells response is DP71L. DP71L 
appears to counteract a common anti-viral response, which is to shut down protein 
synthesis within a cell. Under numerous cell stresses, phosphorylation of translation 
initiation factor α subunit of eukaryotic initiation factor 2 (eIF2α) occurs, which 
triggers shut down of protein synthesis. The DP71L protein indirectly induces 




Table 1.2. ASFV proteins known to host antiviral pathways. Table reproduced 





1.8 African swine fever and variation in porcine RELA 
The difference in host suid species response to ASFV infection suggests a causal 
genetic difference between the porcine breeds. In the Palgrave et al (2011) study a 
candidate gene approach was employed to identify genes underlying differences in 
response to ASFV infection. Candidate genes were selected through association with 
ASF viral protein A238L. Functional variation between the warthog RELA and 
domestic pig RELA was hypothesised to underlie the dramatic difference in response 
to ASFV infection in these two species (Palgrave et al., 2011). RELA encodes for the 
RelA protein, a member of the NF-κB transcription factor family. The NF-κB 
transcription factors play a vital role in upregulating immune and inflammatory 
responses, including many of the pro-inflammatory cytokines indicated in ASF 
pathology (Zhang et al., 2006, Gomez del Moral et al., 1999, Gomez-Villamandos et 
al., 2013).  
Many viral pathogens have evolved to manipulate the NF-κB pathway in order to 
evade host immune response, control host cell cycle and enhance viral replication 
(Hiscott et al, 2001). Genetic variations in the porcine RELA locus have been 
associated with varied responses to infectious diseases such as porcine reproductive 
and respiratory syndrome (PRRS) and classical swine fever (CSF; Li et al, 2011).  
The RelA NF-κB subunit was identified to have three amino acids changes between 
warthog and domestic pig (Figure 1.8). Initial in vitro characterisation of the RelA pig 
and warthog protein variants revealed that domestic pig RelA had a higher activity 
than the warthog RelA. In vitro reporter studies of the RelA variants containing each 
of the three single amino acid changes –, T448A, S485P and S531P –, revealed that 
the S531P mutation contributed the majority of these functional differences (Palgrave 
et al, 2011). In the human RelA the serine at 529 (equivalent of pig S531) is a 
phosphorylation site, which once phosphorylated by CKII (casein kinase II) has 




Figure 1.8 Evolutionary conserved transactivation domain of NF-κB subunit RelA. 
The RelA transactivation domain is subdivided into two regions, TA1 and TA2 
(described later). Diagram displays primary protein sequence of RelA transactivation 
domain of domestic pig, warthog, dog, human and mouse. The sites of variations 
between the warthog and domestic pig are boxed. All amino acid variations from 
domestic pig RelA are highlighted in red. 
 
1.9 Nuclear factor kappa B (NF-κB)  
Nuclear Factor kappa B (NF-κB) is the collective term for the NF-κB family of 
transcription factors. First discovered in 1986 as a DNA-binding factor that bound to 
a specific enhancer element within the gene encoding immunoglobulin kappa light 
chain gene in mature B cells, it later became clear that NF-κB was widespread amongst 
most cell types and regulated a plethora of genetic targets (Sen & Baltimore., 1986). 
NF-κB regulates transcription by binding approximately 10 bp DNA motifs, known as 
κB sites, present in the promoters or enhancers of many genes and is induced by large 
array of stimuli, including bacterial and viral products, various cytokines, ionizing 
radiation and reactive oxygen species (ROS). Active NF-κB is known to regulate gene 
expression at over 150 target loci with important roles in the immune, inflammatory, 
proliferative, stress and apoptotic cellular responses (Pahl., 1999). Due to their role in 
regulating a large number cellular and organismal processes, the NF-κB proteins are 




aberrant NF-κB activation is a characteristic many human diseases; including, cancers 
(Nakshatri et al., 1997, Dejarden et al., 1999, Pacifico & Leonardi., 2006, Jost & 
Ruland., 2007), autoimmune diseases (Schreiber et al., 1998, Okamoto., 2006, Mc 
Guire et al., 2013), premature aging syndromes (Osorio et al, 2012), septic shock (Liu 
& Malik., 2006), neurodegenerative diseases (Mogi et al., 2007, Mattson et al., 2001) 
and heart disease (Valen et al., 2001). There is intense study into unravelling the 
molecular mechanisms behind the NF-κB responses in order to discover targets with 
therapeutic potential for these diseases.  
The NF-κB transcription factors are evolutionary conserved and have representative 
members in a wide range of species, including both vertebrates and invertebrates. 
Homologs of NF-κB proteins, inhibitors of NF-κB proteins (IκB) and IκB kinases 
(IKK) have been identified in invertebrates such as Drosophila (Han & Ip., 1999), 
Cnidarians (sea anemones, corals and hydra; Sullivan et al., 2007, Meyer et al., 2009, 
Lange et al., 2011), Poriferans (sponges; Gauthier & Degnan 2008) and even the 
single-celled eukaryote Capsaspora owczarzaki (Sebé-Pedrós et al., 2011). The 
presence of NF-κB in C.owczarzaki places its origin into a group known as the 
Opisthokonta, which are thought to have existed for around 1000 million years 
(Chernikova et al., 2011).  
1.9.1 The NF-κB protein family 
In mammals, the NF-κB family consists of five structurally related proteins; RelA 
(p65), c-Rel, RelB, p105/p50 (NF-κB1) and p100/p52 (NF-κB2; Figure 1.9). All five 
NF-κB proteins contain a highly conserved Rel Homology domain (RHD) at their N-
terminus, which contains the residues responsible for mediating DNA binding, nuclear 
localisation, interaction with inhibitory proteins (the IκBs) and dimerization. All NF-
κB proteins can form homo- or hetero- dimers, except from RelB which can only form 
heterodimers, to generate a NF-κB transcription factor. Heterodimer NF-κB complexes 
and formed through combinations of either p50 or p52 with either RelA, c-Rel or RelB. 
Each NF-κB dimer targets a distinct, but overlapping, collection of κB site sequences, 
in some cases resulting in the regulation of a specific set of genes (Perkins & Gilmore, 
2006) Among the five NF-κB proteins, three monomers, RelA, RelB and C-Rel, 




transcriptional activity. The other two family members, p100 and p105, serve as 
precursor proteins for active NF-κB subunits, p52 and p50 respectively. These 
precursor proteins have a long C-terminal domain containing multiple copies of 
ankyrin (ANK) repeats, which act to inhibit NF-κB. The ANK repeat residues are 
present in all NF-κB inhibitors (IκB) and function primarily by masking the nuclear 
localisation signal (NLS). Both p100, and p105 are processed by partial degradation 
by the proteasome removing the C-terminal ANK repeat residues to form the active 
NF-κB monomers (Fan & Maniatis., 1991, Lin et al., 1998, Moorthy et al., 2006, 
Senftleben et al., 2001). These p52 and p50 subunits lack the TAD thus can only 
activate transcription when dimerized with any TAD containing NF-κB protein. 
Homodimers of the p52 and p50 subunits bind target κB sites but are transcriptionally 
inactive, thus act as competitive repressors of NF-κB target genes (Bohuslav et al., 
1998, Zhong et al., 2002).  
Although the NF-κB subunits are ubiquitously expressed, they are regulated in a cell 
type and stimulus dependent manner, resulting in a diverse range of NF-κB signalling 
outcomes. Moreover, there is potential for many different dimer combinations. 
However, the most abundant NF-κB complex present in most cells is the RelA-p50 
heterodimer. As a consequence, the term NF-κB is commonly used to refer specifically 
to the RelA-p50 heterodimer. 
Figure 1.9 Mammalian NF-κB family members. All proteins share the N-
terminal Rel homology domain (RHD) which is responsible for DNA binding, 
dimerization, nuclear localisation and interactions with NF-κB inhibitors. The 
three Rel proteins contain one or several transactivation domains (TAD) at their 
C-terminus end. The ankyrin repeats residues are inhibitory to NF-κB activation 
as they bind the RHD and inhibit nuclear localisation. Ankyrin repeats are present 





1.9.2 The IκB protein family 
In resting cells, the NF-κB exists in an inactive state in the cytoplasm primarily 
regulated by its interaction with inhibitory IκB proteins. The IκB proteins are 
characterised by the presence of ANK repeats, which interact with the RHD present in 
the NF-κB dimers. At present nine members of IκB protein family have been 
identified, which can be categorised into three mains groups 1) NF-κB protein 
precursors IκBs, p105 (IκBγ) and p100 (IκBσ), 2) cytoplasmic/typical IκBs, IκBα, 
IκBβ and IκBε, and 3) nuclear/atypical IκBs, IκBζ, Bcl-3, IκBη and IκBNS. These 
inhibitors are regulated slightly differently, with precursors and cytoplasmic IκBs 
being controlled by post-translation modification whereas nuclear IκBs are scarcely 
present in unstimulated cells and are regulated by induced transcription (Hinz et al., 
2012). Furthermore, each of the IκB proteins have differing affinities for specific NF-
κB dimers and are often expressed in a tissue-dependent manner (Zabel et al., 1990, 
Thompson et al., 1995, Li et al., 1997, Whiteside et al., 1997, Sedwick and Smerdon., 
1999., Hoffman et al, 2002). 
IκBα 
The best characterised and founding member of the IκB family is IκBα, which has a 
role in the canonical NF-κB pathway. IκBα primarily interacts with the NF-κB RelA-
p50 heterodimer, binding the RHD domains of the RelA-p50 to block the DNA binding 
ability of NF-κB (Trelle et al., 2016). The NF-κB-IκBα complex has been found to 
shuttle continuously between the cytoplasm and nucleus, with the equilibrium state 
strongly based towards the cytoplasm in resting cells due to a stronger nuclear export 
signal of the IκBα protein (Huang et al., 2000, Johnson et al., 1999, Tam et al., 2000). 
Newly translated IκBα has been shown to translocate into the nucleus to bind 
deacetylated RelA-p50 dimers and shuttle them back to the cytoplasm, terminating 
TNFα induced NF-κB activation (Arenzana-Seisdedos et al., 1997, Chen et al., 2001, 
Huang & Miyamoto., 2001). This ability of IκBα to directly bind NF-κB dimers that 
are either free or bound to DNA allows for efficient inhibition of NF-κB-dependent 




example when IκBβ binds a NF-κB dimer, the complex is retained in the cytoplasm 
(Huang & Miyamoto., 2001, Malek et al., 2001). 
1.9.3 NF-κB pathways 
In unstimulated cells, the NF-κB transcription factor complex is retained in the 
cytoplasm by a cytoplasmic or precursor IκB protein. NF-κB activation mechanisms 
can be broadly characterised into two different pathways termed the ‘canonical’ and 
‘noncanonical’ pathways. Which pathway is activated depends on the extracellular 
stimuli and the receptors engaged. Each pathway leads to a distinct pattern of NF-κB 
dimer activation and thus downstream NF-κB transcription responses. 
Canonical pathway 
The canonical pathway, also known as the classical pathway, relies on the degradation 
of the cytoplasmic IκBs (Figure 1.10). Degradation of these IκBs releases bound NF-
κB dimers, allowing their translocation to the nucleus where they bind and regulate 
NF-κB target genes. The canonical signalling pathway is known for its quick NF-κB 
response to stimuli, as no de novo protein synthesis is required. This rapid NF-κB 
response is a critical requirement of the immune system. Canonical activation of NF-
κB occurs in response to a diverse array of stimuli, including a wide variety of 
cytokines (including TNFα and IL-1), pathogen-associated molecular patterns 
(PAMPs), mitogens, growth factors, hormones and physical and oxidative stresses.  
A well characterized example of canonical signalling is the transduction cascade 
induced by the cytokine TNFα leading to nuclear translocation of the most abundant 
NF-κB dimer RelA-p50. TNFα binds as a trimer to TNF receptor 1 (TNFR1) inducing 
trimerization of the TNFR1 subunits which in turn recruits and activates TNFR1 
associated death domain protein (TRADD), TNF receptor associated factor 2 (TRAF2) 
and a kinase, receptor interacting protein 1(RIP1; Hsu et al., 1996). TRAF2 
subsequently ubiquitinates itself and RIP1, resulting in the recruitment and activation 
of the IκB kinase (IKK) complex (Hsu et al., 1996, Devin et al., 2000, Sebban et al., 
2006., Wu et al., 2006). The IKK complex is composed of three subunits: two catalytic 
subunits IKKα and IKKβ; and a regulatory subunit IKKγ/NEMO (NF-κB essential 




Transforming growth factor β-activated kinase 1 (TAK1) to activate the IKK. The IKK 
kinases are activated by phosphorylation by either the multimerizing of IKKγ which 
permits trans-autophosphorylation or by kinase TAK1 (Iwai., 2012., Adhikari et al., 
2007). Activation of the IKK complex triggers the IKKβ subunit to phosphorylate IκBs 
at two conserved serine residues targeting them for subsequent ubiquitination and 
degradation via the proteasome (DiDonato et al., 1997, Li et al., 1999, Krappman & 
Scheidereit., 2005). The IKK complex preferentially phosphorylates the IkBα protein 
as directed by the IKKγ subunit (Schröfelbauer et al., 2012). Following its release from 
IκB, the NF-κB relocates to the nucleus where it binds κB DNA elements to initiate a 
transcriptional response.  
Most canonical signalling leads to the activation of predominant NF-κB RelA-p50 
dimer. RelA activation is thought to be synonymous with canonical signalling, 
however this is not always the case, as cytosolic IκBs (IκBα and IκBβ) can also 
associate with other NF-κB hetero- and homo- dimers containing either RelA or C-Rel 
(Malek et al., 2001). Moreover, in dendritic cells RelB-p50 dimers were found bound 
to IκBα, thus canonical signalling activates RelB transcriptional control in this cell 
type (Shih et al., 2012). NF-κB induces expression of cytokines such as TNFα and IL-
1β (Collart et al., 1990, Ziegler-Heitbrock et al., 1993, Hiscott et al., 1993), as well as 
some anti-apoptotic genes (Stehlik et al., 1998) and genes involved in innate immunity 
such as the growth factor, granulocyte/macrophage-colony stimulating factor (GM-
CSF; Schreck & Baeuerle., 1990). NF-κB also upregulates genes encoding other NF-
κB subunits, including p100/p52 (Lombardi et al., 1995), p105/p50 (Ten et al., 1992), 
RelB (Bren et al., 2001) and C-rel (Hannink & Temin et al., 1990) and IκB proteins, 
IκBα (Sun et al., 2003) and IκBε (Tian et al., 2005). 
Negative feedback loop 
NF-κB activation is transient, with mechanisms in place to prevent aberrant NF-κB 
activation as this can be associated with chronic inflammation and malignancies (Karin 
& Greten., 2005). IκBα is transcriptionally upregulated by NF-κB and is the primary 
contributor to a self-regulating negative feedback loop that terminates signalling 
(Hoffman et al., 2002). Upon transcriptional induction and synthesis, IκBα enters the 




RelA-p50 complex dissociating from the DNA, and translocates back to the cytoplasm 
(Arenzana-Seisdedos et al., 1997). Due to the delay between proteasomal degradation 
and resynthesis of IκBα, even transient cytokine exposures lead to NF-kB activation 
for approximately one hour (Werner et al., 2008). It is worth noting that free IκBα is 
an intrinsically unstable protein with a half-life of 10 minutes or less when unbound to 
NF-κB (Mathes et al., 2008). This rapid degradation is regulated by a C-terminal PEST 
region on IκBα which is masked when bound to NF-κB, thus stabilising the IκBα 
protein (Huxford et al., 1998, Phelps et al., 2000., Mathes et al., 2008). 
Alternative negative feedback mechanisms regulate the other IκBs; IκBε (Kearns et 
al., 2006) and IκBσ (p100; Shih et al., 2009). Slow transcriptional induction and 
protein synthesis of IκBσ, leads to its role in repressing persistent NF-κB signalling 
(Shih et al., 2009). Another NF-κB-induced negative feedback regulator is A20 (also 
known as TNFα-induced protein 3; TNFAIP3), a zinc finger protein, well-known to 
be anti-inflammatory, NF-κB inhibitory and anti-apoptotic. It consists of two domains, 
an ovarian tumour domain with deubiquitinase activity and a zinc finger domain which 
mediates its ubiquitin ligase and binding activity. The A20 protein interacts with 
ubiquitin enzyme complexes to deubiquitinate RIP1 and TRAF2 and other 
components of the TNFR1 signalling complex, restricting their ability to activate NF-
κB. While the long half-life of the A20 protein renders its impact on the negative 
feedback loop of NF-κB to have low immediate impact, it does make the NF-κB 




Figure:1.10 The canonical NF-κB pathway activated by TNF. Figure adapted 






A second pathway, the non-canonical or ‘alternative’ NF-κB pathway, was first 
discovered in a study on the processing of precursor NF-κB protein p100 (Xiao et al., 
2001). This pathway activates RelB-p52 NF-κB dimer using a mechanism which is 
dependent of the processing of p100 instead of degradation of the cytoplasmic IκBs 
(Figure 1.11). As previously mentioned, p100 acts as a IκB protein until proteolytically 
processed to create p52 (see Section 1.9.1-2). The p100 protein preferentially binds to 
the RelB subunit, inhibiting its translocation to the nucleus (Solan et al., 2002). Thus, 
processing of p100 to p52 typically leads to the nuclear translocation of the RelB-p52 
dimer. The non-canonical NF-κB pathway is known to regulate a distinct set of genes 
with important roles in lymphoid organ development, B-cell survival and maturation 
and bone metabolism (Bonizzi et al., 2004, Dejardin., 2006). The non-canonical 
pathway is induced by a more restricted group of ligands in comparison to the vast 
array that can induce the canonical pathway. Non-canonical inducers include the B 
cell-activating factor, CD40 and lymphotoxin β which target a specific set of receptors. 
A central component of this pathway is the NF-κB inducing kinase (NIK) which 
activates a downstream kinase, IKKα, which in turn phosphorylates p100 leading to 
its processing to p52 (Heusch et al., 1999, Xiao et al, 2001). Unlike the canonical 
pathway, the noncanonical pathway is independent of the IKKβ and IKKγ subunits 
and has slower and more persistence NF-κB activation kinetics, than the canonical 
pathway (Sun., 2011). This delayed NF-κB activation is partly caused by its 
requirement of de novo protein synthesis of the NIK protein, as levels of NIK are 
extremely low in unstimulated cells (Liao et al., 2004, Sun., 2011). As with the 
canonical pathway, the non-canonical pathway is regulated by a negative feedback 
loop, although this is not as tightly controlled as the canonical loop, thus allowing a 
more persistent activation. Upon activation of IKKα dimer by NIK, the IKKα dimer 
in turn phosphorylates NIK, thereby targeting it for proteolysis and preventing 
accumulating levels of NIK; such accumulation is associated with lymphoid 
malignancies (Razani et al., 2010). Processing of p100 to p52 is tightly controlled by 





Figure 1.11 Differences between the canonical and non-canonical NF-κB 
pathways. Figure reproduced from Sun., 2011.  
 
Most NF-κB inducers act through the canonical and non-canonical pathways. 
However, alternative pathways have been discovered that are independent of the IKK 
subunits and instead are activated by other kinases such as casein kinase II (CK2) 
(Kato et al, 2003; Schoonbroodt et al, 2000). These include pathways induced by 
cellular stresses such as hypoxia and UV exposure. 
Mice deficient of one or more of the NF-κB family members have been generated 
revealing redundant and non-redundant roles of these proteins in cell survival, 
haematopoietic regulation, control of innate and adaptive immune responses and the 








1.9.4 The RelA protein 
Of the five NF-κB members RelA is the most extensively studied due to its abundance 
and strong transcriptional activation potential (Schmitz, 1991). As previously 
mentioned the RelA/p50 dimer represents the most common NF-κB complex in most 
cells, with RelA contributing the TAD and thereby all of the transactivation function. 
Mice that lack RelA die at around day 14.5 of gestation as a result of liver degeneration 
(Beg et al, 1995). When these mice were crossed with knockouts of either TNFα or 
TNFR1 the liver degeneration phenotype was rescued (Doi et al 1999; Alcamo et al, 
2001). This revealed the crucial role that RelA plays in protecting cells from TNFα 
induced apoptosis. However, these double deficient mice displayed a compromised 
immune system with a high susceptibility to bacterial and viral infections, and none 
survived beyond 5 weeks after birth (Doi et al 1999; Alcamo et al, 2001). The 
TNFR1/RelA deficient mice were shown to completely lack lymph nodes and Peyer’s 
patches, and displayed a disorganised spleen microarchitecture suggesting that NF-κB 
is a key mediator for secondary lymphoid organ development (Alcamo et al, 2002).  
Alternative animal models have been generated in an attempt to understand RelA’s 
function in the immune system. In order to study RelA’s role in lymphocytes, Doi et 
al (1997) transplanted foetal rela-/- liver cells into irradiated SCID mice. These animals 
display impaired T and B cell functions and proliferation (Doi et al, 1997). A 
conditional mouse knockout of RelA in haematopoietic stem cells (HSCs) was 
generated; depletion of RelA resulted in altered gene expression and defects in 
hematopoiesis, leading to altered blood cell compositions (Stein & Baldwin, 2013). 
These discoveries show that RelA is necessary for normal differentiation, proliferation 
and function of cells that mediate immune response. 
RelA is known to undergo many post-translational modifications such as 
phosphorylation, acetylation and methylation; these have been shown to alter NF-κB 
transcriptional activity and nuclear translocation and can contribute to target gene 
specificity (Huang et al, 2010). The majority of the posttranslational modification sites 





Rel-Homology Domain (RHD) 
The RHD is present in all NF-κB proteins and is essential for dimer formation, nuclear 
localisation, IκB association and DNA binding. The RHD is present at the amino-
terminus of RelA and is approximately 300 amino acids in length. It exhibits high 
homology with RHDs of other NF-κB family members and is also conserved across 
species.  The crystal structure of human RelA’s RHD bound to DNA and IκB proteins 
have been determined (Huxford, 1998). The structure of the RHD is composed of two 
immunoglobulin-like domains connected by a flexible linker of 10 amino acids. The 
first immunoglobulin-like domain is located at the immediate N-terminal 180 amino 
acids and mediates all specific DNA-base contacts. The second is approximately 100 
amino acids in length and mediates dimerization between NF-κB subunits. The 
flexible linker allows structural changes between the closed conformation required for 
binding inhibitory IκB proteins and open conformation to mediate DNA binding. 
Post-translation modifications of RelA are known to alter its structural qualities to 
either weaken or enhance binding to NF-κB co-factors (Huang et al, 2010). Several 
post-translational modifications have been characterized in the RHD, including 
phosphorylation, acetylation and methylation. For example, the phosphorylation of 
S276 on human RelA by PKAc or MSK1 results in an increase in the transcriptional 
activity of NF-κB by enhancing binding of p300/CBP (Zhong et al, 1998, Reber et al, 
2009). Other modifications can decrease transcriptional activity, such as acetylation of 
human RelA at K122 and K123 by p300/CBP or PCAF, which reduces affinity for κB 
enhancer sites (Kiernan et al, 2003). Many other sites of post-translational 
modification have been identified in RelA, most of which are conserved throughout 
mammalian species. 
Transactivation domain (TAD) 
The presence of the TAD in the NF-κB complex is necessary for the induction of target 
gene expression. Conservation of these domains between members of the NF-κB 
family is lower than observed for the RHD, although the RelA TAD is conserved 
across species (Figure 1.2). In RelA the TAD is divided into two transactivation 
domains, TA1 and TA2. TA1 (porcine residues 523-553) is located C-terminal to TA2 




phosphorylation sites. Unlike the RHD, the TAD does not contain lysine (Lys, K) 
residues, indicating that it is not directly influenced by lysine specific modifications 
such as acetylation, methylation and ubiquitination, SUMOylation or succinylation 
(O’Shea & Perkins., 2008). Previous studies on the TAD indicate that there is some 
redundancy between TA1 and TA2 (Schmitz et al, 1995). 
TA1 (human 521-551) is an acidic domain that forms an alpha-helical conformation 
(Schmitz, 1995). Two phosphorylation sites, S529 and S536, have been identified to 
play a key role in transactivation activity of the TA1 domain (pig S531 and S538 
respectively). S529 is phosphorylated by CKII and has been shown to enhance 
transcriptional activity (Wang et al, 2000). S536 has been reported to be 
phosphorylated by multiple kinases, including IKKε, IKKβ, IKKα, NAK and RSK1 
and also enhances the transactivation activity of RelA (Vermeulen et al., 2003, Viatour 
et al., 2005). There are also another five possible phosphorylation sites within TA1 
which could further regulate its activity (O’Shea & Perkins., 2008). 
TA2 (human 428-521) is the larger of the two domains and has been found to contain 
a region of homology with the TA1 domain (458-483). Human RelA contains three 
proven phosphorylation sites, S435, S468 and T505. Phosphorylation of either S435 
or T505 has a negative effect on the transcriptional activity (Perkins., 2006, Msaki et 
al., 2011). S468 has been reported to be phosphorylated by kinases GSK3β, IKKε and 
IKKβ, and has either an enhancing or repressing effect on transcriptional activity, 
depending on the cell context (Holger et al., 2004, Mattioli et al., 2006, Wang et al., 
2012). There are eight other possible phosphorylation sites within TA2 which are 
currently being investigated for their consequences on NF-κB transcription (O’Shea & 
Perkins., 2008). 
These conserved phosphorylation sites are likely to mediate interactions with co-
transcription regulators and basal transcription machinery. Around 30 proteins have 
been identified to directly interact between the RelA TAD; including TATA-binding 






RelA is a member of the NF-κB family of transcription factors, which play an essential 
role in regulating the mammalian immune and inflammatory response. This protein is 
highly conserved throughout mammalian species. Amino acids changes identified 
between the warthog and the domestic pig have been proposed to confer an altered 
activity of the NF-κB transcription factor to specific stimuli (Palgrave et al, 2011). It 
has been hypothesised that the warthog variant of RELA has the potential to underlie 
the warthog’s apparent tolerance to ASFV infection. In order to test this hypothesis, 
genetic engineering tools have been employed to convert the Sus scrofa RELA 
sequence to that of its warthog counterpart. As a first step to test the validity of a 
genetic engineering approach, reagents were constructed to target S.scrofa RELA. 
These were injected into pig zygotes for the production of RELA-edited animals. 
1.11 Thesis objectives 
1. To genotype and characterise porcine RELA genome edited animals at the 
molecular, cellular and morphological level 
 
2. To determine whether the porcine RELA editing events impact on the response 
to ASFV infection in vitro and in vivo 
 
3. To develop and effectively use genome editors to exchange a warthog ‘ASF 
tolerance’ RELA polymorphism into the domestic pig for the production of 





Chapter 2 Materials and Methods 
2.1 DNA techniques 
2.1.1 Genomic DNA extraction  
Ear notching of piglets a few days after birth was routinely carried out by farm staff 
for identification purposes. To genotype piglets, the ear tissue removed during this 
procedure was collected into a falcon tube transferred to the laboratory for genomic 
DNA (gDNA) extraction. The ear tissue was cut into a 2-3 mm3 piece with a scalpel 
before using the DNeasy blood and tissue kit (Qiagen) to extract the gDNA following 
the manufacturer’s protocol.  
2.1.2 Polymerase chain reaction (PCR) 
Unless stated otherwise, PCR reactions were carried out using Phusion® High-Fidelity 
PCR Master Mix (BioLabs). The reactions were set-up on ice and transferred to a T 
Professional thermocycler (Biometra) when the block and lid had preheated to 80-
96°C. A 50 µl PCR reaction mixture contained 25 µl of 2X Phusion High Fidelity 
(containing 3 mM MgCl2, 400 µM of each dNTP plus 1 unit of Phusion DNA 
polymerase), 10 μl of 5X Fi-RED loading dye (see Section 2.12.1), 1.25 µl of each 10 
µM stock primer (forward and reverse), 50-150 ng of genomic DNA template, and 
made up to final volume of 50 μl with nuclease-free water. The PCR program consisted 
of the following steps; initial denaturation step at 98°C for 30 secs, 35 cycles of 98°C 
for 20 secs, an optimised annealing temperature (shown in Section 2.11.1) for 20 secs, 
72°C for 30 secs, followed by a final elongation step of 72°C for 30 secs and then held 
at 10°C. If required samples were stored at -20°C prior to use.  
2.1.3 Agarose gel electrophoresis 
Agarose gels were made by dissolving UltraPure agarose (Life Technologies) in 1X 
TAE buffer (see Section 2.12.1). Different percentages of agarose gels were used 
depending on the size-range of samples being resolved. For example, to make a 1% 
agarose gel, 1 g of agarose was added to 100 ml of TAE and the mixture was heated 
in a microwave to fully dissolve the agarose in solution. Once the gel mixture had 




pouring the gel. The DNA samples were loaded alongside 5 μl of GeneRuler DNA 
Ladder Mix (Thermo Scientific), for both DNA length and mass approximations. 
These were separated by running gels at a voltage between 1-10 V/cm, depending on 
the requirement, and bands were visualized and imaged on UV Transilluminator Gel 
Dock.  
2.1.4 Purification of DNA from agarose gels and PCR 
reactions and agarose gels 
To extract DNA fragments from agarose gels, the desired bands were visualised under 
a UV light source and excised from the gel with a scalpel. DNA from gel slices and 
PCR reactions were purified using the illustra GFX PCR DNA and Gel Band 
Purification Kit (GE Healthcare Life Sciences). Purification was carried out according 
to the manufacturer’s protocol; PCR reactions were mixed thoroughly with 500 µl of 
Capture buffer type 3 and then loaded directly into a GFX column. Gel slices were 
incubated with 500 μl of Capture buffer type 3 at 60°C until the agarose had completely 
dissolved, approximately 15-30 minutes, before loading onto the GFX column. Once 
loaded onto the GFX column the samples were centrifuged, washed once with 500 µl 
of Wash type buffer 1, and then incubated in 30 µl of Elution buffer type 4 for 1 minute 
before centrifugation to elute the DNA from the column into a new DNase free 
collection tube. All centrifugation steps were carried out at 16,000 x g for 1 minute.  
2.1.5 Nucleic acid quantification 
The concentration of DNA samples was routinely estimated using the Nanodrop™ 
1000 spectrophotometer (Thermo Scientific) and ND-1000 software. Prior to 
measuring the DNA samples, the Nanodrop was initialised with 1.5 µl of deionized 
water and then a blank measurement was taken using the 1.5 µl of the buffer that the 
DNA was suspended in. To use the Nanodrop spectrophotometer, 1.5 µl of solution 
was pipetted onto the receiving fiber sensor on the lower pedestal, before lowering the 
upper pedestal arm bringing the source fiber sensor into contact with the liquid sample, 
a spectral measurement was then taken. Once each measurement was completed the 
loaded sample was wiped from both pedestals using a lint-free cloth. The ND-1000 




50 ng/µl of dsDNA). It also displays the 260/280 and 260/230 absorbance ratios for 
each sample, which was used to assess the purity of DNA. A 260/280 ratio of ~1.8 is 
considered “pure” for DNA and an acceptable range for the 260/230 ratio is around 
1.8-2.2. RNA samples were also quantified using the Nanodrop™ 1000 
spectrophotometer (Thermo Scientific) in the same manner. The ND-1000 software 
calculates the concentration of RNA displayed in ng/µl (one OD260 unit = 40 ng/µl of 
RNA). 
2.1.6 DNA sequencing 
4.5-10 ng of purified PCR product (see Section 2.1.4) was sent to Edinburgh Genomics 
in 5 µl of deionized water with 1 µl of 6.4 µM primer solution for Sanger sequencing. 
Edinburgh Genomics performed Big Dye reactions using the BigDye v3.1 Terminator 
Cycle Sequencing Kit (Thermo Fisher Scientific), which were then column purified, 
dried in a vacuum concentrator, resuspended in Hi-Di Formamide (Applied 
Biosystems) and denatured before running capillary analysis on the 3730X DNA 
Analyser (Applied Biosystems). The sequencing data was received from Edinburgh 
Genomics in .ftv file format. The traces were initially analysed using freeware 
program, FinchTV (Geospiza). If further analysis was required Lasgergene software 
was employed.  
2.2 Techniques involving E.coli 
2.2.1 Preparation of chemically competent E.coli 
Top10 E.coli cultures where streaked onto LB agar plates, containing 12.5 µg/ml 
Streptomycin, and incubated at 37°C overnight. The next day a single colony was used 
to inoculate 20 ml of SOC (see Section 2.12.1), containing 12.5 µg/ml Streptomycin, 
in a 250 ml conical flask and incubated at 37°C overnight with shaking. 1 ml of the 
overnight culture was used to inoculate 100 ml of SOB (containing 12.5 µg/ml 
Streptomycin) in a 1 litre conical flask. The culture was incubated at 37°C for ~2-3 
hours, until a cell density of ~4-7x107 cells/ml was reached (equivalent to OD600 of 
0.45). The culture was divided into two 50 ml tubes and the cells were pelleted by 
centrifugation at 6,000 x g for 10 minutes at 4°C. The supernatant was discarded and 




a 25ml serological pipette and incubated on ice for 20 minutes. The cells were pelleted 
again at 6,000 x g for 10 minutes at 4°C, supernatant discarded, and resuspended gently 
in 8 ml of RF2 (see Section 2.12.1) and incubated on ice for 20 minutes. Competent 
bacteria were then distributed into 50 µl aliquots in pre-chilled tubes before snap 
freezing on dry ice and storing at -80°C until use. 
2.2.2 Transformation of competent E.coli 
Aliquots of Top10 chemically competent E.coli cells were thawed on ice prior to use. 
50 µl of Top10 competent E.coli cells were gently mixed with 3 µl (1-10 ng) of DNA, 
and incubated on ice for 10 minutes, followed by heat shocking the mixture at 42°C 
for 45 seconds, then immediately returning to ice for 5 minutes. 125 µl of SOB medium 
was then added to each transformation before incubation at 37°C in shaking incubator 
for 1 hour. 50 µl of each culture was pipetted onto agar plates containing Carbenicillin 
(50 µg/ml) and spread using 10-20 sterile glass beads (3mm in diameter) per plate. The 
beads were removed and plates were incubated overnight at 37°C. The next day plates 
were removed from 37°C incubator and stored at 4°C until analysis of the colonies 
was carried out.  
2.2.3 Small scale preparation of plasmid DNA 
The QIAprep Plasmid Spin Miniprep kit (Qiagen) was used to extract up to 20 µg of 
plasmid DNA and was used for all small scale preparations following the manufactures 
guidelines. All centrifugation steps were carried out at 16,000 x g unless stated 
otherwise.  
Single bacterial colonies were inoculated into 5ml of LB medium (see Section 2.12.1) 
supplemented with Carbenicillin (50µg/ml) and incubated at 37°C with shaking 
overnight. 1.5 ml of the overnight culture was transferred to a 1.5 ml tube and spun at 
6800 x g for 3 minutes to pellet bacteria. After the supernatant was discarded, the 
bacterial pellet was resuspended in 250 µl of buffer P1 and then lysed in 250 µl of 
buffer P2 for no longer than 5 minutes. The cellular debris and genomic DNA was 
precipitated with the addition of 350 µl of buffer N3 and then pelleted by centrifugation 
for 10 minutes. The supernatant was collected and transferred into a QIAprep spin 




was washed with 750 µl of buffer PE, with the flow-through again discarded. The 
centrifugation step was then repeated for 1 minute to remove any residual wash buffer. 
Each column was then transferred into a new 1.5 ml DNase free tube. 30-50 μl of EB 
buffer was added to each column followed by incubation at room temperature for 1 
minute. Plasmid was eluted with a final centrifugation step for 1 minute. The plasmid 
DNA was quantified using the Nanodrop (see Section 2.1.5) and stored at -20°C for 
future use.  
2.2.4 Large scale preparation of plasmid DNA 
The EndoFree Plasmid Maxi kit (Qiagen) was used to extract up to 500 µg of plasmid 
DNA for large scale preparations of plasmids following the manufactures guidelines. 
All incubation steps were carried out at 37°C with shaking unless otherwise stated.  
Single colonies were inoculated into 5 ml of LB medium supplemented with 
Carbenicillin (50 µg/ml) and incubated for 6-8 hours. After initial incubation, the 5 ml 
culture was transferred into a 500 ml conical flask containing 100 ml of LB 
(supplemented with Carbenicillin (50 µg/ml)) and incubated overnight. To harvest 
bacteria, 50 ml of overnight culture was transferred into a 50 ml falcon tube and 
centrifuged at 6000 x g for 15 minutes at 4°C. The supernatant was discarded and the 
cell pellet was left to air-dry by inverting the open tube onto blue cloth until all of the 
medium had drained. The bacterial pellet was resuspended thoroughly in 10 ml of 
Buffer P1 (containing RNase A) by vortexing. The cells were lysed with the addition 
of 10 ml of Buffer P2 and gently mixed by inverting the tube 4-6 times followed by an 
incubation at room temperature for no longer than 5 minutes. The lysis step was 
terminated with the addition of 10 ml of chilled Buffer P3 and immediate mixing by 
inverting the tube 4–6 times. The lysate was transferred into the QIAfilter Cartridge 
and incubated at room temperature for 10 minutes after which it was passed through 
the QIAfilter cartridge using the supplied plunger. To remove endotoxins, 2.5 ml of 
Buffer ER was added to the filtered lysate before inverting the tube 10 times and 
incubating on ice for 30 minutes. The lysate was loaded into an equilibrated QIAGEN-
tip 500 column (column equilibrated by flowing 10 ml of Buffer QBT through the 
column) and allowed to flow through. The column was washed twice with 30 ml of 




free tube. The DNA was precipitated with the addition of 10.5 ml of isopropanol and 
pelleted at 5,000 x g for 1 hours at 4°C. The supernatant was discarded and the DNA 
pellet was subsequently washed with 5 ml of endotoxin-free 70% ethanol and 
centrifuged step was repeated at 5,000 x g for 1 hour at 4°C. The pellet was air-dried 
for 5-10 minutes at room temperature, and resuspended in 200 µl of endotoxin-free 
Buffer TE. Plasmids were quantified using the Nanodrop (see Section 2.1.3) and stored 
at -20˚C until use. 
2.3 Animals 
2.3.1 Pigs 
All pigs in this project are Landrace/Large White crosses. Founder animals in this line 
are described in Lillico et al, 2013.  The procedures and experiments on all animals 
were carried out under approved UK Home Office License regulations. This animal 
line was maintained through natural matings, all carried out at The Large Animal Unit, 
Roslin Institute, University of Edinburgh.   
2.3.2 Blood sampling and analysis 
Blood samples were collected by jugular venepuncture into BD Vacutainer® Heparin 
coated tubes, this procedure was conducted by appropriately licensed large animal 
staff. Blood was collected for the isolation peripheral blood mononuclear cells 
(PBMCs; see Section 2.4.1) and for routine blood count analysis. Approximately 1ml 
of blood from each animal was sent to the R(D)SVS Clinical Pathology Laboratory, 
University of Edinburgh, for blood count analysis.  Total differential white blood cell 
(WBC) counts of samples were measured on the Siemens Advia 2010 analyser within 
two hours after blood collection. 
2.3.3 Tissue processing 
All pigs were sedated with Ketamine (Vetalar) and Azaperone (Stresnil) before being 
euthanised via injection of a lethal dose of Pentoject (Animalcare). Tissues were 
excised from euthanised animals and cross sectioned using a scalpel into pieces no 
larger than ~1 cm³ before placing into 10 % neutral buffered formalin. Samples were 




subsequently sent to the R(D)SVS pathology department to carry out histology. 
Tissues were placed in histology cages and then processed for wax embedding using 
Shadon™ Pathcentre tissue processor (Thermo Fisher Scientific) following the 
protocol:  
 
After processing, the samples were embedded in paraffin wax blocks and stored at 4°C 
prior to sectioning. A microtome was used to cut 5 μm sections which were mounted 
onto poly-L-lysine slides. Slides were dried overnight at 37°C before incubating at 
62°C for 25 minutes, to melt away any excess wax before staining with H&E. Staining 
was carried out using the Gemini AS Automated Slide Stainer (Thermo Fisher 
Scientific) following the protocol below: 
Reagent Incubation time
70% Ethanol 1 hour
95% Ethanol 1 hour
Absolute ethanol 1 hour
Absolute ethanol 1 hour
Absolute ethanol 1 hour
Absolute ethanol 1 hour











Finally, the slides were mounted with Histomount (Thermo Fisher Scientific) and a 
glass coverslip was place on top.  Details of the solutions used during histology can be 
found in Section 2.12.4. 
2.3.4 Bone marrow smear 
To collect bone marrow smears from euthanised pigs the back left femur was excised 
and cut open with a surgical saw. The bone marrow was removed from the femur and 
spread across a microscopy slide. These were immediately taken to the R(D)SVS 
pathology department who carried out Giemsa staining. Once stained, a differential 







Absolute ethanol 2 minutes
Absolute ethanol 2 minute
Absolute ethanol 2 minute
Running water wash 2 minutes
Harris haematoxylin 18 minutes
Running water wash 1 minute
Running water wash 1 minute
Acid alcohol 10 seconds
Running water wash 2 minutes
Scott’s tap water substitute 2 minutes
Running water wash 2 minutes
Eosin 30 seconds
Running water wash 4 minutes
Absolute ethanol 1 minute
Absolute ethanol 2 minutes







2.4 Primary cell isolation and culture 
2.4.1 Porcine PBMC isolation 
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood (see 
Section 2.3.2 for collection details). The blood was transferred into a tissue culture 
hood before diluting 1:1 with PBS. The diluted blood was layered on top of 20 ml of 
Lymphoprep™ (Axis-Shield) in a 50 ml falcon tube before centrifugation for 30 
minutes at 700 x g in a swinging-bucket rotor with no brake. As the vast majority of 
PBMCs have a lower density than the Lymphoprep™ medium (which has a density of 
1.077 g/ml) these cells form a distinct layer at the sample/medium interface after 
centrifugation, this layer is termed the buffy coat (Figure 2.1). The erythrocytes and 
the polynuclear blood cells (granulocytes) sediment through the medium as their 
density is higher than the Lymphoprep™. The buffy coat was carefully removed using 
a 20 ml serological pipette and transferred into a new 50 ml falcon tube which was 
topped up to 50 ml with PBS before centrifugation at 350 x g for 10 minutes. The 
supernatant was discarded before washing the cell pellet with PBS and spinning at 100 
x g for 10 minutes to remove any contaminating platelets, this step was repeated twice. 
If any erythrocytes were visible in the cell pellet they were lysed by resuspending the 
pellet in 5 ml of RBC lysis buffer (see Section 2.12.3) for 2 minutes before washing 
twice with PBS. 
 





2.4.2 Porcine fibroblast isolation 
Porcine adult fibroblasts, PAFs, were isolated from the ear tissue of adult pigs and 
porcine embryonic fibroblasts, PEFs, were isolated from 60-day old pig foetuses.  
Preparation of porcine adult tissue: 
For isolation of PAFs, an ear from a euthanised pig was scrubbed thoroughly with 
Povidone-iodine solution and rinsed with PBS before removing the top half of the ear 
by cutting with a sterile blade. The ear was transported from the farm to the laboratory 
in a container in containing PBS with 2X Antibiotic-Antimycotic (Gibco) on ice.  To 
clean the ear, it was repeatedly scrubbed with Povidone-iodine solution outside the 
tissue culture hood and rinsed with PBS. Once cleaned thoroughly, the hair was 
removed from the ear with a sterile scalpel before scrubbing for a final time with 
Povidone-iodine solution using a fresh sterile brush and then rinsing three times with 
PBS. The ear was transferred into a tissue culture hood onto a sterile round glass dish. 
The skin was removed from both sides of the ear with forceps and a sterile scalpel and 
cut into ~4 cm2 pieces of tissue, these were placed in 50 ml tubes containing chilled 
PBS with 2X Anti-Anti (Gibco) and kept on ice until further processing.  
Preparation of porcine embryonic tissue: 
For the recovery of porcine embryos, a pregnant sow was euthanized 60 days after 
serving. The abdominal cavity of the pregnant sow was opened and the uterus 
removed. The foetuses were excised from the uterus directly into a container 
containing chilled PBS using a fresh sterile blade. Each embryo was kept at 4°C until 
further processing. Once transferred into a tissue culture hood the foetus was rinsed 
three times in PBS, before decapitation and evisceration.  
Further processing of both adult and embryonic tissue:  
In the tissue culture hood, both adult and embryonic preparations were placed on a 
sterile petri dish and minced finely (into 1 mm3 pieces) using two sterile scalpels in a 
scissoring motion. The minced tissue was then placed into a T-75 cm2 flask with 10 
ml of digestion medium (containing collagenase, 2X for adult tissues and 1X for 
embryonic, see Section 2.12.3 for all medium components). The minced tissue was 




incubation for 16 hours at 37˚C with 5 % C02 without agitation. The cells were then 
harvested by transferring all of the overnight digestion into a 50 ml falcon tube. To 
separate large residual clusters of tissue from cells the mixture was thoroughly 
dispersed by pipetting up and down at least 10 times before letting the mixture settle 
for 30-60 seconds. The supernatant, containing cell suspension, was then transferred 
into new 50 ml falcon tube. The large residual tissue that had settled at the bottom of 
the falcon tube was discarded. To pellet cells, the suspension was first topped up to a 
total volume of 50 ml with PBS and then centrifuged at 200 x g for 5 minutes. The 
supernatant was discarded and the cell pellet was resuspended in 25 ml of outgrowth 
media (see Section 2.12.3 for all medium components) and plated in a T-175 cm2 flask. 
When the cells approached 100 % confluency (usually between one and two days) 
these cells were split 1:2 (see Section 2.4.5) and cultured until they reached 95 % 
confluency when they were frozen down (see Section 2.4.3) for future use. Six vials 
of cells were frozen per T-175 cm2 flask.  
2.4.3 Freezing porcine fibroblasts 
To cryopreserve fibroblast cells, the medium was removed from the culture vessel and 
the cells were rinsed with PBS. To dissociate the cells from the culture vessel an 
appropriate volume of TrypLE™ Express (Thermo Scientific) was added to cover the 
bottom of the culture vessel (e.g. 3 ml for a T-75 cm2 flask), and incubated at 37°C for 
3-5 minutes after which an appropriate volume of pre-warmed culture medium was 
added to quench the TrypLE™ Express (e.g. 10 ml for a T-75 cm2 flask). The cell 
mixture was then transferred into a 50 ml falcon tube and centrifuged at 300 x g for 5 
minutes. The supernatant was discarded and the cell pellet was resuspended in the 
appropriate volume of freezing medium (see Section 2.12.3). 1 ml of the freezing 
mixture was then aliquoted into a pre-labelled 1.5 ml tubes, these were first stored in 
an isopropanol freezing container at -80°C overnight which allows a slow and constant 





2.4.4 Thawing porcine fibroblasts 
Frozen cells were thawed quickly in a 37°C water bath, and then transferred to 10 ml 
of fibroblast medium (see Section 2.12.3) and centrifuged for 5 minutes at 300 x g. 
The cell pellets were then resuspended in appropriate volume of medium for the 
culture vessel and grown as standard in a humidified 37°C incubator with 5 % CO2. 
2.4.5 Porcine fibroblast cell maintenance 
When cells reached ~95 % confluency they were split 1:2. To split fibroblasts grown 
in a T-75 cm2 flask, the cell medium was discarded and the attached fibroblast cells 
were washed with 10 ml of PBS. To dissociate the cells from the culture vessel, 3 ml 
of TrypLE™ Express (Thermo Scientific) was added to cover the surface of the flask 
which was then incubated at 37°C for 3-5 minutes. The flask was viewed under a light 
microscope to ensure complete cell detachment before the addition of 10 ml of pre-
warmed media to quench the TrypLE™ Express. The cells suspension was transferred 
into a 50 ml tube and pelleted by centrifugation at 300 x g for 5 minutes. The cell pellet 
was resuspended in 16 ml of medium which was divided between two T-75cm2 flasks. 
All fibroblast cultures were grown in a humidified 37°C incubator with 5 % CO2. 
2.4.6 Porcine bone marrow cell isolation  
Macrophages were collected from pigs to perform in vitro infection studies with 
ASFV. To harvest macrophages, bone marrow cells were flushed from the ribs of 
euthanised pigs. Five posterior ribs from each side of the pig were removed and 
transferred into a sterile bag on ice. The ribs were individually transferred into the 
tissue culture hood for processing. A sterile blade was used to remove as much muscle 
as possible from the bones which were then washed in 70 % ethanol and then rinsed 
in PBS. The ends of each rib were cut off with bone cutters and a bone marrow 
biopsy/aspiration needle (Cardinal Health, USA) is screwed into one extremity of the 
rib. The bone was flushed with 20 ml RPMI media containing 5 mM of EDTA (in 
order to prevent possible clumping) into a sterile culture dish. The media was then 
transferred into a 50 ml falcon tube for centrifugation for 10 minutes at 400 x g to 
pellet the cells. Red blood cells present in the pellet were lysed by resuspending the 




minutes. The cell solution was then brought up to 50 ml with PBS and centrifuged 
again at 400 x g for 10 minutes. The cells were resuspended in 5 ml of RPMI medium 
and counted using a haemocytometer (see Section 2.4.10). The cells were then 
cryopreserved for future use (see Section 2.4.7).  
2.4.7 Freezing porcine bone marrow cells 
Bone marrow cells were cryopreserved at a concentration of 108 cells per vial. The 
cells were pelleted by centrifugation at 400 x g for 10 minutes and then resuspended 
in a volume of FCS, subsequently an equal volume of freezing medium was added. 
The freezing medium comprised 80 % FCS and 20 % DMSO. To retain good viability 
of cells, the freezing medium was added slowly in a dropwise manner with a 1 ml 
pipettor while gently agitating the mixture. The final freezing cell suspension mix, 
which then comprised 90 % FSC and 10 % DMSO, was transferred into pre-labelled 
vials in 1 ml aliquots. The vials were stored in an isopropanol freezing box at -80°C 
overnight and then transferred to a -150°C freezer for long term storage.  
2.4.8 Thawing porcine bone marrow cells 
Cryopreserved bone marrow cells were transferred from -150°C freezer to dry ice and 
subsequently thawed quickly in a 37°C water bath. The thawed cell solution was then 
transferred into an empty 50 ml tube before slowly adding 20 ml of RPMI medium 
drop by drop. This method reduces the chances of cell shock due to sudden changes in 
DMSO concentration and thus increases cell viability. The cells were pelleted by 
centrifugation at 300 x g for 10 minutes and cells were resuspended in an appropriate 
volume of RPMI media for the culture vessel.   
2.4.9 Culturing bone marrow cells to derive macrophages 
Bone marrow cells where cultured with human recombinant CSF-1 to promote the 
maturation of monocytes into macrophages. 1x108 bone marrow cells were plated in a 
non-tissue culture treated 10 cm dish with final concentration of 104 U/ml (100 ng/ml) 
of human recombinant CSF-1 (rhCSF1; a gift from Chiron, Emeryville, CA). The cells 
were initially cultured for five days without agitation at 37˚C with 5 % CO2 after which 




macrophage cells, media was removed and 5 ml of PBS was added with a serological 
pipette to rinse the plate removing all cells other than the adherent macrophages. After 
the initial PBS wash was discarded, 5 ml of fresh PBS was vigorously added to the 
dish using an 18-gauge blunt needle and 10 ml syringe. The action of vigorously 
pushing the PBS in and out of the syringe was repeated 10 times to forcibly detach the 
macrophages from the dish. The cell suspension was transferred to a falcon tube before 
repeating this process with the addition of another 5 ml of fresh PBS. The final 10 ml 
of cell suspension was centrifuged at 400 x g for 10 minutes before resuspending the 
cell pellet in an appropriate volume of cell culture media for re-plating. All 
macrophage cultures were grown in a humidified 37°C incubator with 5 % CO2.  
2.4.10 Counting cells using a haemocytometer 
A cover slip was placed on the haemocytometer and 10 µl of cell suspension was 
carefully added at the side of the glass coverslip, which enters the chamber by capillary 
attraction. The average number of cells were counted using a light microscope as 
indicated below. The haemocytometer is divided to several squares; since each square 
is equal to a volume of 0.1 mm3 (10-4 cm3), and 1 ml is equal to 1 cm3, the total cell 
number per 1 ml solution can then be determined using the following equation:  
Cells/ml = (Average count per square) x 104 (chamber conversion factor)  
Total cells = (cells/ml) x (original volume of solution) 
2.5 Protein techniques 
2.5.1 Preparation of whole cell extracts 
Whole cell protein extracts were prepared in cell lysis buffer containing RIPA buffer 
(Sigma) plus cOmplete™, Mini, EDTA-free protease inhibitor cocktail tablet (Roche) 
and PhosSTOP phosphatase inhibitor cocktail tablet (Roche; see Section 2.12.2). Both 
protease and phosphatase inhibitor tablets were dissolved in deionized water to a 10X 
stock solution and added to the RIPA buffer immediately before use. Prior to cell lysis 
a fully confluent T-75 cm² flask (containing approximately 5 x 10⁶ PAF cells) was 




with the addition of 1 ml of lysis buffer, followed by incubation on ice for 5 minutes, 
swirling the flask occasionally to ensure uniform spreading of lysis buffer. The lysate 
was collected by scraping the flask surface with a cell scraper and pipetting into a fresh 
1.5 ml tube. To pellet the cellular debris, the lysate was centrifuged at 14,000 x g for 
15 minutes at 4°C. The supernatant was distributed into 20 μl into aliquots, flash-
frozen on dry ice and stored at -80°C until use.  
2.5.2 Subcellular Fractionation 
Fibroblast cultures were incubated with and without recombinant porcine TNFα 
(ThermoScientific), at a final concentration of 10 ng/ml, for 30 minutes prior to 
harvesting and fractionation using NE-PER nuclear and cytoplasmic protein extraction 
reagents (Thermo Scientific), CER I, CER II and NER, following the manufacturer’s 
guidelines. All the following incubation steps were carried out on ice and 
centrifugation at 4°C. 
Cells were first harvested from one T-75 cm2 flask using TrypLE™ (see Section 2.4.5) 
and centrifuged at 500 x g for 5 minutes. The cell pellet was resuspended in 1 ml of 
chilled PBS and then transferred into a 1.5 ml tube before centrifugation at 500 x g for 
5 minutes. The supernatant was removed using a pipettor and the cell pellet allowed 
to air dry. 200 μl of ice-cold CER I was added to the cell pellet which was resuspended 
by vortexing for 15 seconds. Samples were incubated for 10 minutes before adding 11 
μl of ice-cold CER II and vortexing vigorously for 5 seconds. Following a 1-minute 
incubation, samples were vortexed for another 5 seconds. To isolate the cytoplasmic 
fraction, samples were centrifuged for 5 minutes at 16,000 x g after which the 
supernatant was transferred to a clean pre-chilled labelled tube. Cytoplasmic lysates 
were flash-frozen on dry ice in 20 μl aliquots, to avoid more than one freeze-thaw 
cycle, before transferring to -80°C for long term storage. To extract proteins from the 
nuclei the insoluble pellet was resuspended in 100 μl of ice cold NER and vortexed 
vigorously for 15 seconds, the samples were then placed on ice and vortexed for 15 
seconds at 10 minute intervals for a total of 40 minutes. Following incubation and 
vortexing steps, the nuclear samples were centrifuged at 16,000 x g for 10 minutes, 
after which the supernatant was immediately transferred into a pre-chilled tube before 




2.5.3 Quantifying protein concentration 
The Bradford method was used to determine the total protein concentration of lysates 
directly before running western blots. The Bradford method was first described in 
Bradford et al, 1976, and involves the binding of Coomassie Brilliant Blue G-250 dye 
to lysine, histidine and arginine residues in proteins.  
In a 96-well plate, 200 μl of Quickstart Bradford Dye Reagent (Biorad) is dispensed 
to all protein sample wells. 5 μl of each of seven Pierce™ pre-diluted BSA protein 
standards (125, 250, 500, 750, 1000, 1500 & 2000 μg/ml, Thermo Scientific), were 
added in duplicate to wells containing Bradford Dye. 2 μl of each cell lysate (thawed 
on ice) were added in duplicate to wells containing Bradford Dye. Two wells were 
kept with only Bradford Dye Reagent for a blank reading. Any air bubbles present 
were burst using a hypodermic needle dipped in EtOH. The absorbance at 595nm was 
then measured using the Biotek Synergy HT plate reader and Gen5 software. Once 
absorbency readings were obtained, the protein concentrations were determined from 
the BSA protein standard curve using Excel software. 
2.5.4 Gel electrophoresis of proteins  
Polyacrylamide gel electrophoresis (PAGE) was used to separate proteins based on 
their size under denaturing conditions. Protein lysates where thawed on ice (previously 
stored at -80°C). Once thawed a Bradford assay was performed to estimate protein 
concentration (see Section 2.5.3). To prepare samples for PAGE the required quantity 
of protein was aliquoted and the volume adjusted to 10 μl with the lysis buffer. The 
protein samples were subsequently denatured by the addition of 10 μl of 2X Novex® 
Tris-Glycine SDS Sample Buffer and incubating at 96˚C for 3 minutes. The denatured 
samples were immediately loaded onto pre-cast Novex® 10% Tris-Glycine 
polyacrylamide gels in the XCellSureLock™ Mini-Cell filled with 1X Novex® Tris-
Glycine SDS Running Buffer. The samples were electrophoresed at 125 V for 90 




2.5.5 Western blotting 
Proteins were transferred from the polyacrylamide gel onto a nitrocellulose membrane 
by electrophoretic blotting in wet conditions. A sandwich of sponge, filter paper, gel, 
membrane, filter paper and sponge was made up immersed in 1X Tris-Glycine transfer 
buffer (set up shown in Figure 2.2). This sandwich was stacked together tightly in a 
Bio-Rad transfer cassette to ensure no bubbles formed between the gel and the 
membrane. The cassette was correctly orientated into a Bio-Rad electrophoresis tank 
with the membrane side closest to the anode, thus the negatively charged proteins 
would migrate from the gel towards the positive electrode and become bound by the 
membrane. An ice pack was placed into the tank before filling with 1X Tris-Glycine 
buffer. Transfer was carried out at a constant current of 100 V for 1 hour. 
Figure 2.2. Diagram of wet transfer set up for western blotting 
Following transfer, the membrane was removed from the cassette and stained with 
Ponceau S (see Section 2.5.6). In order to block non-specific binding sites, the 
membrane was incubated in blocking buffer (5 % semi-skimmed milk, 0.01 % Tween-
20 in PBS) for 1 hour at room temperature. Membranes were incubated overnight at 
4°C in the appropriate primary antibody diluted to optimal concentration (Table 2.4) 
in blocking buffer. The next day, membranes were washed five times in PBS-T on an 
orbital shaker for a minimum of 5 minutes. Once washed, a secondary HRP-conjugated 
antibody (either rabbit or mouse, depending on the primary antibody used) was diluted 
1:1000 in blocking buffer and incubated on the membrane for 1 hour at room 
temperature. After another five washes in PBS-T, the antibody was detected using 
chemiluminescence. The membranes were placed on a sheet of glass and incubated 
with Pierce™ enhanced chemiluminescence (ECL) western blotting substrate 




2 minutes. The membranes on glass were then covered with cling film and placed into 
cassettes and taken to a dark room where they were exposed to X-ray film 
(Hyperfilm™, GE Healthcare) for the required time and developed using an X-ograph 
developer (X-ograph). 
2.5.6 Total protein stain of nitrocellulose membranes 
Total protein was visualised on the nitrocellulose membranes with Ponceau S. The 
membrane was fully submerged in Ponceau S staining solution (see Section 2.12.2) 
for approximately 5 minutes before rinsing the membrane with deionised water. The 
total protein stained membrane was imaged using the white light settings on the gel 
dock imager. The Ponceau S stain was then removed completely by washing the 
membrane several times with PBS.  
2.5.7 Immunocytochemistry (ICC) 
Fibroblast monolayers were grown on round (12mm diameter) glass coverslips in a 
well of a 24-well plate. Fibroblasts were plated at 5 x 104 cells per well and cultured 
overnight at 37°C with 5 % CO2 in a humidified incubator. The next day, the cells were 
~70-80 % confluent and were treated with or without a 5 minute ‘pulse’ of recombinant 
porcine TNFα (Thermo Scientific) and fixed at a specified time-point post treatment. 
To treat cells, the media was removed and replaced with 0.5 ml of media supplemented 
with recombinant porcine TNFα (10 ng/ml) and incubated at 37°C for 5 minutes. 
Immediately after the incubation period the TNFα media was aspirated before washing 
the cells three times with 1ml of fresh media. Finally, 0.5 ml of media (without TNFα) 
was added to the cells for the remaining time in culture at 37°C. Once the desired time-
point was reached post-TNFα stimulation, the cells were rinsed with PBS before fixing 
for 20 minutes in 4 % Paraformaldehyde (PFA) at room temperature. To permeabilise 
the cells, 100 μl of 0.1 % Triton X-100 was added to each well and incubated for 10 
minutes at room temperature. Cells were then washed three times with 1 ml PBS before 
incubating with 500 μl of blocking buffer (1 % BSA, PBS) for 1 hour at room 
temperature. The primary antibody was diluted in blocking buffer and incubated on 
the coverslips for 1 hour at room temperature. The primary antibody was subsequently 




conjugated secondary antibody was incubated on the coverslips for 1 hour at room 
temperature before washing with three rinses of 1 ml of PBS. To prepare slides, 15 μl 
of ProLong® Gold Antifade Mountant with DAPI (Molecular Probes™) was 
dispensed onto a microscopy slide before carefully placing a coverslip (cells side 
down) onto the mountant and pressed gently to ensure the coverslip was flat against 
the slide. The slides where left to dry overnight in the dark and then transferred to 4°C 
in the dark until analysis. Slides were stored for no longer than 1 week before viewing 
and imaging using the inverted Zeiss LSM 710 confocal microscope. 
2.6 ASFV and cell culture 
All of the following work with African Swine Fever Virus (ASFV) was carried out 
within the SAPO4 restricted area of The Pirbright Institute, Surrey. 
2.6.1 Virus isolates 
Initial stocks of both virulent isolate, Benin 97/1, and non-pathogenic isolate, OURT 
88/3, were provided by Dr David Chapman, Pirbright. The Benin 97/1 isolate was first 
isolated from samples submitted during an ASFV outbreak of domestic pigs in West 
Africa in 1997 and the OURT 88/3 isolate was first isolated from Ornithodoros 
erraticus ticks from a pig farm in Portugal in 1988 (as described in Chapman et al., 
2008).  
2.6.2 Titration of ASFV by Immunofluorescence 
To titrate viral stocks, matured porcine bone marrow cells were infected with viral 
stock dilutions. Bone marrow cells were extracted from a 6-week old piglet (see 
Section 2.4.6) and plated out on a 96-well plate at 1 x 106 cells per well and incubated 
for 4 days in a humidified incubator at 37°C with 5 % CO2. After the initial incubation 
period of 4 days, 10-fold serial dilutions of the viral stock, from 10-1 to 10-8, were set 
up in culture medium on a 96-well plate with each dilution performed in triplicate. The 
media was removed from the 96-well plate containing the bone marrow cells using a 
multi-channel pipette and replaced with 100 μl of each virus dilution. The cells were 
then incubated with the virus for three days in a humidified 37°C incubator with 5 % 




μl PBS and then fixed by submerging the plate in 4 % PFA for 1 hour. The cells were 
then washed in PBS three times before adding 0.2 % Triton X-100 (in PBS) for 5 
minutes at room temperature and washed again three times with PBS. The primary 
antibody, anti-vp72 (see Section 2.11.2), was diluted in PBS and 50 μl dispensed into 
each well. Following a 1 hour incubation period with the primary antibody at room 
temperature the cells were washed three times with PBS. 50 μl of anti-mouse 488 
Alexa Fluor was then added to each well and incubated in the dark for 1 hour. The 
cells where then washed three times in PBS before viewing under an inverted UV 
microscope. The lowest virus dilution to contain a positive cell was recorded and used 
to calculate the TCID50 (median tissue culture infective dose) using the Spearman and 
Kärber algorithm as described in Hierholzer & Killington, 1996. The TCID50 equals 
approximately 0.69 FFU (focus forming units).  
2.6.3 Production of virus stocks 
T-175 cm2 flasks, each containing 40 ml of resuspended porcine bone marrow cells 
(BMCs) at a concentration of 107 cells/ml, were cultured in RPMI medium containing 
10 % porcine serum with an ASFV isolate (see Section 2.6.1) at a multiplicity of 
infection (M.O.I) of 5. The flasks were incubated at 37°C, 5 % CO2 for three days 
before the virus was harvested. To harvest the virus, the cells were removed from the 
surface of the flask by scraping and the media was transferred into a 50 ml tube. To 
pellet cellular debris, the mixture was centrifuged at 2000 x g for 20 minutes. The 
supernatant containing virus was collected stored at 4°C until use.  
2.6.4 Virus preparation   
The virus stocks were partially purified for in vitro ASFV infections to remove any 
cellular contaminants. Firstly, the viral stocks were centrifuged at 6000 x g at 4°C for 
10 minutes to pellet cellular debris. The supernatant was then loaded into each 
sterilised centrifuge tube and weighed in the buckets for Beckman SW 32Ti centrifuge 
rotor. Once balanced, the virions were pelleted at 170,000 x g for 1 hour at 4°C. The 
supernatant was discarded and the viral pellet was resuspended in 2 ml of PBS before 
passing through a 0.8 μM syringe filter to remove any large debris. Once filtered the 




a centrifugation spin column with 100 kDa molecular weight cut off (Vivaspin® 20 
concentrator). The 20 ml sample was loaded into the Vivaspin® 20 column in a swing-
out rotor at 6000 x g for 1 hour at 4°C. The sample was brought up to 20 ml again with 
fresh PBS and this process was repeated three times. On the final 6000 x g 
centrifugation step the volume was left to reduce to 1-2 ml in the Vivaspin column 
which was aliquoted as the concentrated virus stock.  
2.7 RNA techniques  
2.7.1 RNA extraction from mammalian cells 
RNA was isolated from cells using TRIzol® Reagent (Life Technologies), following 
the manufacturer’s instructions. All centrifugation steps were carried out at 12,000 x 
g for 15 minutes at 4˚C unless otherwise stated.  
Cells for RNA extraction were grown in monolayer cultures in 6-well plates until ~80 
% confluent. Cells were washed with chilled PBS before lysing directly in the plate by 
adding 1 ml of TRIzol reagent per well. The TRIzol cell lysate was mixed in the well 
by pipetting up and down several times before transferring into a pre-labelled RNase 
free 1.5 ml tube and incubated at room temperature for 5 minutes. 200 μl (0.2 volumes) 
of chloroform was added to the lysate before vortexing on the highest setting for ~15 
seconds and then incubating on ice for 10 minutes. After incubation, the samples were 
centrifuged to separate the mixture into organic phase and aqueous phase. The aqueous 
top layer (~400 µl), containing the RNA, was then transferred into a new RNase free 
1.5 ml tube containing 500 µl of isopropanol and mixed via pipetting. Following 
incubation at room temperature for 10 minutes, the samples were centrifuged to pellet 
precipitated RNA, the supernatant was discarded. The RNA pellet was washed with 
500 μl of nuclease-free 85% ethanol and the samples centrifuged. The supernatant was 
removed carefully with a pipettor and the RNA pellet was left to air dry for 5-10 
minutes before resuspension in 20 μl of nuclease free water. The concentration of RNA 
was then quantified using the Nanodrop (see Section 2.1.5). RNA samples were 




2.7.2 cDNA synthesis  
Before cDNA synthesis, RNA was treated with DNase to remove any contaminating 
DNA. The TURBO DNase kit (Life Technologies) was used following the 
manufactures guidelines. 2-5 µg of RNA was added to 5 µl 10X TURBO DNase 
buffer, 5 µl of DNase I buffer, 1 µl of DNase I and nuclease free water to a volume of 
50 µl. After an incubation at 37°C for 20 minutes, 5.5 µl of DNase inactivation reagent 
was added and the reaction incubated at room temperature for 5 minutes mixing 
occasionally. The samples were subsequently centrifuged at 10,000 x g for 1.5 minutes 
before transferring the supernatant containing RNA into a new RNase free tube. The 
Nanodrop was used to measure RNA concentration (see Section 2.1.5).  
cDNA synthesis was carried out using the SuperScriptTM III First-Strand Synthesis 
System (Invitrogen), the manufacturer’s guidelines were followed. 1 µg of RNA was 
added to 1 μl of 50 µM oligo (dt), 1 μl of 10 mM dNTP mix and made up to a final 
volume of 10 µl in nuclease-free water. The reaction was incubated at 65°C for 5 
minutes and then placed on ice for a 1-5 minutes. The cDNA synthesis mastermix was 
prepared adding each component in the following order, for one reaction; 2 µl of 10X 
RT buffer, 4 µl of 25 mM MgCl2, 2 µl of 0.1 M DTT, 1 µl of RNaseOUT (40 U/µl) 
and 1 µl of SuperScript III RT (200 U/µl). 10 µl of cDNA mastermix was added to the 
10 μl RNA/primer mixture before incubating at 50°C for 50 minutes. The reactions 
were terminated by heating at 85°C for 5 minutes. After cooling the samples on ice, 
1µl of RNase H (2 U/µl) was added and incubated at 37°C for 20 minutes. The cDNA 
was stored at either -20°C or -80°C until use. 
2.7.3 Quantitative PCR  
In order to compare gene expression between control samples and samples containing 
RELA mutants, quantitative real time PCR (qPCR) was used. All of the following 
procedures were carried out on ice unless otherwise stated.  
All cDNA samples were diluted 1:20 before performing qPCR. Each reaction 
contained the following components; 12.5 μl of Platinum® SYBR® Green qPCR 
SuperMix-UDG (Invitrogen), 0.1 μl of ROX reference dye, 2 µl of each 5 µM primer, 




master-mix was made up, containing all components except the cDNA sample, and 
20μl was pipetted into each well of a 96-well Thermo fast PCR plate before adding 5 
μl of each cDNA sample. A no reverse-transcriptase control (see Section 2.7.2) and a 
no cDNA template control (5 μl of nuclease-free water) were also included for each 
primer set. The plates were sealed with strip caps and centrifuged for 1 minute at 6000 
x g before the plate was read on an Mx3005P qPCR machine.  Set-up and analysis was 
performed using the MxPro software (Stratagene). The qPCR programme was as 
follows; 50°C for 2 minutes; 95°C for 2 minutes; then 40 cycles of 95°C for 15 
seconds, 60°C for 1 minute; then 95°C for 1 minute, 60°C for 30 seconds, 95°C for 30 
seconds.  The gene expression was normalised to appropriate porcine reference genes 
(details stated in experimental description) and the comparative Ct (cycle threshold) 
ΔΔCt method used to quantify relative gene expression using the formula: Fold 
Change = 2-Δ(ΔCt), where ΔCt = Ct (target) – Ct (reference) and Δ(ΔCt) = ΔCt, 
(treatment) – ΔCt (control). 
2.8 CRISPR construction and validation 
2.8.1 Short guide RNA (sgRNA) oligonucleotide design 
Short guide RNAs (sgRNAs) were designed to cut close to the codon encoding S531 
of Sus scrofa RELA for the targeted HDR-mediated exchange from domestic pig to 
warthog sequence, S531P. All guides were designed based on the requirements of the 
CRISPR-Cas system derived from Streptococcus pyogenes; these include that a target 
20-nt sequence is immediately followed with 5’-NGG protospacer adjacent motif 
(PAM). The PAM sequence is essential in preceding the 20-nt genomic target DNA 
locus however is not included as part of the sgRNA sequence itself.  
There are a variety of online tools available for designing suitable sgRNAs, these use 
algorithms which rank candidate guides based on predictions of on-target cutting 
efficiencies and potential off-target sites. The online design tools used for the design 
of the RELA sgRNAs included; CCTop (CRISPR/Cas9 target online predictor 
(Stemmer et al, 2015)), which ranks all candidate sgRNA target sites according to their 
off-target quality and Cas-Designer (Park et al, 2015) which ranks guides based on 




sgRNAs were selected based on the list rankings generated for the design tools and 
that had the closest proximity to the target codon.  
2.8.2 Preparation and cloning of short guide RNA (sgRNA) 
oligonucleotides into pSpCas9(BB)-2A-GFP (PX458) 
Oligonucleotides (oligos) containing the sgRNA sequences were cloned into 
pSpCas9(BB)-2A-GFP (PX458; Feng Zhang Lab; Addgene ID 48138) according to 
published methods (Ran et al, 2013).  This plasmid expresses the Cas9 from 
S.pyogenes with a 2A-GFP fusion and contains the human U6 (hU6) promoter to drive 
expression of the sgRNA (see vector map in Appendix A). The hU6 promoter requires 
a purine (usually guanine) to be directly adjacent to it to initiate transcription, thus an 
extra guanine (G) was added to the 5’ end of the selected guide if necessary. Oligos 
were ordered from IDT with the addition of BbsI overhangs to clone the guide 
sequence into the plasmid in the correct orientation (Figure 2.3).  
 
Figure 2.3 sgRNA oligonucleotide design for cloning into PX458. N 
respresents any nucleotide. Additional BbsI overhangs are shown in red and hU6 
promoter guanine requirement shown in lower case.  
Lyophilised oligonucleotides were resuspended in nuclease-free TE buffer to a final 
concentration of 100 µM. To prepare sgRNA oligos for cloning they were annealed in 
the following reaction; 0.5 µl of sgRNA sense oligo (100 µM), 0.5 µl sgRNA anti-
sense (100 µM), 0.5 µl 10X NEB Buffer 2 and nuclease free water to a total volume 
of 5 µl in a PCR strip tube. The oligos where annealed in a thermocycler at 37°C for 
30 minutes, 95°C for 5 minutes, ramping down to 25°C at 5°C minˉ1. The annealed 
oligos were diluted 1:100 in TE before cloning into PX458. 
To clone the sgRNA oligos into PX458 a ligation reaction was prepared; 0.5 µl of 




Scientific), 0.5 µl of DDT (10 mM), 0.5 µl of ATP (10 mM), 0.5 µl of FastDigest BbsI 
(Thermo Scientific), 0.25 μl of T7 ligase and nuclease free water to a final volume of 
10 µl. The ligation reactions where incubated in a thermocycler running the following 
program; 6 cycles of; 35°C for 5 minutes; 21°C for 5 minutes. The ligation reaction 
was then treated with plasmid-safe nuclease to digest any remaining linearized DNA. 
For plasmid-safe treatment the following components were added to the ligation 
reaction (10 µl); 2 µl of 10X plasmid safe buffer, 2 µl of ATP (10 mM), 1 µl of plasmid 
safe nuclease and nuclease-free water to give a final reaction volume of 20 µl. The 
plasmid-safe reactions were incubated in a thermocycler at 37°C for 30 minutes 
followed by 70°C for 30 minutes. 2 μl of the plasmid-safe treated plasmid (2.5 ng/μl) 
was transformed into Top10 competent cells (see Section 2.2.2). Colonies were picked 
the next day for bacterial PCR (see Section 2.8.3) and maxi-prep cultures (see Section 
2.2.4).  
2.8.3 Bacterial PCR 
A PCR was performed directly from bacterial colonies to check that ligated 
oligonucleotides had been successfully cloned into PX458. Three colonies were 
selected from each transformation plate to initiate mini-cultures and perform bacterial 
PCRs. Each colony was picked with a sterile pipette tip and spotted onto the bottom 
of a PCR tube for bacterial PCR and subsequently used to inoculate 125 µl SOB (mini-
culture). The mini-culture was incubated in a 37°C shaking incubator during which the 
bacteria PCR was carried out. The following reagents where added to the bacterial 
PCR tube; 0.5 µl of primer oSL35 (20 mM) which binds PX458 sequence downstream 
of the oligo insert, 0.5 µl of the appropriate sgRNA sense oligo (20 mM), 12.5 µl of 
2X DreamTaq Green DNA polymerase (Thermo Scientific) and nuclease free water to 
give a total reaction volume of 25 µl. The reactions were placed in a thermocycler with 
the following PCR program: 95°C for 60 seconds; 35 cycles of 95°C for 30 seconds, 
50°C for 30 seconds and 72°C for 30 seconds; 72°C for 5 minutes; before being held 
at 10°C after completion of the program. The presence of insert was confirmed by 
resolving 5 µl of this PCR product on a 1 % agarose gel (see Section 2.1.3). Once 
successful cloning was confirmed one of the positive bacterial cultures was selected to 





Table 2.1 CRISPR oligonucleotides used in preparation for cloning into plasmid PX458. 
Bbs1 overhang sequence is highlighted red and additional bases are shown in lowercase.  
 
2.8.4 HDR template oligonucleotides design 
Custom single strand oligodeoxynucleotides (ssODNs) were designed to be 
homologous to the target site with the exception of the desired codon change (encoding 
S531P) and silent single nucleotide change to interrupt the PAM sequence. The 
introduction of the S531P SNP also introduced a XmaI restriction site that can be 
utilised during subsequent RFLP analysis. Four different ssODNs were ordered from 
IDT; these included sense and anti-sense versions of a 70-mer and 120-mer containing 





















































Table 2.2 single strand oligodeoxynucleotides (ssODNs) used as donor templates to 
introduce the S531P codon change. Nucleotide changes from wild-type sequence are 
coloured red and resulting Xma1 restriction site is underlined. 
2.8.5 Transfections  
Low passage porcine embryonic fibroblasts (PEFs; see Section 2.4.2) were used to test 
CRISPRs and HDR templates. CRISPR/Cas9 plasmids and HDR templates were 
delivered into cells using the Neon transfection system (Life Technologies) with 100 
μl reaction tips. PEFs were thawed (see Section 2.4.4) and maintained until ~95 % 
confluent and were subsequently spilt 1:2 and harvested (see Section 2.4.5) for 
transfection the next day, when they reached ~70-80 % confluent. The PEFs were 
washed in PBS and counted using a haemocytometer (see Section 2.4.10) prior to 
resuspending in buffer R at 6 x 106 cells/ml. 2 µl of CRISPR/Cas9 plasmid DNA (1 
μg/μl) with or without 2 µl of 100 µM HDR ssODNs was added to 6 x 10⁵ resuspended 
cells to make up each transfection mixture. To transfect the cells, each mixture was 
electroporated using the following parameters: 1800 V; 1 pulse with 20 ms width. 
After transfection the cells were split into two wells of a 6-well plate containing 
DMEM medium with 10 % FBS and expanded for 48 hours in a humidified 37°C 
incubator with 5 % CO2. After incubation, the PEFs were harvested and resuspended 
in 200 µl of PBS for sorting with the FACS Aria machine (BD Biosciences) using the 
FACSDiva software (BD Biosciences). The PX458 expresses Cas9 linked to eGFP, 
therefore, to positively select transfected cells, they were sorted based on their GFP 




PCR amplification and analysis of target locus with T7 assay and/or Xma1 digestion 
(see Section 2.8.7).  
2.8.6 Lysing cells for PCR  
Cells were lysed at a density of ~5000 cells per 1 µl of PCR compatible lysis buffer 
(1X). Cells were washed once in PBS prior to addition of PCR compatible lysis buffer 
(see Section 2.12.1). To completely lyse cells, samples were incubated in a 
thermocycler at 55°C for 55 minutes before 95°C for 15 minutes and then held at 10°C. 
2 μl of each lysate was used for a 25 μl PCR reaction (see Section 2.1.2) using PCR 
primers for RELA (see Section 2.11.1) that span a 308 bp region (on WT sequence) 
spanning the sgRNA target locus. 
2.8.7 T7 assay and RFLP analysis 
T7 endonuclease I (NEB) was used to detect on-target CRISPR/Cas9 events due to its 
ability to detect and cleave miss-matched DNA. After PCR amplification on DNA 
from transfected cells, 2 µl from each PCR was run on a 1 % agarose gel to estimate 
DNA concentrations. 200 ng of PCR product from each PCR reaction was denatured 
and reannealed in a thermo cycler program to allow the formation of heteroduplex 
DNA. The denature and reanneal program was as follows; 95°C for 10 minutes; then 
decreasing the temperature to 85°C at a rate of -2°C/sec; 85°C for 1 minute; decreasing 
the temperature to 75°C at a rate of 0.3°C/sec; 75°C for 1 minute, decreasing the 
temperature to 65°C at a rate of 0.3°C/sec; 65°C for 1 minute, decreasing the 
temperature to 55°C at a rate of 0.3°C/sec; 55°C for 1 minute decreasing the 
temperature to 45°C at a rate of 0.3°C/sec; 45°C for 1 minute decreasing the 
temperature to 35°C at a rate of 0.3°C/sec; 35°C for 1 minute, decreasing the 
temperature to 25°C at a rate of 0.3°C/sec; 25°C for 1 minute, decreasing the 
temperature to 4°C at a rate of 0.3°C/sec; 4°C hold. After reannealing, 1 µl of T7 
endonuclease was added to each tube, mixed well and incubated at 37°C for 15 
minutes. Immediately after incubation, the reactions were resolved on a 2 % agarose 
gel. The resulting cleaved and full-length PCR products were visualized and imaged 
using a UV Transilluminator Gel Dock. Image J software was used to analyse the 




HDR was detected restriction fragment length polymorphism (RFLP) analysis with 
XmaI (NEB). 200 ng of the PCR reaction (described in Section 2.4.6) was used in a 
restriction digest containing 1 µl of XmaI, 2 μl of 10X CutSmart® buffer (NEB) and 
nuclease free water to a final volume of 20 μl. Reactions were incubated at 37°C for 1 
hour before resolving on a 2 % agarose gel.  
2.8.8 Microinjection of porcine embyros 
Preparation and transfer of embryos was carried out as described in Lillico et al (2013) 
by the staff at The Large Animal Unit, Dryden Farm, Roslin Institute. All embryo 
microinjections were carried out by Dr Simon Lillico. 
2.8.9 In vitro analysis of embyros 
Embryos were cultured for 6-8 days post-injection for in vitro analysis, which was 
carried out by Claire Neil. All embryos that reached blastocyst stage in culture were 
collected and transferred individually to PCR tubes and stored at -20°C for future 
analysis. Embryos were lysed for PCR amplification (see Section 2.1.2). To digest an 
embryo, 10 μl of embryo digestion buffer (see Section 2.12.1) was added to the PCR 
tube and then incubated at 55°C overnight before heating at 95°C for an additional 10 
minutes. 5 μl of the digested embryo product was used per 25 μl PCR reaction (see 
Section 2.1.2). The PCR product was then prepared for sequencing (see Section 2.1.6) 
and analysis of sequence data was carried out on Lasergene Software (DNASTAR).  
2.9 Statistical Analysis 
Data was analysed using Student t-test. All of the results presented display the mean 
and error bars represent the standard error of the mean (S.E.M). Analysis was 
performed using Microsoft Excel. A probability (p) value of less than 0.05 was 
considered statistically significant. 
2.10 Computer software and online resources 








All primer design was carried out NCBI primer BLAST tool: 
http://www.ncbi.nlm.nih.gov/tools/primer-blast/ 
BLAST searches were performed using NCBI databases: 
http://blast.ncbi.nlm.nih.gov/Blast.cgi 






2.11.1 PCR primers 
Table 2.3 All PCR primers used in this thesis. 
Annealing 
Temperature
F: GCAATAACACTGACCCGACCGTG Product  size for 





















































PPIA 68bp Gil et al, 2007






IL12 118bp Gil et al, 2007






qRT-PCR Primer sequences (5'→3') Product Size References
B2M
60°C
180bp Cinar et al, 2012
CCL2 78bp






Table 2.4 Antibodies used in this thesis for immunocytochemistry (ICC) and western 
blots (WB).  
2.12 Buffers and solutions 
2.12.1 DNA techniques 
Luria-Bertani (LB) Broth: 1 % (w/v) Bacto Tryptone, 0.5 % (w/v) Bacto Yeast 
Extract and 125 mM NaCl made up with deionised water, this solution was then 
autoclaved on liquid cycle for 20 minutes at 15 psi before use.  
LB Agar: 1 % (w/v) Bacto Tryptone, 0.5 % (w/v) Bacto Yeast Extract, 125 mM NaCl 
and 1.5 % sugars plus 15 g/L of agar made up with deionised H₂O, this solution was 
then autoclaved as mentioned above. 
Super Optimal Broth (SOB) medium: 2 % (w/v) Bacto Tryptone, 0.5 % (w/v) Bacto 
Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 5 mM MgSO4 made up in 
distilled water, the solution was then autoclaved as previously mentioned. 
Super Optimal Broth with Catabolite repression (SOC) medium: 2 % (w/v) Bacto 
Tryptone, 0.5 % (w/v) Bacto Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 
10 mM MgSO4, 20 mM glucose was made up in distilled water, the solution was 
autoclaved before the addition of glucose. The glucose was filter sterilized by passing 
a 1M solution through a 0.2 µM filter before use.  
  Dilution  (1 / x)
Primary Antibodies Supplier Species ICC WB
α-Tubulin Thermo Scientific (62204) Mouse * 20000
C-Rel Santa Cruz (sc-70) Rabbit * 500
IkB-α Abcam (ab32518) Rabbit * 1000
Lamin A+C Abcam (ab8984) Mouse * 500
p50/p105 Santa Cruz (sc-114) Rabbit * 500
RelA (C-terminal) Santa Cruz (sc-372) Rabbit * 500
RelA (N-terminal) Santa Cruz (sc-8008) Mouse 250 500
RelB Abcam (ab180127) Rabbit * 1000
vp-72 IAH (4H3) (Cobbold et al. 1996) Mouse 5 *
Seconadry Antibodies Supplier Recognises ICC WB
Alexa Fluor 488 Life Technologies (A-11001) Mouse 500 *
Alexa Fluor 596 Life Technologies (A-11012) Rabbit 500 *
Mouse Immunoglobulins HRP Dako (P0447) Mouse * 1000




Tris-acetate-EDTA TAE (50X) Buffer: For 1 litre of 50X TAE stock solution, 242 
g of Tris, 57.1 ml glacial acetic acid, and 100 ml of 0.5 M EDTA (pH 8.0) solution 
was made up to final volume of 1 litre with deionised water. This stock solution is 
diluted 50:1 with deionised water to make a 1X working solution (40 mM Tris, 20 mM 
acetic acid, and 1 mM EDTA) 
Tris-EDTA (TE) Buffer: 10 mM Tris hydrochloride, 1 mM EDTA made up in 
deionised H₂O.  
5X PCR compatible loading buffer (5X Fi-RED): 10 % (v/v) Ficoll-400, trace of 
cresol red dye made up in nuclease-free water in sterile conditions, the solution was 
filtered through 0.22 μM filter before use.  
RF1: 100 mM RbCl, 50 mM MnCl2, 30 mM potassium acetate, 10 mM CaCl2, 15 % 
(w/v) glycerol, made up in deionised water and adjusted to pH 5.8 with acetic acid, 
this solution was filter sterilized with 0.22 μM filter and stored at 4°C until use.  
RF2: 10 mM MOPS, 10 mM RbCl, 75 mM CaCl2, 15 % (w/v) glycerol, made up 
deionised water and adjusted to pH 6.8 with 100 mM NaOH, this solution was filter 
sterilized with 0.22 μM filter and stored at 4°C until use. 
PCR compatible lysis buffer (1X): 10 mM Tris-Cl pH 8.0, 2 mM EDTA, 0.45 % 
(v/v) Triton-X-100, 0.45 % (v/v) Tween-20 and 200 μg/ml Proteinase K made up in 
nuclease-free water. The solution without Proteinase K was kept at room temperature 
and Proteinase K was added immediately before use.  
Embyro digestion buffer (1X): 50 mM KCl, 10 mM TrisHCl (pH 8.3), 2.5 mM 
MgCl₂, 0.1 mg/ml gelatine, 0.45 % (v/v) NP-40, 0.45 % Tween-20 and 200 μg/ml of 
Proteinase K made up in nuclease-free water. The solution without Proteinase K was 
kept at room temperature and Proteinase K was added immediately before use. 
2.12.2 Protein techniques 
RIPA cell lysis buffer: 1X RIPA buffer (150 mM NaCl, 1.0 % IGEPAL® CA-630, 
0.5 % sodium deoxycholate, 0.1 % SDS, 50 mM Tris, pH 8.0) (Sigma) was kept at 




EDTA-free protease inhibitor cocktail tablet (Roche) were dissolved in 20 ml of RIPA 
buffer (Sigma) immediately before use.  
Protein Sample buffer: 2X Novex® Tris-Glycine SDS Sample Buffer (ThermoFisher 
Scientific) was used to diluted with protein samples to prepare them for loading on the 
gel. 
1X Western Running Buffer: 25X Novex® Tris-Glycine Transfer Buffer 
(ThermoFisher Scientific) was diluted 1:25 with deionised water to give working stock 
solution. 
Ponceau S stain: 0.1 % Ponceau S dye (w/v), 5 % acetic acid (v/v) made up in 
deionised water. 
Tris-Glycine transfer buffer: 25 M Tris, 19 mM glycine, 20 % (v/v) methanol made 
up in deionised water. 
Dulbecco’s Phosphate Buffered Saline (PBS): 137 mM NaCl, 10 mM Na₂HPO4, 2.7 
mM KCl, 1.8 mM KH₂PO₄ made up in deionised water and adjusted to pH 7.4 using 
1 M HCl. 
PBS Tween (PBS-T): 0.05 % (v/v) Tween-20 made up in PBS. 
Western blocking buffer: 5 % (w/v) Marvel milk powder made up in PBS-T.  
4 % Paraformaldehyde (PFA): 4 % formaldehyde powder (w/v) made up in PBS 
and adjusted to pH 6.9 using 1 M HCl. To make this solution all steps were carried out 
in a ventilated hood. Formaldehyde powder was added to PBS in a glass beaker which 
is heated on hot plate to 60°C and the mixture was stirred with a magnetic stirrer. 1 M 
of NaOH was added in a dropwise manner to raise pH until PFA was fully dissolved 
and solution goes clear. Once the solution had cooled, the pH was adjusted if required 
with 1M HCl and filtered through a 0.45 μm filter membrane to remove any particulate 
matter. The PFA solution was then aliquoted and stored at -20°C for future use.  
Immunocytochemistry blocking buffer: 1 % (w/v) bovine serum albumin (BSA) 




2.12.3 Cell culture 
100X Antibiotic-Antimycotic (Anti-Anti): Gibco product containing 10,000 units/ml 
of penicillin, 10,000 µg/ml of streptomycin, and 25 µg/ml of Fungizone™ 
Porcine Adult Fibroblast (PAF) digestion media: Collagenase type I 0.5 % (w/v; 
Gibco), 0.2 % (v/v) 100X Anti-Anti, 50 μg/ml Gentamycin (Gibco) made up in 
DMEM containing high glucose, GlutaMAX™ Supplement and pyruvate (Gibco).  
Porcine Embryonic Fibroblast (PEF) digestion media: Collagenase type I 0.25 % 
(w/v; Gibco), 0.1 % (v/v) 100X Anti-Anti made up in DMEM containing high glucose, 
GlutaMAX™ Supplement and pyruvate (Gibco). 
Porcine Fibroblast outgrowth media: 20 % (v/v) FCS (Gibco), 0.1 % (v/v) 100X 
Anti-Anti made up in DMEM containing high glucose, GlutaMAX™ Supplement and 
pyruvate (Gibco). 
Complete medium for Fibroblast cultures: 10 % (v/v) FCS (Gibco), 10 units/ml 
penicillin, 10 μg/ml streptomycin made up in DMEM containing high glucose, 
GlutaMAX™ Supplement and pyruvate (Gibco). 
Complete medium for Macrophage cultures: 10 % (v/v) low-endotoxin FCS (gift 
from Hume group) supplemented with 10⁴ units/ml human recombinant CSF-1 
(rhCSF1; a gift from Chiron, Emeryville, CA) made up in RPMI 1640 Medium 
containing GlutaMAX™ Supplement and HEPES (Gibco).  
Red Blood Cell Lysis Buffer (RBC-LB): 10 mM KHCO₃, 150 mM NH₄Cl, 0.1 mM 
EDTA pH8 dissolved in deionised water and filtered through 0.22 μM filter before 
use.  
Embyromax buffer: 10 mM Tris-HCL, pH7.5, 0.1mM EDTA dissolved in nuclease-





Eosin Stock solution: To make up 1 litre of Eosin Stock solution; 10 g of Eosin Y CI 
45380 (Sigma) was dissolved in 800 ml of Ethanol with 2.5 ml of 1 % Phoxine B (CI 
number 45410, Acid Red 92) made up to 1 litre with deionised water.  
Eosin working solution: For working Eosin solution, 100 ml of stock solution was 
added to 200 ml of 70% Ethanol, 1.5ml of Glacial acetic acid and mix thoroughly.  
Haematoxylin: Harris haematoxylin (Leica Biosystems) 
Scott’s tap water substitute: To make up 2 litres of Scott’s tap water substitute, 7 g 
of NaHCO3 and 40 g of MgSO4 was diluted in 2 litres of deionised water.  
Acid alcohol: To make Acid alcohol, 5 ml of Hydrochloric acid was added to 995 ml 





Chapter 3 The characterisation of gene editing 
in porcine RELA 
3.1 Introduction  
As discussed in Chapter 1, it has been proposed that polymorphisms in porcine RELA 
have the potential to underlie resilience to African swine fever (ASF; Palgrave et al., 
2013). ASF is a highly contagious disease of domestic and feral pigs, caused by 
infection with African swine fever virus (ASFV). Infection with virulent ASFV 
isolates results in a rapid onset haemorrhagic fever and death within 5-10 days in the 
domestic pig. The infected macrophages produce high levels of pro-inflammatory 
cytokines which is thought to initate the course of the disease (Gomez-Villamandos et 
al., 1995; Sierra et al., 1996, Salguero et al., 2005; Blome et al., 2013). Characteristics 
of ASF include lymphocyte and lymphoid tissue depletion, severe disruptions to blood 
clotting process, and lastly heamarhagic lesions predomainantly in the lymph nodes, 
kidneys and heart. In contrast with domestic pigs, African wild suid hosts, the bushpig 
and warthog, show no apparent signs of diease when infected with ASFV (Thomson 
et al., 1980, Oura et al., 1998). Functional variation between the warthog RELA and 
domestic pig RELA is hypothesised to underlie the dramatic difference in response to 
ASFV infection in these two species (Palgrave et al., 2011). RELA encodes for the 
RelA protein, a member of the NF-κB transcription factor family. The NF-κB 
transcription factors play a vital role in upregulating immune and inflammatory 
responses, including many of the pro-inflammatory cytokines indicated in ASF 
pathology (Zhang et al., 2006, Gomez del Moral et al., 1999, Gomez-Villamandos et 
al., 2013). This RELA variation was found to alter the NF-κB transcription activity 
levels in vitro; with reduced transcriptional levels for warthog RELA compared to 
domestic pig RELA (Palgrave et al., 2011). 
To test this hypothesis genome editors were developed to target proximal to the 
identified polymorphic region within porcine RELA (Lillico et al., 2013). This region 
encodes for the C-terminal transactivation domain (TAD), which is essential for 
initiating transcription of target genes (Schmitz & Baeuerle., 1991). The developed 
TALEN editors were directly injected into pig zygotes for the production of RELA-




being born from this procedure. The main objective of this chapter was to define the 
outcome of the genome editing. After initial genotyping was completed, specific 
RELA-editing events were selected for further characterisation, carried out in cells 
before phenotyping of animals. These experiments will be detailed in the following 
section. 
3.1.1 Aims  
The main aims of this chapter are: 
i) To genotype TALEN founder animals and coordinate the breeding of RELA-
edited pigs to produce cohorts for further study 
ii) To investigate the impact of the RELA trunc mutation on NF-κB signalling in 
primary fibroblasts 
iii)  To determine whether RELA trunc pigs display a phenotype, regarding their 






3.2.1 Genotyping and maintaining RELA-edited pigs 
3.2.1.1 RELA editing events identified in founder animals 
As part of a collaboration with Recombinetics Inc. TALENs were designed to cut 
between bases 1458 and 1505 bp of the porcine RELA cDNA (NCBI reference 
sequence: NM_001114281A; Lillico et al., 2013). At the start of this research project, 
live piglets were born resulting from zygotes injected with mRNA encoding these 
TALENs. To identify targeted editing events in these piglets, firstly genomic DNA 
was extracted from ear biopsy tissue, and a 300 bp sequence flanking the TALEN 
target site was PCR amplified for direct sequencing (Figure 3.1). The reverse primer 
was used for DNA sequencing as it provides a longer read sequence before the TALEN 
target site compared to using the forward primer. In the resulting sequence 
chromatograms, multiple traces were evident in 5 out of the 41 live piglets, indicating 
the presence of editing events (Figure 3.2). These five RELA-edited animals are the 
first live born pigs resulting from genome edited zygotes. A single trace of wild-type 
RELA sequence was present in the other 36 animals, signifying the absence of editing 
events. Sequencing chromatograms from two animals, pig 16 and 33, consisted of 
several overlapping traces indicating multiple events, confirmed by sequencing of 
cloned PCR products. Three independent editing events were identified in each of 
these animals. Such genetic mosaicism occurs when gene editing takes place after the 
zygote has undergone cell division. Two traces of similar signal intensities are 
displayed both pigs 26 and 34, suggesting that editing occurred only at the one-cell 
stage. The sequence chromatogram from pig 30 also displays two traces, however, the 
4 bp deletion trace appears at a lower intensity compared to the 111 bp deletion trace. 
This is likely a consequence of the PCR favouring the smaller amplicon size of the 
large deletion product. In total, eight editing events were identified in the five RELA-
edited animals, two of which caused in-frame mutations and six of which caused a 
frameshift mutation; these frameshifts all resulted in the introduction of premature stop 





Figure 3.1 Positions of TALEN binding sites and PCR primers on porcine 
RELA. Schematic diagram showing RelA protein domains, highlighting the 
protein region that is encoded by the final exon of porcine RELA gene. The 
porcine RELA gene contains 11 exons that produce a 2.53 kb mRNA transcript. 
The target region in the final exon is highlighted, and the domestic pig DNA 
sequence is displayed in the lower panel. Each TALEN binding site is circled 
with blue and RELA primer sequences circled in green. The predicted TALEN 
cut sites are indicated with the blue arrows. Codons which encode for the amino 
acid differences identified between the warthog and the domestic pig RelA are 





Figure 3.2 Identification of RELA-editing events in founder animals. A) Image of 
the five RELA-edited piglets B) Sequence chromatograms for a wild-type control and 
the five RELA-edited animals. The dashed line shows where the sequence diverges from 
the wild-type sequence, indicating gene editing. Due to the large deletion identified in 
pig 30, sequence displayed is further downstream than the other edited pigs C) Table 
displaying the RELA-edited pigs and their corresponding RELA editing events D) All 
TALEN editing events identified from sequence analysis in the ear biopsy of the five 
RELA-edited founder animals. The WT control sequence is shown in the top panel with 
encoding amino acids in green above. TALEN DNA binding sites are highlighted in 
grey. The edited sequences contain base changes shown in red and in the case of the 
frame-shift mutations, a premature stop codon, which is highlighted in yellow. Note that 
sequences shown in B are the results of sequencing using the RELA reverse primer and 




3.2.1.2 Impact of RELA editing on encoding protein sequence 
The majority of the indels in the RELA locus cause a frameshift, which in turn 
generates a premature stop codon. As the RELA gene editing occurs within the final 
exon, the resulting mRNA transcripts were anticipated to evade the nonsense mediated 
mRNA decay surveillance and therefore yield a truncated RelA protein.  
The genotypes of all five RELA-edited animals and the predicted changes to the 
encoding protein are shown in figure 3.4. All of the edited pigs contain at least one 
indel in their coding sequence causing a frameshift event, resulting in the loss of the 
C-terminal 60 amino acids of wild-type RelA. However, the premature stop codon is 
not always present at same position in the coding sequence resulting in variety of 
truncated RelA proteins. Two editing events, the 4 bp deletion and the 4 bp insertion, 
present in pigs 30, 33 and 34, introduce at stop codon seamlessly at the cut site. These 
are predicted to result in a RelA protein that lacks the C-terminal 60 residues. The final 
60 amino acids encode for the C-terminal region of the TAD encompassing the entire 
TA1 domain. Editing events that are in-frame include a 111 bp deletion and 6 bp 
deletion, identified in pig 30 and 33 respectively, result in a RelA protein lacking 60 
amino acids in this C-terminal TAD.  
To confirm the expression of RELA protein with a truncated C-terminus in these 
animals, cells were harvested for western blot analysis. Peripheral blood mononuclear 
cells (PBMCs) were isolated from the blood of each edited animal and one wild-type 
control. Subsequently, the PBMCs were counted and equal numbers prepared for 
whole cell lysis. 20 μg of each protein lysate was run per well on an SDS-page and 
probed with antibody recognising the N-terminal region of RelA, allowing detection 
of both truncated and wild-type RelA. As expected full length RelA (553 aa, 65 kDa) 
was detected in the wild-type control and in pigs 26 and 16, both of which maintain a 
WT allele (Figure 3.3.B). Additional products from the truncated alleles were detected 
in samples from all five edited pigs (lower bands). 
Pig 34 is of particular interest as the genotyping and western blot results have revealed 
that both of its RELA alleles encode a truncated protein missing the final 60 amino 
acids at the C-terminal end. As discussed in Chapter 1, rela-/- mice have an embryonic 




viable when housed in typical farm environment, suggesting that the truncated RelA 
protein retains significant functionality despite lacking a highly-conserved domain. 
Initial studies were carried out on pig 34 and 26, as they provide a bi-allelic and a 
heterozygote model to investigate the impact of the truncated RelA on NF-κB 






Figure 3.3 Consequences of RELA-editing to the encoding protein in founder 
animals.  A) Table detailing the genotypes of the five RELA-edited pigs and the 
subsequent changes to the amino acid sequence of RelA. Additional nonsense 
amino acids are shown in bold, and the polymorphic residues of interest are 
indicated (S485P and S531P). The TA1 domain is underlined in blue B) Western 
blot analysis of PBMCs isolated from wild-type control and the five RELA-edited 
animals. The blot was probed with an antibody recognising the N-terminus of 






Figure 3.4 The RelA truncation mutant. A) Schematic diagram of RelA 
protein. The protein sequence of the RelA transactivation domain of the domestic 
pig (Sus scrofa), warthog (Phacochoerus africanus), dog (Canis lupus 
familiaris), human (Homo sapiens) and mouse (Mus musculus) is displayed in 
panel below. The three polymorphic residues of interest are indicated (T448A, 
S485P and S531P). The red arrow shows the final amino acid of the RelA 
truncation mutant. B) Schematic diagram of both full length and the truncated 
RelA identified within RELA-edited pigs 26 & 34. C) Western blot analysis of 
PBMCs isolated from wild-type control and RELA-edited pigs 26 & 34, probed 
with antibody that recognises the N-terminus of RelA. The full-length RelA 
protein is identifiable as expected at 65 kDa and the truncated RelA protein is 




3.2.1.3 Breeding RELA-edited animals for the production of 2 
generations of animals 
Once sexually mature, the RELA-edited animals 26, 30 & 34 were selected for a 
breeding program to generate more animals for this study. Pigs 26 and 30 were mated 
together to produce a cohort of animals bi-allelic for the RelA truncation for analysis. 
Pigs 30 & 34 were also bred against unrelated wild-type controls, to produce 
heterozygous animals. Six female heterozygote F1 offspring were subsequently bred 
against F1 male heterozygotes to produce the second generation (F2) of animals. Only 
F1 animals heterozygous for the 4 bp deletion or the 4 bp insertion, derived from 
founder pigs 30 and 34 respectfully, were selected for breeding (Figure 3.5). These 
edited-RELA alleles encode for the same truncated RelA protein product, missing the 
final 60 amino acids of wild-type porcine RelA. In all subsequent sections, the results 
displayed are from analysis of the F2 animals unless stated otherwise, these are 
collectively referred to as, homozygote or heterozygote for RELA trunc. 
Figure 3.5. Breeding stragey for RELA trunc pigs. 
3.2.1.4 Novel genotyping strategy for 2nd generation piglets 
A more rapid genotyping strategy was sought for the 2nd gereration of piglets. The 
highest mortality rate of live-born piglets is observed within the first four days after 
birth (Marchant et al., 2000). Rapid screening would inform us of the  genotype before 
necessary culls or deaths of young piglets, so we could restrict sampling or further 
treatment to only those animals of the desired genotypes. All previous screening of 
piglets was carried out by sequencing PCR products; this takes 3-4 days from 




strategy was designed omitting the requirement for sequencing and instead utilising 
the CRISPR/Cas9 gene editing system. The customisable component of the 
CRISPR/Cas9 system, the sgRNA, was designed to identify each of the three parental 
RELA-alleles (wild-type, 4 bp deletion and the 4 bp insertion) of the second 
generation. These sgRNAs combined with the Cas9 protein, were intended to be used 
in an in vitro cleavage assay on the RELA PCR product to report on the likely genotype 
(Figure 3.6.a-b).  
In total, four sgRNAs were designed, one to target each of the three individual RELA-
alleles, and a fourth intended to identify both the WT and Δ4 alleles. This overlapping 
sgRNA could be useful for detecting the WT allele in animals known not to contain 
the Δ4 as a result of breeding design background.  
Firstly, to examine if the designed sgRNAs efficiently targeted the intended RELA-
allele, a cell transfection assay was carried out. The sgRNA sequence was cloned into 
plasmid PX458 downstream of a U6 promoter, followed by a CAG driven Cas9-2A-
GFP (for detailed description see Section 2.8.2). Each of the CRISPR/Cas9 plasmids 
were individually transfected into wild-type porcine embryonic fibroblasts (PEFs) 
using the neon electroporation system. The transfected cells were cultured for 48 hours 
before extracting genomic DNA for analysis. The RELA PCR was carried out on the 
genomic DNA to amplify the 308bp region spanning the CRISPR target site. 
Following a denature/anneal cycle a T7 endonuclease assay was performed on the PCR 
product to detect mismatches at the target site (Figure 3.6.c). As expected, T7 
endonuclease activity was observed in both WT CRISPRs signifying successful 
editing of WT fibroblasts and not detected in the Δ4 and +4 specific CRISPR 
transfections (i.e. the target site was absent from WT cells).  
After confirming the WT guides activity in cells, we aimed to test these in an in vitro 
cleavage assay. For this assay sgRNA, Cas9 protein and a DNA template are required. 
PCR amplification of the sgRNA segment from appropriate plasmids using a forward 
primer designed to contain the T7 promoter was used to produce a template molecule 
for in vitro sgRNA synthesis, carried out as described in Section 2.8.5. 400 ng in vitro 
synthesised WT sgRNA were pre-incubated with 2 μg of Cas9 protein (NEB)  in Cas9 




Cas9 protein prior to addition of a DNA template. For the in vitro cleavage assay, 200 
ng of wild-type RELA PCR product was added to the pre-complexed Cas9/sgRNA 
solution and incubated for 1 hour at 37°C. The reaction was then resolved on a 1% 
agarose gel. The resulting gel indicates that the DNA failed to migrate from the well 
and into the gel. A denaturation step of 72°C post incubations in an attempt to resolve 
the issue, but no improvement was observed (Figure 3.6.d). All variations on the 
mixture of components were tried to determine why the DNA did not migrate from the 
well of this assay, (Figure 3.6.d). The results suggest that a non-specific interaction 
between the DNA template resulted in this unexpected outcome, although I was unable 
to find any similar reports in the literature. As a result, this genotyping strategy was 
abandoned, and direct sequencing was used to confirm the RELA genotypes of each 
animal.  
Figure 3.6 Novel genotyping strategy for second generation of animals 
utilising the CRISPR/Cas9 system. A) The sgRNA target binding sites shown 
for detection of wild-type or specific RELA-edited allele, with possible PAM 
sites underlined. Changes from wild-type sequence are shown in red. B) Table 
displays the possible genotypes of the second generation of piglets and how the 
sgRNA cutting pattern could decipher the genotype of individual piglets born. C) 
Gel image of the T7 endonuclease assay conducted on transfected wild-type 






3.2.2 Investigating the impact of truncated porcine RelA on 
NF-κB signalling in pig fibroblasts 
To explore the impact the truncated RelA protein has on the NF-κB pathway fibroblast 
cells were isolated from wild-type pigs, heterozygote and homozygote RELA trunc 
pigs. Primary fibroblasts are cells which constitute connective tissue, maintaining 
structural support of tissues through the production extracellular matrix and collagen.  
Fibroblasts were chosen as they are sensitive to induction by many cytokines and they 
are dependent on the RelA subunit to drive the transcription of the majority of NF-κB 
target genes (Essen et al., 2009, Ouaaz et al., 1999). 
Porcine adult fibroblasts (PAFs) where extracted from skin tissue from the ear of 
individual euthanised pigs and cryopreserved as a fibroblast line labelled with the pig 
ID and genotype for future use (for methodology see Section 2.4.2). Initial tissue 
dissociation resulted in the isolation of additional cell types from skin biopsy, such as 
keratinocytes. While fibroblasts and keratinocytes both adhere to the cell culture 
vessel, both can be clearly distinguished based on their characteristic morphology and 
growth patterns. Fibroblasts have elongated, spindle-like bodies and grow aligned and 
in bundles once confluent, whereas keratinocytes have a polygonal shape and grow in 
distinct patches. While the presence of serum in the culture media favours growth of 
fibroblasts, some keratinocyte colonies are usually observered (Shipley et al., 1989). 
Fortunately we found that the majority of keratinocytes remain adhered to the culture 
vessel after cell dissociation of fibroblasts cultures using light trypsinisation (Figure 
3.7). Thus, all cultures were passaged at least twice to allow for relatively pure 
fibroblast culture before experimentation. The presence of keratinocytes could not be 




Figure 3.7 Fibroblasts culture pre- and post- cell dissociation treatment. 
Growth of keratinocyte cells is indicated with the white arrow. The surrounding 
elongated fibroblast cells are dissociated by the treatment with trypsin. 
To induce the NF-κB pathway in the fibroblast cultures, the cells were treated with 
recombinant porcine TNFα, a well-known activator of the canonical pathway typically 
involving the RelA-p50 heterodimer (for details on the canonical pathway see Section 
1.9.2). Fibroblasts were stimulated with a 5 minute ‘pulse’ of TNFα (10 ng/ml), and 
subsquently washed three times with fresh media before culturing for the remaining 
time, to emulate pulsatile pro-inflammatory signals received in vivo (Ashall et al., 
2009). The TNFα pulse treatment also permits the investigation into the impact of the 
truncated RelA on the NF-κB negative feedback loop.  
3.2.2.1 Impact on RELA-dependent gene expression 
To investigate the impact of the truncation on RelA’s transcriptional activity, gene 
expression analysis was performed on five well-known RelA-dependent target genes 
in unstimulated and TNFα stimulated fibroblasts. Wild-type control, heterozygous and 
homozygous RELA trunc fibroblast cell lines were each plated at the same seeding 
density in four wells. Three wells were treated with TNFα and the other was left as an 
uninduced control. After the specified time in culture post-TNFα stimulation (i.e. 30, 
60 or 120 minutes) the fibroblasts were collected and RNA purified to make cDNA 
(see Section 2.7.1-2). The level of RelA gene expression was analysed by qRT-PCR 
(see Section 2.7.3). The expression level was normalised to the mean of 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and Beta-2-Microglobulin 
(B2M) expression and the expression levels were calculated relative to the uninduced 




After three independent NF-κB inductions, the homozygous fibroblasts showed 
significantly lower induced expression of all five RelA-dependent genes compared to 
wild-type fibroblasts at 30 minutes post-TNFα (Figure 3.8). The heterozygous 
fibroblasts showed significantly reduced expression in two of the five RelA-dependent 
target genes, CSF2 and TNF, compared to wild-type at 30 minutes post-TNFα. At 60 
minutes post-TNFα a significant reduction of induced gene expression was only 
identified in IKBA and TNFAIP3 in homozygous fibroblasts. In contrast, a significant 
increased expression was identified in three out of the five RelA-dependent genes, 
CSF2, IKBA and TNF, at 120 minutes post-TNFα induction. The overall trend of the 
gene panel was a retarded upregulation in response to induction in homozygous 
fibroblasts compared to wild-type cells at 30 and 60 minutes’ post-induction. However 
this later reverted, as at 120 minutes post-induction the relative transcript levels were 
higher in homozygote cells compared to control cells. These results show that the 
expression of all five RelA-dependent genes in response to TNFα was altered in cells 





Figure 3.8 Gene expression analysis of RelA-dependent target genes. qRT-
PCR analysis of RelA-dependent target genes, CSF2, CXCL2, IKBA, TNF & 
TNFAIP3 in fibroblasts containing wild-type and truncated RelA induced with 
TNFα pulse (10 ng/ml). Relative expression was calculated by normalising to the 
corresponding uninduced fibroblasts. Significant difference was calculated 
between the wild-type controls and RelA-edited at each specific time post-TNFα 
using a Student’s paired t-test. Significant difference is indicated with black 
symbol *(p<0.05) or **(p<0.001). Error bars represent the standard error of the 
mean (S.E.M.) from the three independent inductions.  
 
3.2.2.2 Truncated RelA interrupts the NF-κB negative feedback loop  
The qRT-PCR analysis revealed that the induced expression of IKBA (IκBα) and 
TNFAIP3 (A20), which regulate the NF-κB negative feedback loop, were significantly 
reduced in cells homozygous for the RelA trunc mutation (for details on the NF-κB 
negative feedback loop see Section 1.9.4.2). IκBα is the key inhibitor of NF-κB and is 
responsible for the rapid switch off of the NF-κB pathway in TNFα stimulated 
fibroblasts (Hoffman et al., 2002;). For this reason, the impact of truncated RelA on 
the negative NF-κB feedback loop was selected for further investigation. 
Upon induction with TNFα IκBα is rapidly degraded in a variety of cell types, 
including fibroblasts (Baldwin., 1996). Furthermore, the upregulation of IκBα by NF-




NF-κB from the nucleus back to the cytoplasm (Sun et al., 1993, Arenzana-Seisdedos 
et al., 1997). To confirm that the delayed expression of IKBA resulted in the same 
effect on IκBα protein levels in fibroblasts post-TNFα stimulation, cells were assayed 
by western blot. Fibroblast cells from wild-type control, heterozygous and 
homozygous truncated cell lines were each plated into eight wells at the same seeding 
density. After 24 hours in culture, seven wells were treated with TNFα and the final 
well was left as an uninduced control. After a specified time in culture post-TNFα 
stimulation (i.e. 30, 90, 120, 150, 180 or 210 minutes), the fibroblasts were lysed for 
analysis by western blotting (see Section 2.5.5). 30 μg of each protein lysate was run 
per well on an SDS-page and probed with antibodies recognising IκBα and α-tubulin 
(Figure 3.9.a). The level of IκBα was normalised to the α-tubulin level for that sample 
using densitometric analysis (Figure 3.9.b). The data revealed a delayed response in 
the rate at which IκBα returned to basal levels in both the heterozygous and the 
homozygous RELA trunc fibroblasts; as expected this phenomenon was more 
pronounced in the homozygous fibroblasts. Another noticeable difference was 
observed in the basal levels of IκBα which were noticeably lower (42.1%) in the 




Figure 3.9 Levels of IκBα in RELA trunc fibroblasts over-time after NF-κB 
stimulation with TNFα. A) Western blot analysis of cells after TNFα treatment 
with wild-type control cells run in parallel. 30 μg of whole protein lysate was 
loaded per lane and the blots were probed with an antibody recognising IκBα and 
α-tubulin B) Levels of IκBα normalised to the α-tubulin level for each sample, 





3.2.2.3 Nuclear translocation kinetics altered in RELA trunc cells  
Due to the delayed restoration of IκBα levels following TNFα induction in 
homozygous RELA trunc cells, it was reasoned that the truncated RelA protein may 
occupy the nucleus for an extended time. To test this hypothesis, the nuclear 
translocation of truncated RelA was investigated using immunocytochemistry and 
western blotting. 
The nuclear translocation of RelA in wild-type, heterozygous and homozygous RELA 
trunc fibroblast cells was visualised using immunofluoresecent confocal microscopy 
techniques. Wild-type, heterozygous and homozygous RELA trunc fibroblast lines 
were each plated into eight wells at the same seeding density, seven were treated with 
TNFα and the final well left as an uninduced control. After a specified culture period 
post-TNFα stimulation (i.e. 15, 30, 45, 60, 90, 105 or 120 minutes), the fibroblasts 
were fixed in preparation for staining (see Section 2.5.7). RelA was stained with an 
Alexa Fluor® 488 conjugated antibody and nuclei were stained with DAPI (see 
Section 2.5.7). Digital images were taken on the Inverted Zeiss LSM 710 confocal 
microscope. Imaged cells were selected based on DAPI staining to identify areas of 
nearly confluent cells to maximise the number of cells analysed. Sequential scanning 
was used to create separate images for both DAPI (excitation - 405 nm laser) and Alexa 
Fluor® 488 (excitation - 488 nm laser). 
The experiment was repeated on three independent occasions. In each experiment, 
wild-type RelA became highly concentrated in the nucleus by 30 minutes post-TNFα 
treatment. In contrast, translocation to the nucleus in homozygous RELA trunc 
fibroblasts was significantly reduced, with most RelA remaining in the cytoplasm 
(Figure 3.10). This result was unexpected and was investigated further using nuclear 
and cytoplasmic fractionation followed by western blotting. Results from the western 
blotting analysis were in agreement with the immunohistochemistry results, 
demonstrating wild-type RelA to be present to a greater extent in the nucleus compared 
to the truncated RelA 30 minutes post-TNFα treatment (Figure 3.12.c-d). 
Unexpectedly, the nucelar loading control, Lamin A/C, results did not coincide with 
the total loading indicated by Ponceau S total protein membrane stain (Figure 3.12.b-




underlying the inner nuclear membrane which is thought to be involved in nuclear 
stability, chromatin structure and gene expression (Schreiber & Kennedy., 2013).The 
LMNA gene is has not been identified previously as a NF-κB target gene, however, 
Lamin A/C deficient cells have been reported to have impaired NF-κB signalling 
(Lammerding et al., 2004).  
It was previously hypothesised that the delay in restoration of IκBα levels would, in 
turn, delay the translocation of RelA from the nucleus back to the cytoplasm. At 60 
minutes post-TNFα stimulation, wild-type RelA was observed to have translocated 
from the nucleus back to the cytoplasm, although there was imperfect synchronisation 
between cells by 60 minutes post-TNFα stimulation (Figure 3.11). By 105 and 120 
minutes post-TNFα stimulation, wild-type RelA had translocated back to the 
cytoplasm in all cells, appearing no different to unstimulated cells. In contrast, the 
truncated RelA in homozygous fibroblasts did not fully translocate out of the nucleus 
by the final time-point assayed at 120 minutes post-TNFα stimulation, although the 
percentage of nuclear RelA had reduced relative to the 30 minute time-point. 
Quantitation of digital images at 0, 30 and 120 minutes’ post-stimulation of wild-type 
and homozygous cells was carried out, to assess the impact of truncated RelA on 
nuclear translocation, following the method described by Noursadeghi et al., 2008. 
Five images from each genotype at each time-point were analysed using the Image J 
software. A median filter (3x3 pixel radius) was applied to remove background noise, 
then the nuclear and cytoplasmic regions of the cells were defined using binary image 
masks. The images were then converted to binary masks using Image J’s Automatic 
threshold function using the Isodata algorithm (Ridler & Calvard.,1978). The DAPI 
mask was used to define the nuclear RelA and the cytoplasmic RelA was defined by 
subtracting the DAPI mask from the RelA mask using the image calculator function. 
Cells that were on the outer edge of the image were omitted from analysis. Fluorescent 
intensities from the remaining regions of entire cells were quantified from each image 
and data was exported to Excel to calculate the nuclear:cytoplasmic ratio of RelA. The 
ratio of nuclear:cytoplasmic RelA was used as a relative measure of RelA nuclear 
translocation. The results show that at 30 minutes post-TNFα stimulation the 




compared to wild-type controls (p=0.00002; Figure 3.13). Furthermore, at 120 minutes 
post-TNFα, the nuclear:cytoplasmic ratio of RelA was significantly higher in 
homozygous fibroblasts compared to wild-type controls (p=0.034) This quantitative 
analysis supports previously findings that truncated RelA does not translocate into the 
nucleus at the same extent after TNFα stimulation compared to wild-type RelA. 
Moreover, as expected from findings of delayed IκBα production by homozygous 
RELA trunc fibroblasts, the truncated RelA remains within the nucleus for an extended 






Figure 3.10 Effect of RELA trunc on TNFα stimulated nuclear translocation.  Fibroblasts were treated with TNFα and fixed at the indicated time-
points. The cells were subsequently stained using an antibody which recognises the N-terminus of RelA and a nuclear stain (DAPI)and analysed using 





Figure 3.11 Effect of RELA on translocation back out of the nucleus.  Fibroblasts were treated with TNFα and fixed at the indicated time-points. The cells 
were subsequently stained using an antibody which recognises the N-terminus of RelA and a nuclear stain (DAPI) and analysed using confocal microscopy. 




Figure 3.12 Effect of RELA trunc on TNFα stimulated nuclear translocation. 
A) Fibroblast cells were stimulated with a TNFα pulse and fixed 30 minutes later 
for staining, then analysed using confocal microscopy. B) Protein loading was 
assessed by Ponceau S staining of the transfer membrane prior to western blot to 
estimate loading C) The cytoplasmic and nuclear extracts were analysed for RelA 
by western blot. D) Levels of RelA were calculated using densitometric analysis 
normalised to the loading controls for each sample and are displayed graphically. 
α-tubulin was used as a loading control for cytoplasmic extracts and LaminA/C 





Figure 3.13 Quantitative analysis of RelA nuclear translocation. A) 
Immunofluorencence staining of RelA in fibroblasts treated with TNFα and fixed 
at the indicated time-points B) Quantification of nuclear:cytoplasmic ratios of 
RelA staining. Significance was calculated between wild-type controls and 
RELA trunc homozygous at the indicated time-points using a Student’s paired t-
test. Significant difference is indicated with black symbol *(p<0.05) or 
***(p<0.0001). Error bars represent the standard deviation (S.D) from analysis 




3.2.2.4 The impact of the RelA truncation on the production of other NF-
κB members in fibroblasts after induction with TNFα   
Finally, I investigated the impact the truncated RelA has on the production of other 
NF-κB protein members. In humans, the RelA-p50 heterodimer regulates expression 
of NF-κB subunit members REL (C-Rel; Hannink et al., 1990, Grumont et al., 1993), 
RELB (RelB; Bren et al., 2001), NFKB1 (p105/p50; Lombardi et al., 1995) and 
NFKB2 (p100/p55; Ten et al., 1992, Cogswell et al., 1993). The regulatory interaction 
between RelA and other NF-κB members likely plays an important role in the nature 
of the NF-κB response in terms of the duration and type of NF-κB activity in induced 
cells. Since the regulation of several RelA-dependent NF-κB target genes were found 
to be altered by the RELA trunc mutation, I reason that the altered activity of truncated 
RelA would consequently impact on the expression of the other NF-κB family 
members after induction (see Section 3.2.2.1). To investigate this potential impact of 
truncated RelA on the expression of NF-κB family members, qRT-PCR analysis was 
performed on wild-type control and RELA trunc fibroblasts induced with TNFα.  
Wild-type RELA control, heterozygous and homozygous RELA trunc fibroblast cell 
lines were each plated into four wells at the same seeding density, three were treated 
with TNFα and the other was left as an uninduced control. After the specified time in 
culture post-TNFα treatment (i.e. 30, 60 or 120 minutes), the fibroblasts were 
collected, and RNA purified to make cDNA (see Section 2.7.12). The fibroblast cDNA 
used in this experiment were the same samples used to investigate the expression of 
RelA-dependent genes (Figure 3.8). The transcript levels of genes RELA, REL, RELB, 
NFKB1 and NFKB2 were assayed using qRT-PCR. The expression level for each gene 
was normalised to the mean expression of GAPDH and B2M, and the changes in 
expression calculated relative to the uninduced control for each fibroblast line. 
After TNFα induction in wild-type fibroblasts, the expression level of RELA remained 
relatively unchanged whereas those of the NF-κB target genes, REL, RELB, NFKB1 
and NFKB2 were upregulated as predicted. In heterozygous and homozygous RELA 
trunc fibroblasts, the induced levels of NFKB1, NFKB2 and RelB were significantly 
lower compared to wild-type fibroblasts at a minimum of one time-point post-TNFα 




minutes after induction in RELA trunc fibroblasts compared to wild-type. However, 
there was no significant difference between wild-type and RELA trunc fibroblasts at 
the later, 120 minute, time-point in the levels of NFKB1 and NFKB2 post-TNFα 
treatment. These results show that the RelA truncation impacts on the induced 
expression of at least three of the NF-κB subunits, RELB, NFKB1 and NFKB1, in 
fibroblasts induced with TNFα. 
Figure 3.14 Gene expression analysis of NF-κB subunits genes in response to 
TNFα stimulation. qRT-PCR analysis of genes, RELA, REL, RELB, NFKB1 & 
NFKB2, in fibroblasts containing wild-type and truncated RelA induced with 
TNFα pulse (10 ng/ml). Relative expression was calculated by normalising to the 
corresponding uninduced fibroblasts. Significant difference was calculated 
between the wild-type controls and RelA-edited at each specific time post-TNFα 
using a Student’s paired t-test. Significant difference is indicated with black 
symbol *(p<0.05) or **(p<0.001). Error bars represent the S.E.M from the three 
independent inductions. 
To determine if the observed differences in the mRNA levels in RELA trunc 
fibroblasts translate to a similar difference in NF-κB protein levels, western blot 
analysis was carried out. Four flasks of homozygous and wild-type RELA fibroblast 




and the final kept as an uninduced control for each fibroblast cell line. After the stated 
time post-TNFα treatment the cells were lysed in the flask and collected for further 
processing (see Section 2.5.1). 20 μg of each protein lysate, estimated using the 
Bradford assay, was used for western blot analysis. Antibodies that recognise human 
p105/p50, C-Rel and RelA were successfully used to detect their porcine equivalents. 
Unfortunately, the antibodies used for the detection of porcine RelB and p100/p55 
were unsuccessful (data not shown). The level of each NF-κB protein was normalised 
to the level of α-tubulin in that sample using densitometric analysis (Figure 3.15.b). A 
noticeable difference was the decline in the levels of the p50 subunit at 60 and 120 
minutes post-TNFα treatment in the homozygote cell line when compared to the 
control. A delay in the expression of NFKB1 is observed in homozygote RELA 
fibroblasts compared to wild-type. However, there is no apparent decline in the level 





Figure 3.15 The levels of p105, p50, C-Rel and RelA proteins in RELA trunc 
fibroblasts over-time after NF-κB stimulation with TNFα. A) Western blot 
analysis of cells after TNFα treatment with wild-type control cells run in parallel. 
20 μg of whole protein lysate was loaded per lane and the blots were probed with 
antibodies that recognise p50/p105, C-Rel, RelA. and α-tubulin. B) Levels of 
each NF-κB protein was normalised to the α-tubulin level for each sample, 





3.2.3 Characterisation of RELA trunc pigs 
As the RELA trunc pigs are a novel animal model, an overall pathological examination 
of the 1st generation of animals was completed alongside pathologist Dr Pip Beard. A 
full-post-mortem was performed on 5 animals of each genotype, wild-type, 
heterozygous and bi-allelic for the RELA trunc mutations, at 18-20 weeks old. All 
animals were euthanised by lethal injection. Tissues and organs were excised and 
examined at the necropsies and a range of tissues were collected in fixative to allow 
future analyses (see Appendix B). Additionally, tissues were snap frozen to allow 
subsequent DNA, RNA or protein analysis.  
No organs or tissues displayed any macroscopic evidence of pathological alternations 
that could be attributable to the genetic modification of RELA. For this study, 
preliminary analysis was carried out on the spleen, bone marrow and a number of 
lymph nodes including mandibular, ventral superficial cervical, mediastinal, 
mesenteric and popliteal. Prior to fixing, samples of the spleen were excised from a 
defined anatomical location, cross-sections from the lower right side. The lymph nodes 
were dissected free of fat before cross-sectioning and fixing. The bone marrow was 
removed from the upper left femur, one sample was preserved in fixative and another 
used to produce a fresh smear that was Giemsa stained the same day. 
3.2.3.1 Impact of RelA truncation on development of secondary 
lymphoid organs 
As mentioned in chapter 1, RelA plays an important role in the development of 
secondary lymphoid organs and in hematopoiesis (Alcamo et al., 2002, Stein & 
Baldwin., 2013). Mice lacking RelA die at embryonic day 15 due to TNFR1-signaled 
hepatocyte apoptosis (Begg et al., 1995, Begg et al., 1996). Targeted disruption of 
TNFR1 rescues the RelA deficient mice, however the immune system of these animals 
is severely compromised and most die of bacterial infection within 3 weeks after birth 
(Alcamo et al., 2001). Furthermore, RelA/TNFR1 deficient mice have severely 
disorganised splenic microarchitecture and lack all lymph nodes and Peyer’s patches 
(Alcamo et al., 2002).  
To examine the microanatomy of the spleen and lymph nodes of RELA trunc animals, 




staining (see Section 2.3.3 for details). The resulting sections of spleen and lymph 
nodes were examined blindly by pathologist, Dr Pip Beard. 
All the lymph nodes examined displayed the described typical porcine anatomical 
features. Like dolphins, elephants and rhinoceroses, pigs have lymph nodes that are 
described as structurally inverted compared to most other mammals, as the medulla is 
often located peripheral of the cortex (Binns., 1982, Bowes & Kenny., 1986). The 
cortex is densely populated by lymphocytes whereas the medulla is less cellular, thus 
less heavily stained in H&E stained sections. Therefore, to allow a more in depth 
examination of the lymph nodes, scores were assigned in the following three 
categories; 1) an estimate of the percentage of the lymph node cross section which 
consisted of cortical tissue 2) whether the lymphoid nodules were distinctly 
demarcated from the surrounding parenchyma, and 3) whether there were abundant 
apoptotic cells in the lymphoid nodule (characterised by shrunken, hyperchromatic 
nuclei). When the resulting scores were analysed, high variability was observed across 
individual lymph nodes and no significant difference was found in any of the scoring 
categories (see Appendix C).  
The porcine spleen is similar to other species, consisting of two main components, the 
red pulp and the white pulp, which can clearly be identified through staining with H&E 
due to their difference in architecture, cellular composition and vascular organisation. 
Spleen sections were blind examined by Dr Pip Beard and any abnormalities in 
morphology were recorded. Notes were taken on the observations of the red and white 
pulp, including the germinal centres, marginal zones and peri-arteriolar sheaths. In all 
animals analysed there was a variable amount of congestion in the red pulp, most likely 
caused by the barbiturate euthanasia. Other noticeable changes were identified in one 
heterozygote, which showed slightly reduced cellularity in germinal centres, one bi-
allelic which displayed prominent germinal centres, and another bi-allelic which had 
relatively increased amounts of white pulp. A repeat of this analysis was completed 
un-blinded, however no consistent change was identified in the spleen sections of the 




Figure 3.16 H&E staining of spleen and lymph node. The H&E staining of the 
spleen and submandibular lymph node from wild-type (WT) and bi-allelic (BI) 
RELA truncated pigs are displayed.  
3.2.3.2 Impact of RelA truncation on bone marrow composition  
Mice which lack RelA in the hematopoietic compartment have defects in 
hematopoietic stem cell differentiation and extramedullary haematopoiesis (Stein & 
Baldwin., 2013). To investigate the impact of truncated RelA on these processes, 
differential cell counts on both the bone marrow and the peripheral blood were 
performed on wild-type, and heterozygous and homozygous RELA trunc pigs. 
Bone marrow smears and biopsies were all analysed blind by pathologist Prof Elspeth 
Milne. Most normal differentiated hematopoietic cells types can be identified on bone 
marrow smears stained by the Giemsa method based on morphology; these include, 
granulocytes, erythroid cells, megakaryocytes, monocytes, macrophages, mast cells, 
lymphocytes, plasma cells and bone forming cells. The smear samples taken from the 
heterozygotes were too thin for adequate analysis thus were omitted from this study. 
No significance difference in the differential cell counts were observed between the 
wild-type and homozygous RELA trunc pigs (Figure 3.17). However, mild 
megakaryocyte hyperplasia and was found in all five bone marrow biopsies and 




Figure 3.17. Differential cell counts of bone marrow smears from wild-type 
and F1 bi-allelic RELA trunc pigs. No significant difference was identified 
between wild-type controls (n=5) and RELA trunc homozygous (n=5) calculated 
using a Student’s paired t-test. 
3.2.3.3 The impact of RELA truncation on overall pig weight 
Prior to euthanasia the pigs were weighed to calculate drug dosages at which point it 
was noted that the weights of the bi-allelic pigs were often lower than that of wild-type 
and heterozygote pigs of the same age. Thus, the weights of the 2nd generation of 
piglets were recorded at birth, 4 weeks and 8 weeks of age. Homozygous RELA trunc 
pigs were confirmed to have a significantly reduced body weight compared to wild-
type controls at all birth (p=0.004), 4 weeks (p=0.009) and 8 weeks old (p=0.004; 
Figure 3.18). Moreover, the calculated average daily weight gain for homozygous 




Figure 3.18. Body weight comparison of wild-type and heterozygous and 
homozygous RELA trunc pigs. A) Image displaying two boar siblings, one 
homozygous for the RELA trunc mutation and one wild-type. B) Graphs 
displaying the reduced weight gain of homozygous RELA trunc compared to 
wild-type pigs C) Bar chart displaying reduced birth weight of homozygous 
RELA trunc compared to wild-type D) Table displaying the numbers of animals 
weighed at each time-point. Significant difference was calculated between the 
wild-type controls and RELA-edited pigs at each time-point using a Student’s 





In this Chapter, genotyping and subsequent characterisation was carried out on the first 
genome edited pigs born from direct injection of editor mRNAs into zygotes. Five live 
piglets were identified to contain targeted editing events in their RELA locus. Two of 
these editing events resulted in frame-shift mutations and the introduction of a 
premature stop codon proximal to the target site, resulting in a RELA gene predicted 
to encode a RelA protein that lacks the final 60 amino acids of wild-type RelA. These 
founder animals were subsequently bred to produce a larger cohort for further 
characterisation. 
3.3.1 Truncated RelA 
The RelA truncation mutant was predicted to lack the 60 amino acids of the C-terminal 
region of the transactivation domain which encompasses the entire TA1 and part of 
the TA2, and Western blot analysis confirmed that a truncated protein was produced. 
This deleted region is conserved between mammalian species (O’Shea & Perkin., 
2008). Early deletion studies of RelA, performed using in vitro reporter systems, found 
that the TA1 region mediates the majority of RelA’s transcriptional activity in a variety 
of cell types (Schmitz & Baeuerle., 1991). In a study by Mukherjee et al., (2013) the 
final 60 amino acids of the RelA transactivation domain were shown to mediate RelAs 
binding to the TAZ1 domain of the transcriptional co-activators creb binding protein 
(CBP) and p300. RelA’s interaction with CBP/p300 promotes the assembly of basal 
transcriptional machinery on the transcription start site, and is essential for the 
transcription of these RelA-dependent genes (Gerritsen et al., 1997, Merika et al., 
1998, Mukherjee et al., 2013). RelA also makes contact with the KIX domain of 
CBP/p300, an interaction which requires the phosphorylation of a highly conserved 
serine, S276, in the RHD of RelA (Zhong et al., 1998). Mutant mice containing an 
alanine instead of a serine at position  276 (S276A) are embryonic lethal, displaying a 
variety of phenotypes including aberrant eye development (Dong et al., 2008). The 
final 60 amino acids of wild-type RelA also harbours several conserved 
phosphorylation sites including T505, S529 and S536. Phosphorylated T505 represses 
RelAs transactivation at some target genes by promoting association with HDAC1 




although the functional mechanism is not currently known. These sites are 
phosphorylated in response to many inflammatory stimuli including TNFα 
(Vermeulen et al., 2003, Viatour et al., 2005). There are six other possible 
phosphorylation sites in the truncated region which could further mediate regulation 
of RelA’s activity. 
Given the high degree of cross-species conservation of this gene, coupled with the 
known biological function of the protein, it was surprising that there was no obvious 
phenotypic difference in  pigs homozygous or bi-allelic for truncated RelA. These pigs 
were born healthy and were fully viable when housed in a typical farm environment. 
This is in dramatic contrast with rela-/- mice, which have an embryonic lethal 
phenotype, implying that the truncated RelA retains significant functionality. 
It is worth noting that western blotting analysis consistently demonstrated that the 
truncated RelA protein was present in cells at higher levels compared to full-length 
wild-type RelA. Direct quantitative comparison of these proteins is confounded by the 
molecular weight difference, as this could impact on the efficiency of protein 
migration through the polyacrylamide gel during transfer to the membrane. However, 
higher relative levels of truncated RelA were also observed compared to wild-type, 
lending support to the above observation. This could be investigated further with an 
ELISA. Moreover, mutation of single phosphorylation sites within the missing domain 
in truncated RelA are known to decrease the ubiquitination and thus increase the 
stability of the protein (Milanovic et al., 2014). 
3.3.2 Interpreting the impact on NF-κB signalling pathway 
To investigate the impact of altered RELA in vitro, TNFα, a potent inducer of NF-κB, 
was used to stimulate fibroblasts isolated from skin biopsies. The transcriptional 
activity of RelA was assessed by quantifying the expression of several RelA-
dependent genes. In a previous study by Mukherjee et al., (2013) the final 60 amino 
acids region of mouse RelA was found to be essential for the upregulation of a gene 
encoding IκBα, however my analysis shows this is not the case. Rather, we 
demonstrate a delay in upregulation of IKBA (encoding IκBα) along with several of 




has a delayed transcriptional activation. The previous study was performed in 
immortalised mouse rela-/- fibroblasts reconstituted with retroviral vectors containing 
the mouse rela truncation mutants, thus the difference in our results could reflect 
varied requirements for the same sequence between species, altered response of 
immortailsed vs primary cells, or copy number variation/ position effects associated 
with the lentiviral delivery route. In our analysis, higher expression of RelA-dependent 
genes was identified at later time-points post induction, suggesting that while initial 
induction was delayed, this morphed into a prolonged activation of truncated RelA. 
This would fit with a model whereby delayed transcriptional upregulation of IKBA 
resulted in retarded production of IκBα and subsequent deferred termination of  NF-
κB activity (Fagerlund et al., 2015).  
Using a nuclear translocation assay we discovered that following TNFα  stimulation 
truncated RelA translocated into the nucleus at a similar time to the wild-type protein, 
but that in contrast to the full-length protein much of the truncated RelA remained in 
the cytoplasm throughout the timecourse of this experiment. Thus, the lower 
transcriptional activity of the truncated form may in part be due to its reduced nuclear 
translocation. This work provides the first evidence that this C-terminal region of RelA 
is important in promoting nuclear accumulation. Previous studies into the kinetics of 
NF-κB showed that oscillations of this transcription factor from the cytosol to the 
nucleus are mirrored by changes in S536 phosphorylation, suggesting 
dephosphorylation of S536 occurs in the nucleus (Nelson et al., 2004). Mutation of 
S536 resulted in nuclear translocation of the same kinetics as observed for wild-type, 
however the level of nuclear accumulation was not compared in this study (Sasaki et 
al., 2005). Interestingly, phosphorylated S536 RelA has been reported not to associate 
with IκBα and is predominantly found in the cytoplasm (Sasaki et al., 2005). It is 
possible that the phosphorylation sites, missing in our RelA truncation mutant, are 
involved in regulating nuclear translocation. In accordance with study the by 
Mukherjee et al. (2013) we also observe a prolonged nuclear residence time of 
truncated RelA, indicating an impaired negative feedback loop. 
My gene expression analysis revealed delayed induction of two known regulators of 




activity, retaining NF-κB in the cytoplasm until triggered by an appropriate cellular 
stimulant; IκBα is then transiently degraded and then subsequently upregulated by 
newly-active NF-κB (Arenzana-Seisdedos et al., 1997, Chen et al., 2001, Huang & 
Miyamoto., 2001). Western analysis of the IκBα protein post-TNFα stimulation 
confirmed the delayed expression levels observed during quantitative analysis of 
transcript levels. This delay is a likely cause of the prolonged nuclear residence of 
truncated RelA, leading to the observed higher induced expression levels of RelA-
dependent genes at later time-points. The upregulation of  negative feedback regulator 
A20 was also severely impaired in cells homozygous for truncated RelA. A20 
negatively regulates NF-κB by inhibiting RIP1 K63-linked polyubiquitination which 
terminates further downstream activation of NF-κB (Shembade & Harhaj., 2012). This 
renders the NF-κB pathway less sensitive to subsequent inductions. Mice deficient in 
A20 develop uncontrolled and spontaneous multi-organ inflammation (Lee et al., 
2000). 
RelA is known to regulate numerous other components of the NF-κB pathway such as 
TRAF2, REL, NFKBIA, NFKBIE, NFKBIZ, NFKB1, NFKB2, RELB. As a 
consequence, the altered RelA activity of the truncated protein will likely have had an 
influence on the basal cellular levels of a range of proteins prior to experimental 
induction with TNFα. Lower basal levels of both IκBα and C-Rel proteins were 
identified in fibroblasts homozygous for the RelA truncation compared to wild-type. 
Furthermore, the induced expression of  NF-κB subunits, NFKB1(p105/p50), NFKB2 
(p100/p55), RELB (RelB), was significantly reduced in homozygous RelA trunc cells. 
In conclusion, I have identified that the RelA truncation does alter NF-κB signalling, 
although clear understanding of the mechanisms was confounded by the complexity 
of the NF-κB signalling pathway and downstream biological networks. 
3.3.3 Interpretation of the phenotypic analysis of RELA-edited 
animals 
Gross phenotypic analysis of individuals revealed no gross defects associated with the 
modified animals. RelA is known to play an important role in the development of 
secondary lymphoid organs and in hematopoiesis (Alcamo et al., 2002, Stein & 




organs. As this analysis was limited to gross histology, it is possible that the RelA 
truncation may have resulted in more subtle changes in cell distribution in these 
organs, which could be further investigated by immunohistological methods. Overall, 
the RelA-edited animals displayed no apparent anatomical defects associated with the 
modification and surprisingly are healthy living in normal farmyard conditions. In 
recording the weights of our pig cohorts, I unexpectedly found the pigs homozygous 
for the RelA truncation had significantly lower body weights compared to wild-type 
controls. Aberrant NF-κB activation has previously been linked to metabolic diseases 
such as obesitity and type 2 diabeties and identified as a regulator of cell signalling 
pathways which mediate glycolysis and respiration (Tornatore et al., 2012). Thus, the 






Chapter 4 African Swine Fever virus (ASFV) 
challenge of RELA edited pigs 
4.1 Introduction 
African swine fever virus (ASFV) is the causative agent of African swine fever (ASF), 
a highly contagious lethal disease of domestic pigs. To date, no effective vaccines or 
treatments are available. Thus, disease control relies on strict biosecurity, rapid 
diagnosis and the mass slaughter and appropriate disposal of all animals on infected 
sites. Consequently, ASF causes significant economic losses in affected countries. The 
disease is endemic to countries of sub-Saharan African and in 2007 was introduced to 
Georgia in the Caucasus and disseminated into Russia and countries of Eastern Europe 
where it remains prevalent. The increasing global movement of goods and people 
combined with increased transboundary spread of ASFV poses a major threat to pig 
production worldwide. 
ASFV infection of domestic pigs often results in an acute haemorrhagic disease 
causing death within 5-14 days. Infection with ASFV is thought to influence and/or 
compromise the immune response of domestic pigs. The virus predominantly infects 
immune cells of the myeloid lineage, especially monocytes and macrophages, which 
are thought to play a major role in the viral dissemination and persistence (Sierra et 
al., 1991, Sánchez-Cordón et al., 2008). Macrophages are mature tissue differentiated 
monocytes, which accumulate in the spleen, lymph nodes, lung, liver sinusoids, 
connective tissue, serous fluids and skin. These cells play a critical part in the immune 
system by detecting pathogen-associated molecular patterns through various pattern 
recognition receptors, triggering immune responses, secreting cytokines and 
chemokines, presenting antigens and clearing pathogens by phagocytosis. Upon 
infection, ASFV encodes for a number of viral proteins involved in host immune 
evasion; these include the NF-κB and NFAT inhibitor A238L, and the apoptosis 
inhibitors A179L and A224L (Neilan et al., 1997, Miskin et al., 2000, Granja et al., 
2006., Brun et al., 1996, Revilla et al., 1997, Nogel et al., 2001). The anti-apoptotic 
proteins were identified in virulent isolates, and allow for infected cells to survive and 
spread the virus throughout the body (Dixon et al., 2013). Virulent strains of ASFV 




infected macrophages which has been speculated to play an important role in initiating 
the disease pathogenesis (Gómez del Moral et al., 1999, Gil et al., 2008). A 
characteristic of ASF pathogenesis is the widespread apoptosis of lymphocytes leading 
to lymphopenia, which likely impacts on the immune response to ASFV. Other 
characteristics of ASF include apoptosis of arteriolar and capillary endothelial cells, 
and disseminated intravascular coagulation, both of which eventually lead to multiple 
organ failure and shock. 
In contrast to domestic pigs, ASFV causes an unapparent persistent infection in swine 
indigenous to Sub-Saharan African, such as the warthog and bushpig. As discussed in 
Chapter 1, the genetic variation identified between domestic pig RELA and warthog 
RELA has been hypothesised to underlie the difference in their responses to ASFV 
infection (Palgrave et al., 2013). To test this hypothesis genome editors were used to 
target this variable region of porcine RELA in the domestic pig. TALEN reagents were 
utilised in porcine embryos to produce live pigs with various edits in their RELA gene 
(Lillico et al., 2013). The previous results chapter (Chapter 3) discusses the genotyping 
and characterisation of the RELA-edited animals born from this procedure. Several of 
the RELA editing events led to a truncated RelA protein product missing 60 amino 
acids of the highly conserved C-terminal transactivation domain (TAD). These editing 
events have been termed RELA trunc. Pigs heterozygous or homozygous for the 
RELA trunc edit are healthy and viable under normal husbandry conditions, however 
the NF-κB signalling pathway was found to be altered (described in Chapter 3). It has 
been proposed previously that a reduced transcriptional response of warthog RelA 
compared to domestic pig RelA may underlie tolerance to ASFV infection (Palgrave 
et al., 2011). The RELA trunc edited pigs were identified to have a delay in 
upregulation of RelA-target genes in vitro following TNFα stimulation, it was 
hypothesised that these animals would display an altered response to ASFV infection. 
There are two main objectives for the experiments described in this chapter. The first 
objective was to determine whether the porcine RELA-editing impacts on the cytokine 
response to ASFV infection in vitro and in vivo and the second objective was to 
evaluate the impact of RELA-editing on the clinical outcome and mortality of animals 






The main aims of this chapter are: 
iv) To investigate the impact of RELA trunc on the upregulation of ASF-
associated cytokines in ASFV infected macrophages in vitro. 
v) To investigate the impact of RELA trunc on the outcome of infection with 






4.2.1 In vitro ASFV challenge 
To investigate the impact of the RELA trunc genotype on the cytokine response to 
ASFV infection, macrophages derived from wild-type, heterozygous and homozygous 
RELA trunc animals were infected with ASFV in vitro for analysis of cytokine 
production during infection. Quantitative real-time PCR (qRT-PCR) was utilised to 
examine the cytokine gene expression response and production of secreted pro-
inflammatory cytokines were examined using enzyme-linked immunosorbent assays 
(ELISAs). All laboratory work with ASFV was carried out at the SAPO CL4 
(Specified Animal Pathogens Order Containment Level 4) biocontainment facility at 
the Pirbright Institute, Surrey. 
Bone marrow cells were isolated from the ribs of 16-week old pigs, 5 animals from 
each RELA genotype (i.e. wild-type, heterozygous and homozygous RELA trunc; see 
Section 2.4.6). After extraction, the cells were immediately cryopreserved and stored 
at -80°C until transportation to the Pirbright Institute. At the Pirbright Institute, high 
virulence isolate Benin 97/1 and the low virulence isolate OURT 88/3 were propagated 
in pig bone marrow macrophages (see Section 2.6.3). These isolates were selected as 
both are members of the same virus genotype, Genotype 1 (Chapman et al., 2008). The 
virus was harvested and concentrated by a centrifugal method, described in Section 
2.6.4. An indirect immunofluorescence assay, which detects viral protein 72, was used 
to titrate each virus by limiting dilution (see Section 2.6.2). Prior to infection with 
ASFV, the cryopreserved bone marrow cells isolated from RELA-edited and control 
pigs were thawed and cultured on non-tissue culture treated dishes with human 
recombinant CSF-1, to stimulate maturation of monocytes into macrophages. The 
adherent cell populations isolated from each animal were harvested and subsequently 
plated at a density 1.25 x 105/cm2 in eight wells of a 12-well plate (see Section 2.4.7-
9). Macrophages were infected at a multiplicity of infection (M.O.I) of 5 with Benin 
97/1 in two wells and OUR T88/3 for another two wells. Two uninfected wells were 
continually stimulated with 1 μg/ml of lipopolysaccharide (LPS; Sigma) and the final 
two wells were left as uninduced i.e. without the addition of virus or LPS. At 4 and 8 




80°C, for ELISA analysis. After removal of the cell supernatant the adherent 
macrophages were washed with PBS and lysed with the Trizol (Invitrogen) which was 
then collected and stored at 80°C, for RNA extraction. The extracted RNA was reverse 
transcribed into cDNA then heat-inactivated in a water bath at 56°C for two hours 
before transferring to the Roslin Institute for RT-qPCR analysis (see Section 2.7.1). 
Cytokine expression during in vitro ASFV infection 
To date, few studies have revealed the effects of ASFV infection on the cytokine 
responses of macrophages in vitro (Gil et al., 2003, Zhang et al., 2006, Gil et al., 2008, 
Fishbourne et al., 2013a Franzoni et al., 2017). Others have studied the cytokine 
response in peripheral blood of infected animals (Fishbourne et al., 2013b, Zakaryan 
et al., 2015). A panel of 10 of these cytokine genes, found to be differentially expressed 
after infection with ASFV and known to be directly regulated by NF-κB, were selected 
for qRT-PCR analysis (Collart et al., 1990, Hiscott et al., 1993, Libermann & 
Baltimore., 1990, Kunsch & Rosen, 1993, Murphy et al., 1995, Schreck & Baeuerle., 
1990, Hiscott et al., 1989, Hein et al., 1997, Ueda et al., 1997, Burke et al., 2014). 
These include proinflammatory cytokines (TNF, IL1B, IL6, IL8), immunoregulatory 
cytokine (IL12p40), colony stimulating factor (CSF2), interferon alpha (IFNA) and 
chemokines (CXCL10, CCL2, CXCL2). Two time-points, 4 hours and 8 hours, were 
selected to analyse the early cytokine response of ASFV-infected wild-type and 
RELA-trunc mutant macrophages. These time-points were chosen as they occur after 
viral entry and viral protein synthesis but prior to any apparent ASFV-induced cell 
death (Zhang et al., 2006). The expression level of each gene was normalised to the 
mean of cyclophilin A (PPIA) and beta-2-microglobulin (B2M) expression and the 
expression levels were calculated relative to the uninduced control for each 
macrophage line. These genes were selected for normalisation as their expression was 
found to remain stable under induction with LPS in porcine macrophages and are not 
anticipated to fluctuate during ASFV infection (Cinar et al., 2012). 
Both homozygous and heterozygous RELA trunc macrophages showed a significantly 
lower induced expression of the pro-inflammatory cytokine TNFα (~1-fold increase) 
at 4 hours’ post infection with virulent isolate Benin 97/1 compared to wild-type 




with LPS stimulation (Figure 4.1). However, the induced expression of pro-
inflammatory cytokine IL1B was significantly higher in homozygote macrophages 
(~5-fold increase) compared to wild-type macrophages (no significant change from 
uninduced) at 4 hours’ post infection with Benin 97/1. Moreover, the induced 
expression of chemokines, CXCL10, CCL2 and CXCL2 was significantly higher in 
homozygous RELA trunc macrophages (~1-fold, ~1-fold & ~6-fold increase) 
compared to wild-type controls (no significant change from uninduced) at 4 hours’ 
post infection with Benin 97/1. This significant induction of CXCL10 and CXCL2 
expression was also observed at 4 hours’ post-infection with non-pathogenic isolate 
OURT 88/3. A significantly higher expression was also observed in IL12p40 at 4 
hours’ post-infection (~2-fold increase) with both ASFV isolates compared to wild-
type (no significant change from uninduced). No statistically significant difference in 
IL6, IL8, CSF2 and IFNA responses were observed in macrophages infected with 
either viral isolate or LPS stimulated. These results show that at the early time-point 
of 4 hours post-infection (PI), when the virus has entered cells and initiated synthesis 
of early viral proteins, the cytokine response of macrophages contain RELA trunc 
editing is altered. However, no significance difference was identified at the later time-





Figure 4.1 Gene expression analysis of ASFV-associated cytokine genes. qRT-PCR analysis of ASF-associated cytokine genes, TNF, 
IL1B and IL12p40, in macrophages containing wild-type and truncated RelA infected with pathogenic (Benin 97/1) or non-pathogenic 
(OURT 88/3) ASFV isolate or continuous stimulation with LPS (1 μg/ml). Relative expression was calculated by normalising to the 
corresponding uninduced macrophages. Significant difference was calculated between the wild-type controls (n=5) and RelA-edited 
(heterozygous (n=3) and homozygous (n=3)) at each time post-infection or stimulation using a Student’s paired t-test. Significant difference 





Figure 4.2 Gene expression analysis of ASFV-associated chemokine genes. qRT-PCR analysis of ASF-associated chemokine genes, CXCL10, 
CCL2 and CXCL2, in macrophages containing wild-type and truncated RelA infected with pathogenic (Benin 97/1) or non-pathogenic (OURT 
88/3) ASFV isolate or continuous stimulation with LPS (1 μg/ml). Relative expression was calculated by normalising to the corresponding 
uninduced macrophages. Significant difference was calculated between the wild-type controls (n=5) and RelA-edited (heterozygous (n=3) and 
homozygous (n=3)) at each time post-infection or stimulation using a Student’s paired t-test. Significant difference is indicated with black symbol 





Figure 4.3 Gene expression analysis of ASFV-associated cytokine genes. qRT-PCR analysis of ASF-associated cytokine genes, IL6, IL6, 
CSF2 and IFNA, in macrophages containing wild-type and truncated RelA infected with pathogenic (Benin 97/1) or non-pathogenic (OURT 
88/3) ASFV isolate or continuous stimulation with LPS (1 μg/ml). Relative expression was calculated by normalising to the corresponding 
uninduced macrophages. Significant difference was calculated between the wild-type controls (n=5) and RelA-edited (heterozygous (n=3) 
and homozygous (n=3)) at each time post-infection or stimulation using a Student’s paired t-test. No significant difference was identified. 





Analysis of TNFα and IL-1β secretion 
To investigate changes to levels of secreted cytokines in vitro following ASFV 
infection, ELISA assays were employed to measure the levels of two pro-inflammatory 
cytokines, TNFα and IL-1β. These cytokines are of particular interest as both have 
been speculated to play a major role in the pathogenesis of ASF (Gómez del Moral et 
al., 1999, Carrasco et al., 2002). Furthermore, the RELA trunc homozygous 
macrophages were shown to have altered induced expression of both TNFα and IL-1β 
after infection with highly virulent isolate, Benin 91/1 (Figure 4.1). To determine if 
the observed differences in mRNA levels translated to a similar difference in secreted 
protein levels, ELISA analysis was carried out. The supernatants from the experiment 
described previously were collected for analysis. Before ELISA analysis the 
supernatants were thawed and left to equilibrate to room temperature. ELISA 
immunoassay kits were used, following manufactures instructions, to detect porcine 
TNFα and IL-1β protein levels in the supernatants. Results revealed no significant 
difference in levels of TNFα in medium from RELA-edited macrophages compared to 
wild-type at any time-point (Figure 4.4), thus these results do not follow the predicted 
profile based on the mRNA transcript analysis (Figure 4.1). However, a significant 
increase in the level of IL-1β was observed in both heterozygous and homozygous 
samples compared to wild-type at 8 hours’ post-infection with Benin 97/1. This result 
correlates with the finding previously that IL-1β transcripts are induced higher in 





Figure 4.4 Levels of pro-inflammatory cytokines TNFα and IL-1β secreted 
by ASFV infected cells. A) ELISA analysis of ASF-associated cytokines TNFα 
and IL-1β in macrophages containing wild-type and truncated RelA infected with 
pathogenic (Benin 97/1) or non-pathogenic (OURT 88/3) ASFV isolate or 
continuous stimulation with LPS (1 μg/ml). Significant difference was calculated 
between the wild-type controls (n=5) and RelA-edited (heterozygous (n=3) and 
homozygous (n=3)) at each time post-infection or stimulation using a Student’s 
paired t-test. Significant difference is indicated with black symbol *(p<0.05). 





4.2.2 In vivo ASFV challenge 
To determine the differences in immune and pathogenic responses between control 
pigs and the RELA trunc edited pigs a live animal challenge was carried out with 8 
wild-type controls, 8 heterozygous and 8 homozygous for the RELA trunc edit. These 
animals were born and housed at the Roslin Institute’s animal facility until 8 weeks of 
age before transporting to biosafety level 3 (BSL3) animal biocontainment facilities at 
the Pirbright Institute. Ear tags were assigned to each pig before transporting and the 
Pirbright animal caretakers and researchers were blind to the genotype of each pig. At 
the Pirbright animal facility, the pigs were housed 6 per room in a total of 4 rooms. 
Each room was to contain 2 pigs from each cohort. The animals were acclimatised to 
this new environment for 4 days before initiation of the pilot ASFV challenge study. 
The Pirbright Animal Welfare and Ethical Review Committee requested a pilot study 
be carried out with 2 animals from each cohort (i.e. 2 controls, 2 heterozygous and 2 
homozygous for the RELA trunc edit) to ensure clinical signs of RELA-edited pigs 
were not more severe than control pigs before proceeding with full experiment. 
However, due to a misinterpreted ear tag identification number (#9 was selected 
instead of #6) the pilot study consisted of 2 controls, 3 heterozygotes and one 
homozygote. All animals were infected via intramuscular injection with 1ml 
containing 104 HAD50 of high virulence ASFV isolate Benin 97/1. 
Throughout the experiment clinical signs and rectal temperatures were monitored 
twice daily. A clinical sign score was assigned based on pig’s temperature, appetite, 
recumbency, and any skin haemorrhages, joint swelling, laboured breathing, ocular 
discharge, diarrhoea or vomiting (see Appendix D for clinical scoring guidelines). 
Animals were to be terminated when symptoms had reached a clinical score of ≥6 or 
they displayed the following; a fever above 40.5⁰C at the beginning of the third 
consecutive day and/or not eating for a second consecutive day. Animals were 
terminated by injection of a lethal dose of pentobarbital and necropsies were carried 





Clinical signs  
After infection with Benin 97/1, all pilot experimental animals displayed a change in 
behaviour from alert and bright on day 0 to lethargic and depressed at day 3 PI. 
Moreover, an increase in temperature and clinical signs (including loss of appetite, 
lethargy and recumbency) was observed in all pigs at day 3 PI. Overall, no substantial 
difference in clinical signs was identified between RELA-edited and control pigs. 
However, the homozygous pig displayed a lower temperature at day 3 PI compared to 
the others (see Figure 4.5). The pilot study was terminated at day 4 PI, although 
moderate severe end-point had not been met; all animals displayed inappetence, fever 
and recumbency. The clinical signs of the RELA-edited pigs in the pilot study 
appeared to be less severe than the control pigs, although significance was lacking due 
to sample size. As the disease in the edited animals was no more severe than controls 
we proceeded with the full experiment by infecting all remaining pigs with Benin 97/1.  
The remaining cohort included 6 wild-type controls, 5 heterozygous and 7 
homozygous animals. These pigs were infected intramuscularly with 1 ml containing 
104 HAD50 of high virulence ASFV isolate Benin 97/1 as in the pilot study. At day 3 
PI, all animals had an increased rectal temperature. With exception of a single control 
animal which appeared lethargic no other clinical signs were apparent. At day 4 PI, all 
animals displayed varying levels of recumbency and loss of appetite. One homozygous 
animal (ID #17) displayed a second consecutive day of fever above 40.5°C and 
erythema (redness of the skin) on left ear, and was euthanised for necropsy at day 4 PI 
before reaching the moderate severe end-point. The remaining animals did not display 
clinical signs severe enough to reach the moderate severe end-point at day 4 PI. On 
the morning of day 5 PI, one control (ID #13) and one homozygous pig (ID #11) were 
found dead in their pens. The remaining live pigs had all stopped eating and displayed 
a fever and varying levels of recumbency. Only one homozygote pig (ID #12) met the 
moderate severe endpoint on day 5 PI, however, due to the sudden deaths of the two 
animals, the decision was made to terminate the experiment so all pigs were euthanised 
and necropsies were performed. Unfortunately, another homozygote pig (ID #23) died 
before euthanasia in the morning of day 5 PI. The sudden deaths of these animals were 
not anticipated but as the group contained both control and RELA trunc animals it is 




Collated data from both the pilot and main experiment show the mean temperatures 
increased from 39°C on day 0 to approximately 41.0°C on day 4 PI for all genotypes 
(see Figure 4.5). There was no statistically significant difference between the three 
RELA genotypes on any day post infection (p>0.3). Overall, there was no observable 






Figure 4.5 Rectal temperatures of wild-type (WT) and knockout (KO) pigs 
infected with high virulence ASFV isolate, Benin 97/1. A students t-test 
analysis showed no significant difference between temperatures of WT and 







Necropsies were performed on all animals. Macrolesion scoring was carried out during 
each post-mortem under the supervision of veterinary pathologist Dr Pedro Sanchez-
Cordon. Details of the macrolession scoring system can be found in the Appendix E. 
Necropsies of pilot study animals revealed the presence of gross lesions characteristic 
of acute forms of ASF such as hydropericardium, ascites, retroperitoneal edema, 
hemorrhagic lymphadenitis (gastrohepatic and renal lymph nodes being the most 
severely affected), hyperemic splenomegaly as well as petechiae in lungs, gallbladder 
and kidneys (cortex and medulla). In necropsies of the main study animals, many of 
the pigs displayed more severe macroscopic lesions, also characteristic of acute ASF, 
such as cyanotic and haemorrhagic areas on skin (ears, chest, abdomen, tail, limbs, 
perianal area), severe hydropericardium and ascites, non-collapsed lungs with 
interstitial and alveolar oedema as well as foam in trachea, petechial haemorrhages in 
lung, heart, kidney and urinary bladder, retroperitoneal oedema, severe hepatic 
congestion and oedema in gallbladder wall, hyperaemic splenomegaly and 
haemorrhagic lymphadenitis affecting submandibular, retropharyngeal, 




Figure 4.6 Examples of the main lesions observed in both wild-type and 
RELA-edited pigs post infection with high virulence ASFV isolate Benin 
98/1. A. Cyanotic and haemorrhagic areas on skin (limbs and perianal area); B. 
Enlarged purple/black spleen (hyperemic splenomegaly) C. Petechial 
haemorrhages in kidney (cortex); D-F. Tracheobronchial, renal and gastrohepatic 
lymph nodes with various degrees of haemorrhagic lymphadenitis. 
Lesions typical of ASF were observed more frequently and/or severely in the final 
experiment compared to those observed during the pilot experiment, possibly due to 
euthanasia occurring one day later PI (Fig. 4.7.A). No statistical difference in the total 
macroscopic lesions were found between the control and RELA trunc pigs. However, 
a significant difference was identified between gall bladder scoring of control and 
homozygotes (p = 0.0345), with oedema identified in the gallbladder of 5/8 of the 





Figure 4.7 Macrolesion scoring. A) Macrolession scoring for individual animals 
at termination. B) Macrolession scoring for each cohort, wild-type, heterozygous 
and homozygous for the RELA trunc mutation. Significant difference was 
calculated between the wild-type controls (n=8) and RelA-edited (heterozygous 
(n=8) and homozygous (n=8)) at each category using a Student’s paired t-test. 
Significant difference is indicated with black symbol *(p<0.05). Error bars 





Analysis of cytokine expression in whole blood during ASFV infection 
During the experiment, blood samples were collected from each pig at day 0, day 3 or 
4 (day 3 for pilot study and day 4 for final study) and at termination. Due to difficulties 
in bleeding pigs, blood samples were not obtained from some animals. RNA 
extraction, approximately 3 ml of whole blood was collected into Tempus™ blood 
RNA tubes containing 6 ml of Stabilizing reagent (Applied Biosystems). RNA was 
extracted from whole blood and reverse transcribed to cDNA. The cDNA was heated 
at 56°C for 2 hours to ensure inactivation of any contaminating virus before 
transporting to the Roslin Institute. The same panel of 10 cytokines analysed in the in 
vitro experiment were assessed again in the blood samples by qRT-PCR (see Section 
2.7.3). The expression level of each gene was normalised to the mean of cyclophilin 
A (PPIA) and beta-2-microglobulin (B2M) expression and the expression levels were 
calculated relative to the uninfected control for each animal. Comparisons between 
groups were made at day 4 PI and at day 6 PI (i.e. termination). The total number of 
bloods analysed at day 4 PI included 6 wild-type controls, 5 heterozygotes and 6 
homozygotes; and analysis at day 6 PI included 6 wild-type controls, 6 heterozygotes 
and 4 homozygotes. The results show that the relative mRNAs levels for chemokines 
CXCL10, CCL2 and CXCL2 were significantly lower induced at least one time-point 
following infection in the RELA-edited animals compared to the wild-type controls 
(Figure 4.8). It is also worth noting that the induction of TNF, IL1B, IL6, CXCL2, 
CSF2 and IFNA in the homozygote animals was lower with low variability compared 
to the other genotypes at day 6 PI, although this difference was not statistically 





Figure 4.8 Blood transcript levels over time of animals from final study. qRT-PCR 
analysis of ASF-associated cytokine genes (CXCL10, IL1B, CCL2, CSF2, CXCL2, 
IL6, IL8, IL12p40, TNF, IFNA) in whole blood of wild-type and RELA-edited pigs 
after infection with pathogenic Benin 97/1 ASFV isolate. Relative expression was 
calculated by normalising to the corresponding uninfected animal (blood taken at day 
0). Significant difference was calculated between the wild-type controls (n ≥ 6) and 
RelA-edited (heterozygous (n ≥ 6) and homozygous (n ≥ 4)) at each time post-infection 
or stimulation using a Student’s paired t-test. Significant difference is indicated with 






The ASF virus is likely to have evolved to carefully manipulate its natural hosts, 
including soft ticks, bushpig and warthog, in a persistent sylvatic cycle of infection. 
ASFV and Sus scrofa have not co-evolved, and ASFV infection generally leads to a 
rapid haemorrhagic disease with an extremely high mortality rate; fatal pathologies 
may occur before infected animals can mount an adaptive immune response. Elevated 
production of pro-inflammatory cytokines by infected macrophages are speculated to 
cause the rapid onset of ASF pathogenesis that leads to death in the domestic pig 
(Gómez del Moral et al., 1999, Gil et al., 2008).  
The overall aim of the Whitelaw group is to genetically engineer an immune response 
in the domestic pig for tolerance of ASFV infection, similar to that of the warthog. To 
achieve this an understanding of the genetics underlying the tolerance of the natural 
hosts to infection with ASFV is required. A previous study identified variation within 
porcine RELA as a likely candidate (Palgrave et al., 2011). The three functional 
changes identified in warthog RELA results in the loss of three possible 
phosphorylation sites present in the TAD domain of domestic pig RelA. This is 
hypothesised to cause an altered transcriptional response to infection with ASFV. RelA 
is a prominent regulator of cytokines associated with ASF pathogenesis. It is also 
worth noting that RelA is a known regulator of both pro- and anti-apoptotic genes 
(Baldwin et al., 2001, Barkett and Gilmore., 1999, Kasibhatla et al., 1998, Pahl., 1999, 
Campbell et al., 2004). Virulent ASFV isolates are known to repress the apoptotic 
response of infected macrophages, likely promoting the survival and dissemination of 
the virus (Sierra et al., 1991, Sánchez-Cordón et al., 2008). Conversely, apoptosis of 
uninfected bystander lymphocytes is induced by ASFV infected macrophages, which 
is thought to play a major role in ASF pathogenesis (Oura et al., 1998). 
It has been proposed that a reduced NF-κB activation may subdue the rapid onset of 
ASF pathogenesis allowing time for an adaptive immune response to the virus to 
initiate immunity (Palgrave et al., 2011). We hypothesised that ASFV infected 
macrophages would retain a similar delay in transcription response to TNFα observed 
in fibroblast cells containing the RELA trunc mutation (see Chapter 3). An altered 




homozygous and heterozygous macrophages in vitro compared to wild-type controls 
(see Section 4.2.1). 
4.3.1 Examination of in vitro results 
Macrophages were infected with either a high virulence isolate, Benin 97/1, or low 
virulence isolate, OURT 88/3. The clinical outcome varies depending on the ASFV 
viral isolate. Most ASFV isolates are considered highly virulent, like Benin 97/1, with 
infection resulting in a highly acute disease with 100% mortality. However, some 
isolates are of moderate virulence with 50% mortality or low virulence with no 
fatalities. Low virulence isolate, OURT 88/3 is naturally attenuated and can provide 
infected pigs with protection against subsequent challenge with related virulent 
isolates (Oura et al., 2005, King et al., 2011). However, OURT 88/3 infection often 
induces mild clinical symptoms with an extremely low mortality rate (Boinas et al., 
2004., Oura et al., 2005., King et al., 2011). Previous reports focus on comparing the 
cytokine responses of host macrophages to infection with either low virulence and high 
virulence ASFV isolates (Gil et al., 2003, Zhang et al., 2006, Gil et al., 2008, 
Fishbourne et al., 2013a). Understanding of the different cytokine responses of 
macrophages infected with isolates of differing virulence could indicate which 
responses are necessary for developing sufficient immune response or for inducing the 
ASF pathogenesis.  
In previous studies, mRNA levels of the pro-inflammatory cytokine TNFα were 
significantly increased in macrophages infected with a low virulence isolate (NH/P68) 
compared to infection with high virulent isolate (L60; Gil et al., 2003., Gil et al., 2008). 
In contrast, in this study we observed significantly enhanced TNFα mRNA levels in 
wild-type macrophages infected with high virulent isolate (Benin 97/1) compared to 
infection with low virulence isolate (OURT 88/3). These conflicting results may be 
due to the effect of the different isolates used and/or the time-points examined PI. In 
our analysis comparing the induced mRNA levels of the RELA trunc macrophages to 
wild-type control macrophages, the TNFα transcript level was significantly lower at 
the 4 hours PI with Benin 97/1 in the RELA trunc macrophages. Conversely, the TNFα 
protein levels in the supernatants of ASFV-infected macrophages quantified by ELISA 




proteins detected by the ELISA analysis are influenced not only by the mRNA levels 
but also by the protein translation, processing, stability and secretion during infection. 
Thus, it is possible that the increased mRNA levels of TNFα observed in the wild-type 
macrophages will not translate to increased levels of secreted TNFα protein levels. 
Alternatively, this change in mRNA level could be translated to levels of secreted 
protein however it was not detected at the time-points examined. Another pro-
inflammatory cytokine, IL-1β, was previously been found to be differentially 
expressed in wild-type macrophages infected with high virulence isolate Malawi 
LIL20/1 ASFV compared with un-infected cells (Zhang et al., 2008). Furthermore, 
high virulence isolate induced higher levels of secreted IL-1β compared to the low 
virulence isolate OURT 88/3 (Zhang et al., 2008). In our study, differential expression 
of IL-1β was not observed in wild-type macrophages after infection with either isolate. 
Again, this may be the result of different isolates and time-points PI used in this study. 
However, homozygous macrophages were found to be have enhanced IL-1β mRNA 
and secreted protein levels after infection with virulent isolate Benin 97/1. The release 
of cytokines TNFα, IL-1β, IL-6 and IL-8 from ASFV infected macrophages is pro-
inflammatory, pro-apoptotic and pro-coagulant, and thought to be the primary inducers 
of lymphocyte depletion, disseminated intravascular coagulation and haemorrhagic 
lesions observed in acute ASF (Gómez-Villamandos et al., 2013). 
An immunoregulatory cytokine identified previously to be upregulated early in ASFV 
infection of host macrophages response is IL-12p40 (Gil et al 2008). This cytokine is 
important for the promotion of proliferation and survival of NK and T cells and the 
differentiation of the CD4+ and CD8+ T cells populations (Kim et al., 2008). The Gil 
et al., (2008) study identified that IL-12p40 mRNA levels were significantly increased 
in macrophages infected with a low virulence ASFV isolate NH/P68 (NHV). IL-12p40 
is speculated to favour the host by promoting activation of T-cells vital for the 
formation of an adaptive immune response that is lacking in highly virulent infections. 
Once again, our study did not concur with the previous report, as ASFV infected wild-
type macrophages upregulate expression of IL-12p40 when infected with either OURT 
or Benin. However, ASFV infected homozygous macrophages did display 




isolates. It is worth noting that IL-12p40 also acts as a chemoattractant for 
macrophages (Cooper & Khader., 2007). Recruiting macrophages to infection sites 
could be of benefit to the virus, concentrating macrophages for further cycles of 
infection. 
A study carried out by Fishbourne et al., (2013a) of the chemokine response of in vitro 
ASFV infected macrophages found that CXCL10, CCL2 and CXCL2 amongst others 
where differentially expressed. Chemokines are chemotactic cytokines which promote 
recruitment and activation of leukocytes. CXCL10 is a chemoattractant for CD4+ T-
cells and was found to be upregulated in response in macrophages infected with ASFV. 
In accordance with the study by Fishbourne et al., (2013a), the upregulation of 
CXCL10 was higher in cells infected with low virulence isolate, OURT 88/3, 
compared to high virulence isolate, Benin 97/1. Increased levels CXCL10 were 
speculated to contribute to induction of adaptive immune response providing effective 
protection against ASFV in low virulence infections. However, CXCL10 has also been 
reported, together with either IL-2 or IFNα to induce apoptosis of bystander T-cells 
(Sidahmed et al., 2012). Chemokines CCL2 and CXCL2 were previously found to be 
down-regulated in macrophages infected with ASFV at 16 hours PI. In our study, 
analysing earlier time-points PI, the mRNA levels of CCL2 and CXCL2 were down-
regulated in OURT 88/3 infected wild-type macrophages but not in Benin 97/1 in 
infected wild-type macrophages. In fact, CCL2 was upregulated in wild-type 
macrophages at 8 hours PI with both OURT 88/3 and Benin 97/1. This upregulation 
was significantly higher in cells infected with Benin 97/1 compared to OURT 88/3. 
CCL2 is involved in the recruitment of monocytes to sites of active infection, and as 
such could possibly act to concentrate susceptible cells for infection (Deshmane et al., 
2009). CXCL2 is a chemoattract of neutrophils and elevated expression is often 
associated with autoimmune and inflammatory disorders (Kobayashi., 2008). 
Increased IFNA expression was previously in identified in macrophages infected with 
the low virulence ASFV NH/P68 isolate compared to high virulence ASFV L60 isolate 
(Gil et al., 2008). Our results of IFNA expression are in accordance with this study, 
however no difference was observed between RELA genotypes. IFNA, encodes 




interferons are a multi-gene family of cytokines which are best known for their 
involvement in early antiviral responses (McNab et al., 2015). Furthermore, 
preincubation of porcine macrophages with either IFNα or IFNγ inhibits ASFV 
replication in vitro (Esparza et al., 1988). The ASFV multigene families 350 and 505 
are involved in inhibition of host type I IFN expression and recent studies have found 
that deletion of these regions from the genomes of highly virulent ASFV isolates 
attenuates them (Afonso et al., 2004, O’Donnell et al., 2015, Reis et al.; 2016). NF-κB 
is known to regulate expression of both IFNβ (Hiscott et al., 1989) and IFNγ (Sica et 
al., 1997). Thus, inclusion of these genes in future analysis of RELA-edited animal’s 
response to ASFV infection would be of interest due to their potential importance in 
the clinical outcome of ASFV infection.  
It is generally accepted that ASF is caused primarily by the factors secreted by the 
infected macrophages. From our in vitro analysis, we have identified that several 
cytokines previously associated with ASF are dysregulated in ASFV infected 
homozygous macrophages compared to control cells, these include TNFα, IL-1β, IL-
12p40, CXCL10, CCL2 and CXCL2. Although some studies have analysed the 
cytokine responses of infected macrophages in vitro, they often have conflicting 
results, likely due to differences in both the ASFV isolates used and the time-points PI 
analysed. It is difficult to decipher the downstream impact of these early cytokine 
responses on the in vivo disease pathogenesis. The in vivo response adds multiple 
layers of complexity influenced by the site and dose of ASFV infection along with 
environmental differences including factors secreted by other cells and tissues, and the 
downstream effects of the secreted cytokines on the surrounding uninfected cells. 
However, predictions can be made based on known functions of specific cytokines. It 
has been proposed that higher levels of IL12p40 and CXCL10 expression in response 
to ASFV infection may contribute to an effective immune response to low virulence 
isolates. As these two genes are upregulated more in macrophages homozygous for the 
RELA trunc mutation we could expect this to be beneficial to the host. Conversely, 
higher expression of both CCL2 and CXCL2 were observed in the infected 
homozygous cells compared to wild-type cells, potentially contributing to increased 




4.3.2 Examination of in vivo results 
An in vivo study was carried out to see if these changes in the ASFV induced cytokine 
response identified in RELA-edited macrophages translated to an altered clinical 
outcome to infection with Benin 97/1.  
During the infection with Benin 97/1 blood samples were taken from each animal for 
cytokine expression analysis. Significantly lower mRNA levels of chemokines 
CXCL10, CXCL2 and CCL2 were identified in infected homozygous animals 
compared to infected wild-type controls. In an animal challenge study carried out by 
Fishbourne et al (2013b) a significantly higher expression of these three chemokines 
was observed in the whole blood of pigs infected with high virulence ASFV isolate 
Benin 97/1 compared to the low virulence ASFV isolate OURT 88/3, suggesting that 
lower mRNA levels may result in less severe clinical outcome. However, 
unfortunately all RELA-edited animals went on to develop acute ASF with no 
significant difference in their clinical outcomes to ASFV infection compared with 
controls.  
Our in vivo results contrast with findings from in vitro analysis of infected 
macrophages, where mRNA levels of CXCL10, CXCL2 and CCL2 were found to be 
significantly higher in Benin 97/1 infected homozygous cells compared to infected 
wild-type cells. The in vivo study analysed mRNA levels in whole blood days after 
infection. Moreover, the cytokine response in vivo may be influenced by the various 
different cell types and the local cytokine environment present in the blood. 
Acute ASF is characterised by multiple haemorrhages, lymphopenia associated with 
intense destruction of lymphoid tissue and disseminated intravascular coagulation, 
leading to death, usually within less than 10 days. In this study, clinical signs and 
characteristic macroscopic lesions of acute ASF were recorded. However, no analysis 
was made on the levels of lymphopenia, a hallmark of the disease. Lymphocyte 
depletion has been observed in the peripheral blood, bone marrow, spleen and lymph 
nodes of ASFV infected animals (Zakaryan et al., 2015). As NF-κB is a regulator of 
apoptosis it may have been interesting to compare the levels of lymphopenia between 




Two homozygotes and one control died before their clinical signs met the moderate 
severity end-point set. In retrospect, these sudden deaths make us question the design 
of the animal experiment. The highly virulent Benin 97/1 isolate was initially selected 
for this study as cytokine expression data from previous publications existed providing 
comparative data (Fishbourne et al., 2013a, Fishbourne et al., 2013b). It is possible 
that the sudden deaths occurred due to the viral dose. It has been suggested that for 
future experiments, testing of viral doses be carried out before initiating the main 
study. This would involve inoculating control pigs with different viral titres and 
evaluation disease progression to select optimum dose for the experiment. It may be 
that inoculating RELA-edited animals for slow disease progression would permit time 
to develop an effective immune response. In this study, we use intramuscular injection 
to administer ASFV however intranasal administration also exists, which may offer a 
more ‘natural’ route of infection (Sánchez-Cordón et al., 2017). Alternatively, one or 
two animals could be inoculated and co-housed with un-infected animals. However, 
this method is particularly difficult to control compared to administered inoculations. 
In conclusion, our results show that live pigs carrying the RELA trunc mutation are 





Chapter 5 Using CRISPR/Cas9 gene editing 
system to introduce S531P into the 
domestic pig RELA locus 
5.1 Introduction 
Polymorphisms within porcine RELA have been hypothesised to underlie resilience to 
African swine fever (ASF; Palgrave et al, 2011. ASF is a highly contagious lethal 
disease of domestic and feral pigs, caused by infection with African swine fever virus 
(ASFV). Domestic pigs infected with virulent ASFV isolates undergo a rapid-onset 
lethal haemorrhagic fever. In contrast, porcine species indigenous to Sub-Saharan 
Africa, such as warthogs and bushpigs, display no clinical signs post-infection with 
virulent ASFV isolates (Anderson et al, 1998; Oura et al, 1998; Thomson et al, 1980; 
Thomson et al, 1985). To date, no genetic variation is known to exist within the 
domestic pig populations that confers resilience to ASF. A previous study in the 
Whitelaw group sought out to identify genetic variation between two pig species, the 
highly susceptible domesitic pig (Sus scrofa), and the ASF resilient warthog 
(Phacochoerus africanus), that could underlie the difference in host response to ASFV 
infection. This lead to the discovery an intriguing candidate, after identifying 
functional polymorphisms in porcine RELA (Palgrave, et al, 2011). 
RELA encodes for a subunit of NF-κB, which is a key transcription factor involved in, 
amongst other roles, activating immune and inflammatory responses. The NF-κB 
subunits, including RelA, are known to be evolutionary and structurally conserved 
across mammalian species (O’Shea & Perkins, 2008). Moreover, the NF-κB 
transcription factor family is suggested to have originated as far back as the beginning 
of the metazoan lineage (Gauthier & Degnan, 2008; Sulivan et al, 2007). Three amino 
acid differences were identified between the warthog and the domestic pig RelA, 
T448A, S485P, and S531P, which are displayed in Figure 5.1. It was demonstrated 
that these changes, in particular S531P, impacted on the activity of NF-κB in vitro; the 
warthog RELA displays reduced NF-κB activity in basal and induced conditions 




It was hypothesised that the warthog variant RELA had the potential to underlie the 
warthog’s apparent tolerance to ASFV infection. In order to test this hypothesis, 
genetic engineering tools have been employed to introduce the warthog RELA changes 
into the domestic pig RELA locus. This has been achieved by members of the 
Whitelaw group using ZFNs (Lillico at el, 2016). ZFN encoding mRNA alongside a 
plasmid donor template, containing the desired warthog SNP flanked by sequence 
homologous to the DNA target, were delivered directly into zygotes by microinjection, 
before subsequent transfer into recipient sows. Three piglets born from this procedure 
were either heterozygous or homozygous for the desired changes. Two piglets 
contained all three desired warthog SNPs and one piglet was homozygous for SNPs 
encoding only the first two amino acid modifications (i.e. T448A and S485P). 
As previously mentioned, it was observed that one SNP, causing a serine to proline 
change at position 531, was responsible for significantly reducing the NF-κB activity 
of warthog RelA (Palgrave et al, 2011). This serine site a well-characterised 
phosphorylation site in human RelA, which when phosphorylated increases activity of 
NF-κB (Wang et al., 2000). It was hypothesised that this single amino acid change 
between the warthog and the domestic pig caused by one SNP, may be responsible for 
warthog’s resilience to African Swine Fever.  
The following results chapter will describe the utilisation of the CRISPR-Cas9 editing 
system to introduce one warthog SNP, causing the serine to proline amino acid change, 




Figure 5.1 RelA protein alignment. The domestic pig (SS) amino acid sequence 
is displayed, with sequence variation in the warthog (PA), Babyrousa (BB) and 
human (HS) indicated underneath. The three amino acid differences, T448A, 
S485P, and S531P, between the warthog and domestic pig are highlighted in 
black. The Rel homology domain (RHD) is indicated with a single underline, the 
transactivation domain 2 (TA2) is dashed underlined and the transactivation 
domain 1 (TA1) is double underlined. The nuclear localisation signal (NLS), 






The main aims of this chapter are: 
• To investigate if the serine at position 531 in porcine RelA is conserved across 
mammalian species. 
• To use the CRISPR-Cas9 editing system to produce domestic pigs that contain the 





5.3.1 Comparison of the RelA 531 site between mammalian 
species   
In order to investigate whether the S531 of domestic pig RelA is evolutionarily 
conserved in mammals, an alignment was carried out, using all known mammalian 
RelA protein sequences present in the NCBI databases.  
Out of the 88 mammalian species screened, only six did not contain the serine at the 
equivalent domestic pig 531 site, these include; two species of bat, the little brown bat 
and Brandt’s bat; two species of shrew, the common shrew and the cape elephant 
shrew; one species of lagomorph, the American pika, and one species of swine, the 
warthog (Figure 5.2).  Two of these species, Brant’s bat and the cape elephant shrew, 
contain a threonine at the equivalent domestic pig 531 site. Threonine, along with 
serine and tyrosine residues have the potential to receive a covalently bound phosphate 
group (i.e. be phosphorylated). Casein kinase II (CKII) controls the phosphorylation 
of the equivalent pig 531 serine in humans (S529), which phosphorylates both 
threonine and serine residues (Wang et al, 2000; Litchfield, 2003). Thus, the threonine 
amino acid substitution would likely preserve the phosphorylation status of RelA. The 
remaining four species, the common shrew, little brown bat, pika and warthog, with 
an amino acid substitution at position 531 contain either a proline or an alanine residue 
in place of the serine, thus absolutely abolishing this phosphorylation site.  
This protein alignment has revealed that the serine at 531 in the domestic pig sequence 
is conserved across the majority of mammalian species with a few exceptions, one of 
which is the warthog, which is the only swine species identified that does not contain 
serine at position 531. To further investigate if this amino acid substitution plays a role 
in the differing response to African Swine Fever virus infection between the domestic 
pig and the warthog, we set out engineer domestic pigs to contain the warthog proline 




Figure 5.2 The final 60 amino acid of RelA protein alignment in mammalian 
species. This figure displays an alignment of the final 60 C-terminal amino acids 
of the RelA protein in a range of mammalian species. All amino acids changes 
from the domestic pig are represented in red and the vertical red line indicates the 
position of the relevant serine residue.  
 
5.3.2 Design and validation of short guide RNAs (sgRNAs) in 
fibroblasts 
The CRISPR-Cas9 system derived from Streptococcus pyogenes was selected for the 
HDR-mediated allele exchange from the domestic pig S531 to the warthog P531 
RELA allele. Four sgRNAs were designed to target a DSB in close proximity to the 
codon encoding S531 in the domestic pig. The target binding site sequences, shown in 




Cas9-2A-GFP (further details can be found in Section 2.8.2). Each of the four CRISPR 
plasmids were transfected into porcine embryonic fibroblasts (PEFs) using the neon 
electroporation system. The transfected cells were cultured for 48 hours before 
extracting genomic DNA for analysis. A PCR was carried out on the genomic DNA to 
amplify a ~300bp region spanning CRISPR target site, using RELA primers. A T7 
endonuclease assay was performed on the PCR product to detect on-target cutting 
events (Figure 5.4). Editing was observed with all four CRISPR transfections, however 
it was difficult to determine which CRISPR appeared to be most active due to variation 
in transfection efficiencies. In all subsequent experiments, fluorescence-activated cell 
sorting (FACS) was used to positively select transfected cells. A GFP sort was 
performed on the cells following 48 hours in culture before subsequent analysis was 
carried out. As shown previously, editing was observed in all four CRISPRs (Figure 
5.5). Quantification of the T7 gel image was carried out using ImageJ software as 
described in Guschin et al, 2010. CRISPR #4 was estimated to be the most efficient, 
so was taken forward to introduce the S531P change in HDR experiments (see 
following results sections). It is important to note that T7 endonuclease efficiently 
cleaves mis-matches of ≥2 bases long, however single nucleotide editing events are 
not always detected, potentially resulting in an underestimation of editing efficiency 




Figure 5.3 Positions of sgRNA binding site on porcine RELA. Schematic 
diagram showing RelA protein domains, highlighting the protein region that is 
encoded by the final exon of porcine RELA gene. The porcine RELA gene 
contains 11 exons that produce a 2.53 kb mRNA transcript. The sgRNA target 
region in the final exon is highlighted and target DNA sequence is displayed in 
the lower panel. Each sgRNA binding site is shown individually circled with the 
corresponding to PAM site underlined in a representative colour. All CRISPRs 
were designed to induce double strand breaks close to the target codon, 





Figure 5.4 Transfection of PEFs with four CRISPRs targeted against porcine 
RELA. A) Brightfield (BF) and GFP images of transfection of CRISPR plasmid 
containing Cas9-GFP giving an indication of the transfection efficiency. B) Gel 
image of the T7 endonuclease assay conducted on transfected fibroblasts. 





Figure 5.5 Repeat transfections of PEFs with CRISPRs targeted against 
porcine RELA. Transfected cells were positively selected with GFP cell sorting 
prior to performing a T7 endonuclease assay. The T7 endonuclease results are 
displayed with estimations for editor cutting efficiency underneath the 
appropriate lane. 
5.3.3 HDR oligo design and validation in fibroblasts  
For all HDR experiments in fibroblasts, CRISPR plasmid #4 was used combined with 
a series of single stranded oligodeoxynucleotide (ssODN) donor templates designed to 
introduce codon conversion (TCG to CCG) for desired serine (domestic pig) to proline 
(warthog) change. All donor templates contain a single nucleotide change (T to C) 
which introduces both the desired codon change and a novel restriction site (Xma1), 
enabling RFLP analysis, and a single silent nucleotide change (G to T) to disrupt the 
PAM site, to block further Cas9 targeting. The four ssODNs were oriented in either 
sense or anti-sense directions with varying homology arm designs (Figure 5.6, A-B). 
The 70-mer ssODNs were designed using our laboratory’s standard method, in which 
homology arms are equal lengths with the insert sequence in the centre. The 127-mer 
anti-sense ssODN was designed based on findings from Richardson et al, 2016 that 
show an asymmetrical ssODN donor design, comprised of a 35bp homologous 
sequence that is complementary to the DNA fragment that is released by the Cas9 
immediately after cleavage, with insert sequence on the other side of the cut followed 
by 86bp of homologous sequence, this was found to increase HDR efficiency in human 




Each of the four ssODNs were transfected into PEFs alongside the CRISPR #4 plasmid 
using the neon electroporation system. The PEFs were cultured for 48 hours before 
selecting GFP positive cells for extraction of genomic DNA for analysis. A PCR was 
carried out on the genomic DNA to amplify a ~300bp region spanning CRISPR target 
site, using RELA primers(see Table 2.3 for primer sequences). A T7 endonuclease 
assay was subsequently performed on the PCR product to confirm on-target cutting 
events. To estimate the HDR efficiency, RFLP analysis with Xma1 was performed on 
the same PCR product. HDR was detected in all cells transfected with CRISPR #4 plus 
each of the donor ssODNs, however the efficiency was too low for image 





Figure 5.6 Co-transfection of ssODNs and CRISPR#4 to incorporate 
mutations into the RELA locus. A) The schematic shows the four ssODNs 
donor DNAs. Each ssODN was designed to introduce a precise change (green 
box) which also introduces an XmaI site into the RELA genomic locus (yellow 
box) following cleavage by Cas9 (blue triangle). B) ssODN donor DNAs used to 
incorporate mutations into the porcine RELA locus; a single nucleotide change 
(T→C) converts, TCG to CCG, encoding the desired S531P conversion. This 
same base change also introduces an XmaI site (underlined) which can be utilised 
to assess HDR efficiency. A second proximal single nucleotide change disrupts 
the PAM site to block re-cutting. The four ssODNs are oriented in either the sense 
or the antisense direction with varying left and right homology arm lengths. C) 
Agarose gel analysis of PCR products from genomic DNA of PEFs transfected 
with CRISPR#4 plus the ssODN indicated. RFLP with XmaI or a T7 




5.3.4 Improving HDR efficiencies 
Due to the low frequency of HDR observed in the experiments described previously, 
it was hypothesised that the introduction of compounds known to inhibit NHEJ could 
be used to bias the cells repair system to HDR. The HDR experiments were repeated 
with the addition of NHEJ inhibitors SCR7 or L755507 in the post-transfection cell 
culture media at a final concentration of 1 μM and 5 μM respectively. SCR7 and 
L75507 were found to increase the HDR frequency in studies using mammalian cell 
lines and embryos (Maruyama et al, 2015; Chen et al, 2015). However, in this study 
the RFLP analysis clearly shows that these inhibitors did not work, neither of the NHEJ 
inhibitors increased the levels of HDR (Figure 5.7).  
All data thus far suggested that the ssODNs were unlikely to work with a high 
efficiency. However, other members of the Whitelaw group have reported that the 
frequency of HDR is significantly higher in embryos compared to somatic cells. It is 
often the case that HDR is lower in somatic cell types compared to stem cell types, 
due to the lower fraction of cells that will be in S phase, where HDR is the primary 
DSB repair mechanism (Kass et al, 2012). As these editor reagents have been 
developed for the production of genetically engineered animals they were taken 






Figure 5.7 HDR results with NHEJ inhibitors. Agarose gel analysis of PCR 
products from genomic DNA of PEFs transfected with CRISPR#4 plus the 
ssODN indicated, that were subsequently cultured with or without the indicated 
NHEJ inhibitor. RFLP with Xma1 or a T7 endonuclease assay were used to assess 






5.3.5 Porcine embryo injections 
To produce genome edited pigs with the desired changes, the CRISPR-Cas9 editors 
and donor template were delivered into the fertilised porcine oocytes by cytoplasmic 
micro-injection carried out by Dr Simon Lillico. It has been reported that CRISPR-
Cas9 editors are most efficient when delivered into the cell in a combination of crRNA, 
tracrRNA, Cas9 protein, pre-complexed before delivery, so this method was selected 
for this study (Aida et al., 2015). CRISPR #4 crRNA was used for all zygote injections 
based on the high on-target cutting efficiency the CRISPR#4 sgRNA identified in 
fibroblasts (see Section 2.1.2). It was not possible to quantify which ssODN was 
optimal based on the HDR experiments in fibroblasts (see Section 2.1.3) thus the 127-
mer anti-sense ssODN was selected based on previous success reported in Richardson 
et al, 2016.  
Each zygote was subjected to a single 2-5 pl cytoplasmic injection of a mix containing 
CRISPR #4 and 127-mer anti-sense ssODN. Approximately 40 injected zygotes where 
transferred into each of 4 recipient sows, the remaining zygotes were cultured to 
blastocyst stage (day 6-7) before harvesting to carry out further analysis. Blastocysts 
were analysed by PCR and sequencing to detect any on-target editing events. 
In the first round of injections the injection mixture, referred to as Mix 1, contained 
CRISPR #4 crRNA and tracrRNA both at a concentration of 0.5 pmol/μl, Cas9 protein 
at a concentration of 0.24 pmol/μl and 127-mer anti-sense ssODN at a concentration 
of 100 ng/μl. The in vitro development of zygotes injected with Mix 1 to blastocyst 
stage was observed by Dr Simon Lillico to be poor compared with previous work 
carried out by the Whitelaw group. In contrast with Mix 1, the injection components 
previously used by the Whitelaw group all contained sgRNA and NEB Cas9 protein, 
which were both resuspended and stored in Embyromax buffer before use (see Section 
2.12.3 for buffer details). Our injection mixes all contain IDT Cas9 protein, 
synthesised crRNA and tracrRNA, which were resuspended and stored in IDT Duplex 
Buffer according the manufacturer’s guidelines. In preparation of Mix 1, these 
components were subsequently diluted in Embyromax to the desired concentration 




2, the concentration of each component was reduced by half in Embyromax buffer in 
attempt to reduce any toxicity effects. The development of zygotes injected with Mix 
2 to blastocysts was higher compared to Mix 1 injected zygotes (microinjection mixes 
are summarised in Table 5.1 and in vitro culture results are summarised in Table 5.2). 
Sequencing of the RELA locus revealed that three of the six blastocysts analysed were 
edited. Editing events included HDR and NHEJ events, indicated by the indel 
mutations identified, see Figure 5.8 for sequence traces. For one of the edited embryos, 
mix 1 blastocyst 2, the NHEJ editing event was identified in a lower signal intensity 
trace from the wild-type trace, suggesting that this embryo is mosaic for this editing 
event i.e. the editing event occurred in a single cell after the zygote had gone through 
cell division, thus not all cells contain the edited allele. The remaining two edited 
blastocysts, contain a wild-type trace and edited trace in their chromatogram with 
similar signal intensities indicating that they are heterozygotes i.e. the editing event 
occurred in the one cell zygote before cell division. Due to the low number of injected 
zygotes that developed to blastocyst stage, it was unexpected that any would contain 
the desired HDR editing event. However, a HDR event was identified in a single 
blastocyst, mix 1 blastocyst 1, confirming that the CRISPR-Cas9 reagents plus 127-
mer ssODN donor template are effective in zygotes. The predicted protein changes for 
each of the identified editing events are displayed in Figure 5.9. 
Out of the four recipient sows, two were confirmed as pregnant (embryo transfers and 
recipient pregnancies are summarised in Table 5.3). Despite the lower blastocyst 
development observed in vitro, the two pregnant sows were both recipients of zygotes 
that had been injected with Mix 1. Analysis of these animals will be carried out once 






Table 5.1 Injection mixes. Details of concentration of reagents used in each injection 
mix. All components were ordered from IDT.  
 
Table 5.2 In vitro embryo culture results. 
 
Table 5.3 Embryo injections and transfers. 
Injection mix No. of embryos No. developed No. of blastocysts
cultured to blastocyst   edited
Mix 1 30 2 of 30 2 of 2
Mix 2 23 4 of 23 1 of 4
Uninjected controls 20 7 of 20 N/A
Injection mix No. of embyros No. embyros No. of No. of 
 injected  transfered recipients pregnancies 
Mix 1 110 80 2 2 of 2




Figure 5.8 In vitro blastocyst sequencing analysis. A) Diagram displaying the 
sequence of both the genomic locus targeted for double strand break (site 
indicated with triangles) and the ssODN donor template. B) Sequence 
chromatograms from wild-type control and edited blastocysts. Note sequencing 
was performed using the RELA reverse primer and that the reverse complement 
of the chromatogram is displayed. The black line on each chromatogram indicates 
the start of the deviations from wild-type sequence. C) Displays the sequence 
reading for each trace from edited blastocysts chromatogram with HDR induced 





Figure 5.9 Protein coding changes based on editing events identified in blastocysts.  Schematic diagram showing RelA’s protein domains, 
highlighting the TA1 domain, which is expanded to show the amino acid sequence predicted from the blastocyst editing events identified in the final 
exon of porcine RELA. The DNA sequence is displayed in black with base pair changes from wild-type sequence in lower case. Above the encoding 





Programmable nucleases have given us the capabilities to induce targeted genomic 
modification into virtually any organism with relative ease and success. Traditional 
breeding has been blindly manipulating the genomes of livestock and crops for 
thousands of years. With the use of genome editors, we can modify the genomes 
precisely to improve or alter any trait in which the underlying genetics is understood.  
In this chapter I have demonstrated how CRISPRs can be used to generate a precise 
change into the porcine RELA locus, ultimately for the production of genetically 
engineered domestic pigs that are resilient to African Swine Fever.  
5.4.1 Interpretation of conservation of S531 in porcine RelA 
across Mammalian species 
Immune-related genes usually undergo rapid evolutionary change due to selective 
pressures induced by aggressive pathogens present within different environments. 
However, many of the identified putative phosphorylation sites located in the 
transactivation domain in RelA are highly conserved across species (O’Shea & 
Perkins, 2008). The equivalent 531 domestic pig serine site in humans (S529) is one 
of the characterised phosphorylation sites that is reportedly conserved across species. 
When phosphorylated by CKII, the NF-κB transcriptional activity is upregulated 
(Wang et al, 2000). We chose to further investigate how conserved this serine residue 
is in mammals by aligning all the predicted RelA protein sequences currently in the 
NCBI database. The equivalent domestic pig 531 serine was present in the majority of 
species screened, with exception of 6 species including the warthog. This has been 
previously hypothesised to underlie the difference in response to infection with ASFV 
between the domestic pig and the warthog, all other swine were found to retain this 
serine site. We identified that this serine site is not completely conserved across all 
mammalian species as five other species where identified to contain an amino acid 
substitution at this position. However, two of these species contained a threonine 
residue at this site which can also phosphorylated by CKII. The remaining three other 
species contain an alternative amino acid that cannot be phosphorylated, thus they will 
most likely display a lower NF-κB activity in response to some NF-κB signal 




evolutionary adaptation against a pathogen, as hypothesised in the warthog against 
ASFV. 
5.4.2 HDR efficiency in fibroblasts 
All CRISPRs generated in this study were found to be efficiently active in primary 
porcine embryonic fibroblasts (Figure 5.5). However, when donor ssODN templates 
were introduced, only a low level of HDR editing events were detected via RFLP 
analysis. The HDR efficiency was even too low for accurate quantification, as the 
uncut band is oversaturated on the gel image (Figure 5.6). In general, NHEJ is the 
predominant mechanism of double strand break (DSB) repair in somatic cells, even in 
the presence of homologous donor templates (Fattah et al, 2010). Thus, low levels of 
HDR were to be expected, yet, many other studies have reported much greater 
frequencies of HDR in somatic cells than that observed in this study (Tan et al, 2013; 
He et al, 2016; Abu-Bonsrah et al, 2016). It is difficult to interpret why such a low 
HDR frequency was observed in this study without direct comparisons, however it is 
possible that the cell type and the target locus could be restrictive factors. Miyaoka et 
al, 2016, identified that the frequency of HDR-mediated editing events, when using 
the CRISPR-Cas9 system, is highly dependent on the target locus, nuclease and cell 
type. 
There are a few strategies used to stimulate HDR-mediated editing events in CRISPR-
Cas9 experiments, one is to suppress the NHEJ by inhibiting key molecules in the 
pathway. This method has been successful, increasing the efficiency of HDR editing 
events up to 19-fold in mammalian cells (Chu et al, 2015; Vartak et al, 2015; Yu et al., 
2015). In attempt to increase the frequency of HDR in this study, two small NHEJ 
inhibitor compounds, SCR7 and L755507, were employed, however neither were 
found to improve levels of DNA template introgression (Figure 5.7). It is possible that 
these treatments were not used at the appropriate concentrations as no optimisation 
was carried out prior to use. Concentrations were selected based on data from treated 
mouse embryonic fibroblasts (Maruyama et al, 2015). This result was disappointing, 
however, as the HDR frequency is highly dependent on cell type, and we generate 
transgenic animals by embryo microinjection, the developed reagents were taken 




If higher a HDR frequency was required in fibroblast cells, there are alternative 
strategies that could have been tested. These involve synchronising the cells to a HDR 
permissive phase (i.e. late S and G2 phases) of the cell cycle and delivering the 
CRISPR/Cas9 and donor template in a time-dependant manner (Lin et al, 2014). 
5.4.3 Embryos injections and in vitro culture  
Low numbers of zygotes injected with the CRISPR-Cas9 mix 1 developed to 
blastocyst in vitro. The poor blastocyst development in vitro suggests that the 
concentration of CRISPR-Cas9 and/or the ssODN may be toxic to the embryo.  Thus, 
the concentration of each reagent i.e. crRNA, tracrRNA, ssODN and Cas9 protein was 
reduced by half in the subsequent CRISPR-Cas9 microinjections (mix 2), which 
improved the in vitro development to blastocyst (see Table 5.2). The observed toxicity 
may also be accountable to the Duplex buffer, which had not previously been used in 
any embryo injections carried out by the Whitelaw group, it was recommended by 
supplier for storage of the Cas9 protein and synthesised crRNA and tracrRNA. The 
Duplex buffer concentration was also diluted in half for the final round of CRISPR-
Cas9 injections (mix 2).  
In general, the development of porcine zygotes to blastocyst stage in vitro is low 
compared to other mammals, such as sheep, cattle and mice (Dang-Nguyen et al, 
2011). Moreover, the microinjection procedure reduces this embryo viability further 
due to inflicted physical damage to the zygote. Despite, the lower in vitro porcine 
embryo development of zygotes injected with Mix 1, these injected zygotes resulted 
in maintained pregnancies in both recipient sows. Pregnancy in pigs is only maintained 
when a minimum of 4-5 embryos implant at day 14, this suggests that embryo 
development of injected zygotes was significantly higher in vivo than in vitro (King et 
al, 2006). 
5.4.4 Mosaicism caused by CRISPR-Cas9 
A mosaic mutation was identified one of the injected blastocysts (Figure 5.8). This 
most likely due to the CRISPR-Cas9 systems ability to repeatedly target genes past the 
one cell stage in embryonic development, often leading to mosaicism of the introduced 




editors for the production of genetically engineered organisms, particularly when 
targeting in zebrafish and Xenopus. Mosaicism is high in these vertebrates, likely due 
to their very rapid early development. The zygotes of zebrafish and Xenopus go 
through their first cell division at approximately 45 and 90 minutes respectfully (Zhang 
& Masui., 1999, Fuentes & Fernandez., 2010). In contrast, the pig zygote takes 
approximately 16 hours before reaching the two-cell stage. Prolonged expression of 
the Cas9 in the embryo is a likely cause of mosaicism. Thus, in attempt to reduce the 
frequency of mosaics in this study, Cas9 protein was directly injected into zygotes 
instead of more frequently used Cas9 mRNA. As we observed in this study, mosaicism 
can also occur when using Cas9 protein. If any of the founder animals are born for this 
study are mosaic for the desired editing event, they can be checked for germline 
transmission to determine if they should be used to produce first generation edited 
animals.  
An alternative method to generate transgenic animals, instead of embryo 
microinjection, is to perform editing in somatic cells followed by somatic cell nuclear 
transfer (SCNT). This route avoids mosaicism and, as the editing events can be 
identified in cells before use, it can guarantee that any animals born from this 
procedure would contain the selected editing event. However, SCNT has many 
limitations, it is very expensive as it requires a high level of technical expertise and 
the efficiency of producing live animals from cloning is low meaning that large 
numbers of animals are required to supply oocytes and to act as recipients.  
5.4.5 Off-target effects of CRISPR-Cas9 
In this study, we identified the on-target editing events in the injected blastocysts by 
sequencing across the target locus. However, many studies have demonstrated that off-
target DNA cleavage is common in the CRISPR-Cas system, as mismatches are often 
tolerated between the crRNA and the target DNA, particularly in the sequence furthest 
away from the PAM site (Cong et al, 2013; Jiang et al, 2013; Pattanayak et al, 2013; 
Fu et al, 2013). Some of these studies observed that the mutagenesis frequency of off-
site targets was occasionally higher than the intended target site (Jiang et al, 2013; Fu 
et al, 2013). This lack of complete specificity required for the Cas9 nuclease cleavage 




genomes evolve rapidly, the CRISPR-Cas systems allowance of DNA cleavage at sites 
containing mismatches may permit host defence against the next genetically similar 
invading genome. However, in applications of genetic engineering, off-target 
mutagenesis is undesirable. In this study, we utilised web-based tools (see Section 2.10 
for details) that improve the sgRNA design to minimise the off-target effects. Previous 
studies have shown that when rational sgRNA design strategies are employed, off-
target effects are significantly reduced, although often still detectable, they are rare 
enough to be accepted for use in biological studies (Doench et al, 2016). However, for 
applications in human therapeutics the CRISPR-Cas9 off-target phenomena is 
considered a major safety issue. In the case of genetically engineered livestock species, 
a low off-targeting effect is unlikely to create major safety issues however it does have 
the potential to confound the phenotype of founder animals, if required a breeding 
program may be performed to remove any unwanted mutations. Recently, 
Streptocococcus pyogenes Cas9 (spCas9) has been modified to reduce its ability to 
make to non-specific DNA contacts, this version of spCas9 has proven to diminish any 
detectable off-targeting effects (Kleinstiver et al, 2016). This alternative Cas9 will 
likely be wide-spread in all future applications of the CRISPR-Cas system.  
Despite the low frequency of HDR-mediated editing events observed when testing the 
developed CRISPRs in fibroblasts, the desired HDR editing event was present in one 
of six analysed blastocysts. Making it more plausible that some of the piglets born 
from the two pregnant recipients may contain this desired editing event, bringing us 
closer to having animals with the desired warthog polymorphism that is hypothesised 





Chapter 6 General Discussion 
6.1 Background and aims 
Animal disease imposes a huge burden on the livestock industry, impacting both 
welfare and production. Major outbreaks of transboundary diseases, such as foot and 
mouth disease, rinderpest, classical swine disease and African swine fever (ASF), have 
resulted in devastating global economic losses. As a result, scientific research is 
engaged in lowering this impact by generating effective preventative measures and 
treatments. One way to reduce livestock disease is to select animals that are genetically 
resistant, traditionally carried out through selective animal breeding programs; 
however, this is a time-consuming process and requires that appropriate genetic 
variation exists within the population. Advances in genome engineering technologies 
offer us an alternative approach, with the capability to make genetic improvements in 
livestock within a single generation.  
ASF is a re-emerging global threat to the swine industry. At present, there is no vaccine 
or treatment for ASF, and disease control relies on rapid diagnosis, quarantine and the 
mass slaughter of animals. Unlike the domestic pig, swine indigenous to Sub-Saharan 
Africa, such as the warthog, show no clinical signs of disease following infection with 
ASFV. A comparative study identified three functional polymorphisms in the porcine 
RELA hypothesised to underlie the difference in host response to ASFV. RELA 
encodes for NF-κB subunit, RelA. NF-κB, is an evolutionary conserved transcription 
factor family evolutionary which plays a vital role in upregulating immune and 
inflammatory responses, including many of the pro-inflammatory cytokines indicated 
in ASF pathology (Zhang et al., 2006, Gómez del Moral et al., 1999, Gómez-
Villamandos et al., 2013). The specific RELA polymorphisms identified alter potential 
phosphorylation sites within the C-terminal transactivation domain of RelA which 
have been found to modulate NF-κB transcriptional activity in vitro. In order to test 
this hypothesis, the Whitelaw group set out to investigate whether genome editing 
tools could be employed to engineer the RELA sequence of domestic pigs. When this 
project was initiated it was unknown whether the direct injection of editor mRNAs 




polymorphic region of porcine RELA and directly injected into pig zygotes for the 
production of RELA-edited animals  
The original aims of this thesis were to genotype pigs born following zygote injection 
with mRNAs encoding genome editors targeting RELA, to carry out phenotypic 
characterisation, and to subsequently define their response to African swine fever virus 
infection.  
6.2 Progress 
In Chapter 3, initial genotyping was completed and a specific set of editing events were 
selected for further characterisation. These editing events encoded for a RelA protein 
that lacked the final 60 amino acids of wild-type RelA. These missing residues encode 
the C-terminal region of the transactivation domain encompassing the entire TA1, 
which is conserved between mammalian species and thought to be responsible for 
mediating most of RelA’s transcriptional activity (O’Shea & Perkin., 2008, Mukherjee 
et al., 2013). To investigate the impact of altered RELA in vitro I used TNFα, a potent 
inducer of NF-κB, to stimulate fibroblasts isolated from skin biopsies and assessed 
their resultant transcriptional activity by quantifying the expression of several RelA-
dependent genes. As anticipated, fibroblasts containing only truncated RelA displayed 
a delay in upregulation of the genes examined, suggesting a reduced transcriptional 
activity. This included a gene that encodes for IκBα, which is known to be important 
for termination of TNFα induced NF-κB activation, providing a NF-κB negative 
feedback loop (Arenzana-Seisdedos et al., 1997, Chen et al., 2001, Huang & 
Miyamoto., 2001). I also observed higher induced expression levels of RelA-
dependent genes at later time-points in cells containing only truncated RelA, which 
may indicate a prolonged NF-κB activation as a consequence of delayed IκBα 
production. To investigate further, a RelA nuclear translocation assay was carried out 
which demonstrated that truncated RelA had an extended presence in the nucleus post-
induction compared to wild-type, again implying a prolonged period of NF-κB 
activation. During these experiments, I unexpectedly discovered that truncated RelA 
translocated to the nucleus with both delayed kinetics and at reduced total level at all 
time-points analysed post-TNFα stimulation. This work provides the first evidence 




transcriptional activity of the truncated form may in part be due to its reduced nuclear 
translocation. However, the current data  are difficult to interpret as we observe the 
confounding effects of altered translocation kinetics with the truncated transcription 
activation domain – the altered rate at which the truncated protein shuttles within the 
cell is likely to be influenced by its prior influence on basal cellular levels of a range 
of proteins which are regulated by NF-κB, including many which encode other NF-κB 
pathway components, such as TRAF2, A20, REL, NFKBIA, NFKBIE, NFKBIZ, 
NFKB1, NFKB2, RELB. Lower basal levels of in IκBα and C-Rel proteins were 
identified in fibroblasts homozygous for the RelA truncation compared to wild-type. 
In conclusion, I found that this truncation did alter the NF-κB signalling although clear 
understanding of the mechanisms was complicated by the complexity of the biological 
network. Gross phenotypic analysis of individuals revealed no defects associated with 
the modified animals, including histological analysis of the lymphoid tissues. 
Interestingly and unexpectedly, pigs homozygous for the RelA truncation were found 
to have significantly lower body weights compared to wild-type controls. 
In Chapter 4, I investigated how the altered NF-κB signalling identified in the edited 
animals would impact on their cytokine response when macrophages were challenged 
with ASFV in vitro. The dysregulation of gene transcription in ASFV infected 
macrophages has been demonstrated by many studies and is thought to be a major 
factor underlying the disease state (Powell et al., 1996, Gómez del Moral et al., 1999, 
Gil et al., 2008). I isolated macrophages from both edited and control pigs, carried out 
an ASFV infection in vitro, and observed whether there was any change in the 
expression profile of cytokines reported to be perturbed during ASFV infection. 
Differences were observed in the upregulation of ASF-associated cytokines in 
response to infection in RELA-edited cells. However, it was difficult to predict how 
these would impact on disease pathogenesis in vivo due to the complex nature of the 
immune response. An in vivo study was carried out to see if the changes identified in 
vitro translated to an altered clinical outcome for the RELA-edited pigs. Unfortunately, 
these pigs displayed similar clinical outcome to that of the wild-type controls. 
At the start of this study, genome editing in livestock was in its infancy, in fact the 




editing directly in zygotes (Lillico et al., 2013). Subsequent application of genetic 
engineering tools has allowed the introduction of these warthog RELA changes into 
the domestic pig RELA locus, producing live pigs with all three warthog SNPs (Lillico 
at el, 2016). In Chapter 5 of this thesis, I designed, tested and applied reagents to 
demonstrate how CRISPRs can be used to generate a precise change into the porcine 
RELA locus. I successfully introduced a single warthog SNP into Sus scrofa RELA 
locus. This SNP was previously found to be responsible for significantly reducing the 
NF-κB activity of warthog RelA compared to wild-type (Palgrave et al, 2011). 
Once made, interpreting the potential downstream effects of this change to the RelA 
protein will be complicated. The RelA subunit is the most abundant of the 
transcriptionally active subunit of the NF-κB transcription factor family, regulating 
expression of a plethora of genes in the majority of cell types (Schmitz & Baeuerle, 
1991). Moreover, the activation of NF-κB is typically the cell’s first response to 
potentially harmful stimuli and it in turn upregulates genes that mediate the activation 
of many other signalling pathways involved in immune and inflammatory response, 
cell survival response and cell proliferation. Thus, altering the NF-κB pathway will 
likely impacts on many intra- and inter-cellular biological networks. Furthermore, 
translating observations made in vitro to predict an outcome in tissues or at the level 
of the entire organism in vivo is extremely challenging due to the complexity of 
interactions within these biological systems. 
6.3 Alternative approaches with the aim of creating 
an ASF resilient domestic pig 
Variation between warthog and domestic pig RELA was identified by Palgrave et al 
(2011), using a candidate approach which aimed to identify genetic variation between 
these species that could potentially underlie their differing responses to ASFV 
infection. Since this initial study, significant progress has been made in identifying 
ASFV genes important in inducing pathogenesis in the domestic pig. Deletion of viral 
multigene families MGF360 and MGF530 has been shown to attenuate highly virulent 
isolates in the domestic pig (O’Donnell et al., 2015, Reis et al., 2016). The MGF360 
and MGF530. genes are known to be involved in inhibiting induction of IFNs in host 




encoding proteins are yet to be uncovered. Further research into understanding the 
targets and functions of the viral proteins encoded by MGF360/MGF530, may provide 
us with novel candidate genes to compare between the ASFV-tolerant-warthog and the 
highly susceptible domestic pig. Interestingly, RelA is also a known regulator of 
several IFNs (Hiscott et al., 1989, Sica et al., 1997).  
The majority of traits are polygenic, so it may be that the warthog’s apparent tolerance 
to ASFV infection is mediated by a composite of genetic differences between the 
immune system of the domestic pig and the warthog. In a recent genomic study, 
differences in the repertoire of immune-related genes in the domestic pig were 
identified in comparison with other mammals (Dawson et al., 2016). It would be 
interesting to extend this study to include the warthog genome, which may reveal 
differences in the immune systems genes and therefore the basis of their resistance to 
ASFV. 
A recent study has shown that genome editors can be successfully used to engineer 
pigs to be resistant to PRRSV (Whitworth et al., 2016, Burkard et al., 2017). This was 
achieved through CRISPR/Cas9 editing to delete part of the viral receptor, CD163, 
required for PRRSV entry. ASFV enters cells by either receptor-mediated endocytosis 
or through macropinocytosis (non-specific mechanism; Alcamí et al., 1990, Hernáez 
et al., 2016). Cellular receptors that mediate ASFV entry have not yet been identified.  
ASFV is known to be able enter numerous different cells types from a variety of 
species, but only swine monocytes/macrophages demonstrate robust viral replication 
(Alcamí et al., 1989, Alcamí et al., 1990, Carrascosa et al., 1999). This suggests that 
specific host factors in these cells are required for the ASFV production process. 
Recently, libraries of sgRNAs have been designed to efficiently generate loss-of-
function mutations in every protein-coding gene in the genomes of mice and humans 
(Koike-Yusa et al., 2014; Wang et al., 2014), enabling genome wide CRISPR-Cas9 
knockout (GeCKO) screens. This approach is proving to be an effective systematic 
approach to identify novel genes essential for various biological processes (Shalem et 
al., 2014, Koike-Yusa et al., 2014). A domestic pig GeCKO library is currently being 




genes that facilitate ASFV replication in swine monocyte/macrophage cells via 
positive and negative selection using a recombinant ASFV expressing GFP.  
Further investigation into the warthog RELA will continue with a planned challenge 
of the genome edited pigs reported by Lillico et al (2016) with ASFV.  
6.4 Obstacles to overcome with genetic engineering 
for livestock purposes 
Genome editing technologies have the potential to revolutionise agriculture. There is 
tremendous pressure on the livestock industry to increase the sustainability of 
production, while also enhancing animal welfare. Genetic improvement of livestock 
using editors has many benefits over selective breeding methods, as it permits; the 
fixation of alleles without any deleterious inbreeding effects; the introduction alleles 
that are not present in the population and; the desired genetic change can be 
implemented within one generation. Editors can be used to introduce genetic changes 
to remove alleles associated with deleterious traits and increase desirable alleles 
associated with favourable traits. However, the majority of traits are polygenic 
meaning that they are controlled by variation in multiple genes. Several studies have 
shown that CRISPR/Cas9 can be employed in a multiplex format (i.e. to 
simultaneously edit multiple genetic loci in the same cell) by co-introduction of 
multiple site-specific sgRNAs with or without repair templates, into zygotes of mice 
and pig (Wang et al., 2013., Wang et al., 2016). Other technical issues to overcome 
are off-targeting effects, genetic mosaicism and low HDR efficiency in using the 
CRISPR/Cas9 system in zygotes (see Section 5.4.2,4-5 for further discussion on these 
technical obstacles). 
Aside from the practical issues associated with the technical delivery and function of 
genome editors in vivo, an important component for the success of engineering of 
livestock genomes will be the discovery of genetic variants that underlie beneficial 
traits. Currently, many livestock breeding companies are collecting genomic data 
which when combined with advances in genomic analysis of allelic sequence variation 
may lead to an increased understanding of the genetics underlying desirable traits. 




quantitative trait loci, or haplotypes of SNPs that are associated with a specific trait. 
To date the largest region knocked in using CRISPR/Cas9 is a 200 kb region performed 
in mouse zygotes (Yoshimi et al., 2016). It may be possible to knock-in larger regions 
utilising editors alongside large templates delivered in either lentivirus or artificial 
chromosomes such as BACs and YAC.  
Another major obstacle for genome engineering in livestock is the acceptance of 
technology by society, regulators and breeding industries. Current regulations on the 
use of gene-editing (GE) technologies in food animal production are unclear. At 
present, the majority of legislation on GMOs for food consumption relates to crops 
rather than animals. In general, GM and GE plants are widely grown and accepted for 
human consumption. However, regulation varies internationally. Europe currently has 
one of the most restrictive regulations in place, with only a few GM crops authorised 
to be grown. In contrast with crops, the number of GMO animals that approved for 
human consumption is lagging. In 2015, AquAdvantage salmon, produced by insertion 
of a transgene, were the first GMO to be approved for human consumption by the FDA 
in the United States. However, the assessment process on this application lasted nearly 
10 years from first submission. The level of regulation on genome edited livestock has 
yet to be set in most countries. Uncertainties surrounding these regulations are 
restricting investment and thus development of GE technologies for commercial use. 
Less restrictive regulations on GMOs for food would encourage novel applications, 



























Appendix B: List of tissues collected in 




Submandibular lymph node 
Prescapular lymph node 
Popliteal lymph node 
Mesenteric lymph node 





Heart (right ventricle) 


















Appendix C: Lymph node scoring 
H&E stained sections of lymph nodes were examined by pathologist, Dr Pip Beard. 
Scores were assigned for the following; 1) whether the lymphoid nodules were 
distinctly demarcated from the surrounding parenchyma (catergoriesed into either 
distinct, indistinct or variable), 2) whether there were apoptotic cells in the lymphoid 
nodule (either yes or no) and 3) an estimate of the percentage of the lymph node cross 
section which consisted of cortical tissue. No significant difference was found in any 
of the scoring categories. 
  Submandibular lymph node 
Pig ID RELA Genotype lymphoid nodules apoptosis % cortical tissue 
258 Wild-type       
261 Wild-type indistinct yes 40 
262 Wild-type distinct yes 70 
268 Wild-type       
269 Wild-type       
271 Bi-allelic indistinct no 50 
275 Bi-allelic distinct yes 70 
276 Bi-allelic       
278 Bi-allelic distinct yes 70 
274 Heterozygous distinct yes 90 
223 Heterozygous variable yes 90 
214 Heterozygous distinct yes 70 
     
  Prescapular lymph node 
Pig ID RELA Genotype lymphoid nodules apoptosis % cortical tissue 
258 Wild-type distinct yes 80 
261 Wild-type       
262 Wild-type indistinct no 60 
268 Wild-type       
269 Wild-type distinct yes 20 
271 Bi-allelic       
275 Bi-allelic   yes 20 
276 Bi-allelic       
278 Bi-allelic indistinct no 50 
274 Heterozygous       
223 Heterozygous distinct yes 80 
214 Heterozygous indistinct no 80 




  Mediastinal lymph node 
Pig ID RELA Genotype lymphoid nodules apoptosis % cortical tissue 
258 Wild-type variable no 90 
261 Wild-type       
262 Wild-type       
268 Wild-type indistinct no 60 
269 Wild-type indistinct yes 80 
271 Bi-allelic       
275 Bi-allelic distinct yes 70 
276 Bi-allelic       
278 Bi-allelic distinct yes 70 
274 Heterozygous variable yes 60 
223 Heterozygous distinct yes 50 
214 Heterozygous indistinct no 50 
     
  Mesenteric lymph node 
Pig ID RELA Genotype lymphoid nodules apoptosis % cortical tissue 
258 Wild-type       
261 Wild-type indistinct no 90 
262 Wild-type       
268 Wild-type indistinct yes 90 
269 Wild-type indistinct yes 90 
271 Bi-allelic distinct yes 80 
275 Bi-allelic       
276 Bi-allelic variable yes 70 
278 Bi-allelic distinct yes 60 
274 Heterozygous distinct yes 80 
223 Heterozygous indistinct no 50 
214 Heterozygous indistinct no 70 





     
  Popliteal lymph node 
Pig ID RELA Genotype lymphoid nodules apoptosis % cortical tissue 
258 Wild-type indistinct yes 70 
261 Wild-type       
262 Wild-type indistinct yes 30 
268 Wild-type       
269 Wild-type distinct no 40 
271 Bi-allelic indistinct no 50 
275 Bi-allelic indistinct yes 60 
276 Bi-allelic       
278 Bi-allelic       
274 Heterozygous       
223 Heterozygous       






Appendix D: Clinical scoring guidelines 
 
ITEM Score Description 
Inappetence 0-6 
0: No abnormality 
1: MILD (reduced eating) 
4: MODERATE (only picking at food) 
6: SEVERE (not eating) 
Recumbence 0-6 
0: No abnormality 
1: MILD (lethargic) 
2: MODERATE (get up only when touched) 
4: MODERATE/SEVERE (slow to get up when touched) 
6: SEVERE (remain recumbent when touched) 
Skin hemorrhage/cyanosis 0-3 
0: No abnormality 
1: MILD (hemorrhagic areas on ears and body) 
3: MODERATE/SEVERE (generalised hemorrhage all over body) 
Joint swelling 0-4 
0: No abnormality 
1: MILD (joint swelling) 
4: SEVERE (joint swelling with difficulty walking) 
Laboured breathing and coughing 0-3 
0: No abnormality 
1: MILD  
3: SEVERE 
Ocular discharge 0-1 
0: No abnormality 
1: MILD (gummed up eyes) 
Diarrhoea 0-3 
0: No abnormality 
1: MILD  
3: SEVERE (bloody diarrhoea) 
Blood in Urine 0-4 
0: No abnormality 
4: Blood in Urine 
Vomiting 0-4 
0: No abnormality 
4: Vomiting 
Rectal temperature (°C) 0-5 
0: < 39 
1: 39.0 < to 39.5 
2: 39.5 ≤ to < 40 
3: 40.0 to ≤ 40.5 
4: 40.6 ≤ 41 






Appendix E: Macroscopic lesion scoring 
guidelines 
 
ITEM Score Description/Lesion 
External examination 
Body condition 0-4 0: Normal    4: Cachectic 
Eyes/conjunctiva 0-3 
1: Slight hyperaemia  
2: Hyperaemia, swelling of eyelids and clear ocular discharge 
3: Congested ocular mucosa with haemorrhages, inflamed eyelids 
and intense cloudy ocular discharge (gummed up eyes) 
Nostrils 0-3 
1: Moderate nasal discharge  
2: Intense mucosal nasal discharge 
3: Foam material in nostrils 
3: Nasal haemorrhages (epistaxis)/blood traces around nostrils 
Tonsils 0-3 
2: Erythema in tonsils  
3: Necrotic areas in tonsils 
Oral cavity 0-3 
3: Necrotic areas in tongue 
3: Foamy material in mouth 
Skin 0-6 
1: Areas with skin erythema (ears, flanks, abdomen) 
1: Cyanotic areas (tip of the ears or tail, distal limbs, chest and 
abdomen)  
3: Generalized reddening of the skin with haemorrhages all over 
body 
4: Varioliform skin eruptions 
4: Abscess 
5: Necrotic areas on skin/chronic skin ulcers 
6: Necrotic areas/chronic skin ulcers all over the body 
Subcutis 0-3 
2: Areas with subcutaneous oedema, haemorrhages and 
haematomas  
3: Generalized subcutaneous oedema, haemorrhages and 
haematomas all over the body 
Musculoskeletal system 
Skeletal muscle 0-3 
2: Areas with oedema/haemorrhages within the fascial planes 
3: Generalized oedema/haemorrhages within the fascial planes all 
over the body 
Joints 0-4 
3: Moderate joint swelling due to serofibrinous periarthritis/arthritis 




1: Moderate hydrothorax (with reddish fluid) 
2: Severe hydrothorax (with deep red fluid) 
3: Haemothorax 
Pericardium 0-3 
1: Moderate hydropericardium (with reddish fluid)  
2: Severe hydropericardium (with reddish fluid) 
3: Haemopericardium 
3: Fibrinous pericarditis 
Heart 0-3 
1: Petechial haemorrhages on epicardium 
2: Variable presence of petechial haemorrhages/ecchymoses on 
epicardium, myocardium and endocardium 
3: Haemorrhagic heart with extensive coalescent haemorrh 
(ecchymoses) on epicardium, myocardium and endocardium 
Lung (lack of) collapse 0-3 
1: Mild lack of collapse with no ribs impressions 
2: Moderate lack of collapse with mild or scarce ribs impressions 
3: Moderate to severe lack of collapse with apparent ribs 
impressions 
Congestion/haemorrhage 0-3 
1: Mild congestion or active hyperaemia, diffuse or patchy 
distributed in parenchyma. No haemorrhages 
2: Variable degree of congest. or active hyperaemia. Multifocal to 




3: Variable degree of congest/hyper. Multifocal to coalescent 
random and interlobul. distributed haemorrh (ecchymoses) 
Oedema (foam in trachea) 0-3 
1: Scarce or no presence of foamy material in trachea/bronchus 
(alveolar oedema) and minimal (interstitial oedema) 
2: Mild to moderate presence of foamy material in 
trachea/bronchus and moderate distension of interlobular walls 
3: Marked presence of foamy material in trachea/brochus and 
intense distension of interlobular walls 
Consolidation of pulmonar 
parenchyma 
0-4 
1: Minimal to mild cranio-ventral (uni/bilateral) consolidation 
(bronchopneumonia) 
2: Moderate cranio-ventral (uni/bilateral) consolidation 
(bronchopneumonia) 
3: Marked-extended cranio-ventral (uni/bilateral) consolidation 
bronchopneum.(with red and grey hepatization of lobules) 
4: Necrotic pneumonia 
4: Purulent lesions 








1: Petechiae on serosa surface 
2: Petechiae/ecchymoses on serosa surface 
3: Petechiae/ecchymoses on serosa & haemorrhages on mucosa 
surface 
4: Necrotic areas/ulcers 
Duodenum 0-4 
1: Petechiae on serosa surface 
2: Petechiae/ecchymoses on serosa surface 
4: Petechiae/ecchymoses on serosa & haemorrhages on mucosa 
surface 
4: Necrotic areas/ulcers 
Jejunum 0-4 
Ileum 0-4 





1: Mild multifocal parenchymatous  colour changes with slight 
hepatomegaly 
2: Hepatomegaly, moderate congestion and presence multifocal 
punctiform redness areas/haemorrhages 
3: Hepatomegaly, intense congestion and presence of coalescent 
punctiform redness areas/ haemorrhages 
Gallbladder 0-4 
1: Mild to moderate oedema affecting gallbladder wall/cystic duct 
2: Oedema affecting gallbladder wall/cystic duct with haemorrhages 
on serosa/submucosa surface 
3: Intense oedema affecting gallbladder wall/cystic duct with severe 
haemorrhages on ser/subm surface and blood clots 
4: Necrotic areas/ulcers 
Urinary system 
Kidney 0-1 1: Perirrenal oedema 
Parenchymal kidney hemmorhages 
(cortico-medular) 
0-3 1: Mild multifocal cortical and medullar petechiae with multifocal 
vascular angiectasia 
2: Moderate multifocal cortical (petechiae) and medullar (purpurae) 
haemorrhages with moderate pelvic dilation 
3: Marked diffuse cor-med haemo. with diffuse general renal 
darkness, marked pelvic dilation and extens. subcapsul haemo 
Parenchymal kidney hemmorhages 
(medulo-cortical) 
0-3 1: Minimal to mild multifocal cortical and medullar petechiae 
2: Moderate multifocal cortical and medullar haemorrhages 
(petechiae) with preponderance of cortical affectation 
3: Marked multif. cor-med petechiae with preponder. of cortical 
affectation with/without multif. moderate pelvic purpurae 
Urinary Bladder 
0-3 1: Mild multifocal petechiae on mucosa surface without/with mild 
colour changes in urinary bladder wall 
2: Multifocal petechiae and ecchymoses on mucosa, submucosa and 
serosa with oedema in urinary bladder wall 
3: Coalescent haemo. on muc. Subm. and ser. with intense oedem. 






0-4 1: Mild hyperemic splenomegaly (minimal to mild bleeding after 
sectioning) 
2: Moderate/partial hyperemic splenomegaly (moderate bleeding 
after sectioning) 
3: Intense hyperemic splenomegaly (marked bleeding after 
sectioning) 
3: Focal necrosis/infarcts 
4: Hyperplasic splenomegaly (no bleeding after 
sectioning)/cicatrization of partial hyperemic splenomegaly 
Submandibular lymph node 0-3 1: Increased size and edematous with moderate colour changes 
2: Increased size, edematous and haemorrhagic 
3: Increased size, edematous and completely haemorrhagic similar 
to a blood clot 
4: Hyperplasia without haemorrhagic changes/with occasional 
peripheral haemorrhages 
Retropharingeal lymph node 0-3 
Tracheobronchial lymph node 0-3 
Gastrohepatic lymph node 0-3 
Renal lymph node 0-3 
Mesenteric lymph node 0-3 
Thymus 
0-2 1: Moderate colour changes with occasional petechiae 
2: Petechiae and ecchymoses 
 
Endochrine system 
Thyroid gland 0-1 1: Increased size/haemorrhages  
Adrenal gland 0-1 
Pancreas 0-1 
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